Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 424
Encontrada(s) 5 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Relationship between the risk of gastric cancer and adherence to the mediterranean diet according to different estimators. MCC—Spain Study

  • Álvarez Álvarez, Laura
  • Vitelli Storelli, Facundo Ezequiel
  • Rubín García, María
  • Aragonés, Nuria
  • Ardanaz, Eva
  • Castaño Vinyals, Gemma
  • Obón Santacana, Mireia
  • Dierssen Sotos, Trinidad
  • Salas Trejo, Dolores
  • Tardón, Adonina
  • Jiménez Moleon, José Juan
  • Alguacil, Juan
  • Chirlaque, María Dolores
  • Perez Gomez, Beatriz
  • Pollán, Marina
  • Kogevinas, Manolis
  • Martín Sánchez, Vicente
[EN]The aim was to assess the effect of adherence to the Mediterranean Diet, measured with five different indexes, on the risk of gastric cancer. Data come from the multicase-control study MCC—Spain, which included 354 gastric cancer cases and 3040 controls with data on diet. We used five indexes to evaluate adherence to the Mediterranean diet and assess the association between each pattern with the risk of gastric cancer, using multivariate logistic regression. The analyses were performed for the whole set of gastric cancer cases, by anatomical location (cardia and noncardia) and by histological type (intestinal and diffuse). According to the used index, a high adherence protects one from gastric cancer (between 48% (aOR = 0.52; CI 95% = 0.28–0.94) and 75% (aOR = 0.25; CI 95% = 0.12–0.52)), fromnon-cardia (between 48%(aOR = 0.52; CI 95% = 0.36–0.75) and 65% (aOR = 0.35; CI 95% = 0.23–0.52)), and from the intestinal type (between 41% (aOR = 0.59; CI 95% = 0.36–0.95) and 72% (aOR = 0.28; CI 95% = 0.16–0.50)), but not from the diffuse type. In conclusion, high adherence to a Mediterranean diet pattern is a protective factor for the risk of gastric cancer, with greater adherence leading to greater protection., SI, The study was partially funded by the “Accion Transversal del Cancer”, approved on the Spanish Ministry Council on 11 October 2007; by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773-Cantabria, PS09/01286-León, PS09/01903-Valencia, PS09/02078- Huelva, PS09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032, PI17CIII/00034); by the Fundación Marqués de Valdecilla (API 10/09); by the ICGC International Cancer Genome Consortium CLL (the ICGC CLL-Genome Project is funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII (RD12/0036/0036)); by the Junta de Castilla y León (LE22A10-2); by the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra); by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10); by the Recercaixa (2010ACUP 00310); by the Regional Government of the Basque Country; by the Consejería de Sanidad de la Región de Murcia; by the European Commission grants FOOD-CT-2006-036224-HIWATE; by the Spanish Association Against Cancer (AECC) Scientific Foundation—grant GCTRA18022MORE; by the Catalan Government—Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723 and 2014SGR850; by the Fundación Caja de Ahorros de Asturias; and by the University of Oviedo. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. M Obón-Santacana received a post-doctoral fellowship from the Spanish Association Against Cancer (AECC) Scientific Foundation. M Obón-Santacana is part of group 55 of CIBERESP and AGAUR 2017SGR723. M. R-G. is supported by the Ministry of Education of Spain (FPU17/06488).
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

The β-amyloid peptide compromises Reelin signaling in Alzheimer’s disease

  • Cuchillo Ibáñez, Inmaculada
  • Mata Balaguer, Trinidad
  • Balmaceda, Valeria
  • Arranz Santos, Juan José
  • Nimpf, Johannes
  • Sáez Valero, Javier
[EN] Reelin is a signaling protein that plays a crucial role in synaptic function, which expression is influenced by β-amyloid (Aβ). We show that Reelin and Aβ oligomers co-immunoprecipitated in human brain extracts and were present in the same size-exclusion chromatography fractions. Aβ treatment of cells led to increase expression of Reelin, but secreted Reelin results trapped together with Aβ aggregates. In frontal cortex extracts an increase in Reelin mRNA, and in soluble and insoluble (guanidine-extractable) Reelin protein, was associated with late Braak stages of Alzheimer's disease (AD), while expression of its receptor, ApoER2, did not change. However, Reelin-dependent induction of Dab1 phosphorylation appeared reduced in AD. In cells, Aβ reduced the capacity of Reelin to induce internalization of biotinylated ApoER2 and ApoER2 processing. Soluble proteolytic fragments of ApoER2 generated after Reelin binding can be detected in cerebrospinal fluid (CSF). Quantification of these soluble fragments in CSF could be a tool to evaluate the efficiency of Reelin signaling in the brain. These CSF-ApoER2 fragments correlated with Reelin levels only in control subjects, not in AD, where these fragments diminished. We conclude that while Reelin expression is enhanced in the Alzheimer's brain, the interaction of Reelin with Aβ hinders its biological activity, SI, We thank Prof. T. Curran (Eppley Institute, University of Nebraska Medical Center, Omaha, USA) for generously providing cDNAs, and Drs M. Calero (CIBERNED, Spain) and José-Manuel Mingot (Inst. Neurociencias, Universidad Miguel Hernández-CSIC, Spain) for technical advice. This work was supported by grants from the Fundación Ramón Areces, Fondo de Investigaciones Sanitarias (PI11/03026; PI12/00593; PI15/00665 cofunded by the Fondo Europeo de Desarrollo Regional), and under the aegis of the EU BIOMARKAPD-Joint Programming on Neurodegenerative Diseases (JPND) project; and through CIBERNED (Instituto de Salud Carlos III, Spain). VB was supported by a JAE-Predoctoral fellowship from the CSIC (Spain), co-funded by the Fondo Social Europeo (FSE), E.C.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Residential proximity to industrial pollution sources and colorectal cancer risk: A multicase-control study (MCC-Spain)

  • García Pérez, Javier
  • Fernández de Larrea Baz, Nerea
  • Lope, Virginia
  • Molina de la Torre, Antonio José
  • O’Callaghan Gordo, Cristina
  • Alonso, María Henar
  • Rodríguez Suárez, Marta María
  • Mirón Pozo, Benito
  • Alguacil, Juan
  • Gómez Acebo, Inés
  • Ascunce, Nieves
  • Vanaclocha Espí, Mercedes
  • Amiano, Pilar
  • Chirlaque, María Dolores
  • Simó, Vicente
  • Jiménez Moleon, José Juan
  • Tardón, Adonina
  • Moreno, Víctor
  • Castaño Vinyals, Gemma
  • Martín Sánchez, Vicente
  • Aragonés, Nuria
  • Pérez Gómez, Beatriz
  • Kogevinas, Manolis
  • Pollán, Marina
[EN] Background: Colorectal cancer is the third most frequent tumor in males and the second in females worldwide. In Spain, it is an important and growing health problem, and epidemiologic research focused on potential risk factors, such as environmental exposures, is necessary. Objectives: To analyze the association between colorectal cancer risk and residential proximity to industries, according to pollution discharge route, industrial groups, categories of carcinogens and other toxic substances, and specific pollutants released, in the context of a population-based multicase-control study of incident cancer carried out in Spain (MCC-Spain). Methods: MCC-Spain included 557 colorectal cancer cases and 2948 controls in 11 provinces, frequency matched by sex, age, and region of residence. Distances were computed from subjects’ residences to each of the 134 industries located in the study area. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (95%CIs) for categories of distance (from 1 km to 3 km) to industrial facilities, adjusting for matching variables and other confounders. Results: Excess risk (OR; 95%CI) of colorectal cancer was detected near industries overall for all distances analyzed, from 1 km (2.03; 1.44–2.87) to 3 km (1.26; 1.00–1.59). In general, industries releasing pollutants to air showed higher excess risks than facilities releasing pollution to water. By industrial sector, excess risk (OR; 95%CI) was found near (≤3 km) production of metals (2.66; 1.77–4.00), surface treatment of metals (1.48; 1.08–2.02), glass and mineral fibers (2.06; 1.39–3.07), organic chemical industry (4.80; 3.20–7.20), inorganic chemical industry (6.74; 4.38–10.36), food/beverage sector (3.34; 2.38–4.68), and surface treatment using organic solvents (6.16; 4.06–9.36). By pollutants, the main excess risks (OR; 95%CI) were found near (≤3 km) industries releasing nonylphenol (9.19; 5.91–14.28), antimony (5.30; 3.45–8.15), naphthalene (3.11; 2.16–4.49), organotin compounds (2.64; 1.76–3.98), manganese (2.53; 1.63–3.93), dichloromethane (2.52; 1.74–3.66), and vanadium (2.49; 1.59–3.91). Conclusions: Our results support the hypothesis that residing in the proximity of industries may be a risk factor for colorectal cancer, SI, The authors thank all those who took part in this study providing questionnaire data. This study was funded by: Scientific Foundation of the Spanish Association Against Cancer (Fundación Científica de la Asociación Española Contra el Cáncer (AECC) – EVP-1178/14); “Acción Transversal del Cáncer”, approved on the Spanish Ministry Council on the 11th October 2007; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP); Spain's Health Research Fund (Fondo de Investigación Sanitaria - FIS 12/01416); Carlos III Institute of Health (ISCIII) grants, cofunded by ERDF funds–a way to build Europe– (grants PI08/0533, PI08/1359, PI08/1770, PS09/00773- Cantabria, PS09/01286-Leon, PS09/01662-Granada, PS09/01903- Valencia, PS09/02078-Huelva, PI11/00226, PI11/01403, PI11/01810, PI11/01889-FEDER, PI11/02213, PI12/00150, PI12/00265, PI12/ 00488, PI12/00715, PI12/01270, PI14/00613, PI14/01219, PI15/ 00069, PI15/00914, PI15/01032, PI17-00092); the Fundación Marqués de Valdecilla (API 10/09); the Fundación Caja de Ahorros de Asturias; the University of Oviedo; the Junta de Castilla y León (LE22A10-2); the Regional Government of the Basque Country; the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10); the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra); the Catalan Government DURSI grant 2014SGR647; the European Commission grants FOOD-CT-2006- 036224-HIWATE; the Recercaixa (2010ACUP 00310); Agency for Management of University and Research Grants (AGAUR) of the Catalan Government grant 2017SGR723; and the Spanish Association Against Cancer (AECC) Scientific Foundation. ISGlobal is a member of the CERCA Program, Generalitat de Catalunya
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Lifetime Swimming Pool Attendance and Cancer Risk: Findings from the Multicase-Control Study in Spain (MCC-Spain)

  • Donat Vargas, Carolina
  • Vallbona Vistós, Miquel
  • Castaño Vinyals, Gemma
  • Moreno González, Víctor
  • Aragonés, Nuria
  • Boldo, Elena
  • Molina de la Torre, Antonio José
  • Gómez Acebo, Inés
  • Guevara, Marcela
  • Jiménez Zabala, Ana
  • Amiano, Pilar
  • Molina Barceló, Ana
  • Fernández Tardón, Guillermo
  • Chirlaque, María Dolores
  • Pollán, Marina
  • Kogevinas, Manolis
  • Villanueva, Cristina M.
[EN] Swimming in pools involves inhalation and skin absorption of potential carcinogenic disinfection byproducts (DBPs) as well as physical activity, which is protective for some cancer sites. We evaluated the association between lifetime pool attendance and the risk of breast, colorectal, and prostate cancer in a multicase-control study that recruited 4,941 hospital-based cancer cases (1,724 breast, 2,111 colorectal, 1,106 prostate) and 4,039 population-based controls in Spain (2008–2013). Lifetime swimming pool attendance in summer (as a surrogate of outdoor pools) and the rest of the year (as a surrogate of indoor pools), socio-demographics, and lifestyle were ascertained in face-to-face interviews. Cancer risk associated with pool attendance markers was estimated using linear mixed-effect models, adjusting for covariates with recruitment area as a random effect. Participants reporting lifetime pool attendance compared to those who did not showed lower odds of breast and colorectal cancer (approximately 5% lower risk). Swimming more than 10 times/month did not increase the protective association. For breast and colorectal cancer, only pool attendance outside the summer months was associated with a lower risk, whereas it was associated with increased prostate cancer risk. Findings suggest that lifetime swimming in pools may reduce breast cancer and colorectal cancer risk despite DBP exposure. These novel findings require replication, SI, The study was partially funded by the \u201CAccion Transversal del Cancer\u201D, approved by the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773, PS09/01286, PS09/01903, PS09/02078, PS09/01662, PI11/01889, PI11/00226, PI12/01270, PI12/00715, PI14/0613, PI15/00914, PI17CIII/00034), by the Fundacio\u0301n Marque\u0301s de Valdecilla (API 10/09), by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10), by the European Commission grants FOOD-CT-2006-036224-HIWATE, by the Spanish Association Against Cancer (AECC) Scientific Foundation, by the Catalan Government-Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723 and 2014SGR850, and by the Fundacio\u0301n Caja de Ahorros de Asturias and by the University of Oviedo. We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033 and support from the Generalitat de Catalunya through the CERCA Program
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Human Bone Marrow Stromal Cells Differentiate into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice

  • Sánchez Abarca, Luis Ignacio
  • Hernández Galilea, Emiliano
  • Lorenzo, Rebeca
  • Herrero, Carmen
  • Velasco, Almudena
  • Carrancio, Soraya
  • Caballero Velázquez, Teresa
  • Rodríguez Barbosa, José Ignacio
  • Parrilla, Marta
  • Cañizo, Consuelo del
  • San Miguel, Jesús
  • Aijón, José
  • Pérez Simón, José Antonio
[EN] Clinical trials have assessed the use of human bone marrow stromal cells (hBMSCs) for the treatment of immune-related disorders such as graft-versus-host disease (GVHD). In the current study, we show that GFP+-transduced hBMSCs generated from bone marrow migrate and differentiate into corneal tissue after subconjunctival injection in mice. Interestingly, these hBMSCs display morphological features of epithelial, stromal, and endothelial cells and appear at different layers and with different morphologies epending on their position within the epithelium. Furthermore, these cells display ultrastructural properties, such as bundles of intermediate filaments, interdigitations, and desmosomes with GFP− cells, which confirms their differentiation into corneal tissues. GFP+-transduced hBMSCs were injected at different time points into the right eye of lethally irradiated mice undergoing bone marrow transplantation, which developed ocular GVHD (oGVHD). Remarkably, hBMSCs massively migrate to corneal tissues after subconjunctival injection. Both macroscopic and histopathological examination showed minimal or no evidence of GVHD in the right eye, while the left eye, where no hBMSCs were injected, displayed features of GVHD. Thus, in the current study, we confirm that hBMSCs may induce their therapeutic effect at least in part by differentiation and regeneration of damaged tissues in the host. Our results provide experimental evidence that hBMSCs represent a potential cellular therapy to attenuate oGVHD, SI, The authors would like to thank Didier Trono for pWPI vector plasmid. Teresa Caballero was supported by a Rio Hortega grant (code: CM10/00161) from Instituto de Salud Carlos III. We thank R. Sánchez and M. T. Sánchez for their technical assistance. We would like to thank Dr. Anton Martens, from the University Medical Center Utrecht, for providing the vectors for GFP assays. This study was partially supported by grants from FIS (PI11/02366 and PI12/00939) and Junta de Castilla y León (GR 183). The authors declare no conflicts of interest
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Genome-wide interaction analysis of long-term trihalomethane exposure in drinking water and colorectal cancer risk in a Spanish Multicenter Case-Control Study (MCC-Spain)

  • Moratalla Navarro, Ferrán
  • Obón Santacana, Mireia
  • Rius Sansalvador, Blanca
  • Guinó, Elisabet
  • Moragas, Núria
  • Donat Vargas, Carolina
  • Larrea Baz, Nerea Fernández de
  • Molina Barceló, Ana
  • Guevara, Marcela
  • Morón Duran, Francisco D.
  • Dierssen Sotos, Trinidad
  • Tardón, Adonina
  • Castaño Vinyals, Gemma
  • Cabrera Castro, Natalia
  • Molina de la Torre, Antonio José
  • Aizpurua, Amaia
  • Morales Suarez Varela, María M.
  • Martín Sánchez, Vicente
  • Fernández Navarro, Pablo
  • Villanueva, Cristina M.
  • Moreno, Victor
[EN] We conducted a genome-wide interaction analysis between long-term exposure to trihalomethanes in drinking water and colorectal cancer (CRC) risk in a multicenter case-control study in Spain, including 1037 CRC cases and 2100 controls. Exposure categories were estimated based on sex-specific median and quartile values of total trihalomethanes (TTHM), chloroform (CHCl3), and brominated trihalomethanes (Br-THMs) among controls. In addition, TTHM exposure was assessed relative to the WHO guideline thresholds. Gene-environment interaction models were computed with the GxEScanR package. To explore biological plausibility, relevant results were inspected in search of expression quantitative trait loci (eQTLs) in two independent resources: BarcUVaSeq and the Genome Tissue Expression (GTEx) v8. Finally, we searched the Comparative Toxicogenomics Database to identify candidate genes previously linked to trihalomethane exposure, retrieved their eQTLs, and evaluated gene-environment interactions with TTHM levels. We found three variants that modulated CRC risk in relation to CHCl3 and TTHM exposure: rs77985109 near LRRC8B, chr15:28997737 near WHAMMP2, and rs7890183 near MAGEB2. Two additional variants were specifically found for women and one for rectal cancer. Functional assessment suggested a regulatory role of rs77985109 in LRRC8B expression. Moreover, eQTL analysis of candidate genes revealed an additional variant associated with CCL2 which could modulate CRC risk under different TTHM exposure levels. The present study identified novel loci potentially influencing CRC susceptibility under THM exposure, highlighting the importance of integrating environmental and genetic data to better understand environmental driven cancer risks. Further research is needed to confirm these results and clarify underlying mechanisms., SI, Funding This work was partially supported by Programa FORTALECE del Ministerio de Ciencia e Innovacion´ ”, through the project number FORT23/00032; Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) action Genrisk; DISCERN HORIZON-MISS-2021-CANCER-02–03 101096888; Instituto de Salud Carlos III–FEDER [PI08/1770, PI08/0533, PI08/1359, PI09/00773-Cantabria, PI09/01286-Leon, ´ PI09/01903-Valencia, PI09/ 02078-Huelva, PI09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/ 00069, PI15/00914, PI15/01032, PI17CIII/00034]; CIBERESP [CB06/ 02/0073]; Fundacion ´ Marqu´es de Valdecilla [API 10/09]; the Junta de Castilla y Leon ´ [LE22A10-2]; Conselleria de Sanitat of the Generalitat Valenciana [AP_061/10]; Recercaixa [2010ACUP 00310]; Regional Government of the Basque Country; Consejería de Sanidad of the Regi´ on de Murcia; the European Commission [FOOD-CT-2006–036224-HIWATE]; Fundacion ´ Caja de Ahorros de Asturias; and the University of Oviedo;. BR-S received a pre-doctoral grant from Instituto de Salud Carlos III − grant PFIS FI21/00056 (co-founded by the European Union). Sample collection of this work was supported by the Plataforma Biobancos (PT17/0015/0024) and ICOBIOBANC, sponsored by the Catalan Institute of Oncology. We thank CERCA Programme, Generalitat de Catalunya for institutional support.
Docta Complutense
Publication Artículo científico (JournalArticle)

Clinical, cognitive, and neuroimaging evidence of a neurodevelopmental continuum in offspring of probands with schizophrenia and bipolar disorder

  • Sugranyes, Gisela
  • Serna, Elena de la
  • Borras, Roger
  • Sanchez Gistau, Vanessa
  • Pariente, Jose C.
  • Romero, Soledad
  • Baeza, Inmaculada
  • Martínez Díaz-Caneja, María Covadonga
  • Rodríguez Toscano, Elisa
  • Moreno Ruiz, María del Carmen
  • Bernardo, Miguel
  • Moreno Pardillo, Dolores María
  • Vieta, Eduard
  • Castro Fornieles, Josefina
Background: Studies in child and adolescent offspring of patients with schizophrenia or bipolar disorders may help understand the influence of neurodevelopmental factors on the premorbid phenotype of these disorders. Aims: To assess whether a combination of neurodevelopmental factors discriminates between young offspring of patients with schizophrenia (SzO) or bipolar disorder (BpO) and community controls (CcO). To assess the association between these factors and rates of psychiatric diagnoses in high risk (HR) youth. Methods: One hundred thirty-three HR offspring (47 SzO and 86 BpO) and 84 CcO, aged 6–17, underwent cross-sectional clinical, neurocognitive, and structural neuroimaging assessment. Information on perinatal events and early childhood development was also obtained. General linear mixed models were performed to assess group discrimination and association with lifetime axis I psychiatric disorders. Results: Multivariate analyses revealed that greater neurological soft signs (NSS), less total grey matter volume (GMV) and a higher frequency of obstetric complications discriminated HR offspring from CcO. When comparing each group individually, greater NSS and a higher frequency of obstetric complications discriminated SzO from CcO, and BpO from CcO, while lower intelligence also discriminated SzO from CcO and from BpO. Within HR offspring, lower intelligence and less total GMV were associated with lifetime incidence of psychiatric disorders. Conclusions: Both SzO and BpO showed evidence of neurodevelopmental insult, although this may have a greater impact in SzO. Lower intelligence and less total GMV hold potential as biomarkers of risk for psychiatric disorders in HR youth.
Docta Complutense
Publication Artículo científico (JournalArticle)

Hemodiafiltration with endogenous reinfusion improved microinflammation and endothelial damage compared with online-hemodiafiltration: a hypothesis generating study

  • Esquivias Motta, Elvira
  • Martín Malo, Alejandro
  • Buendía, Paula
  • Álvarez Lara, María A.
  • Soriano, Sagrario
  • Crespo, Rodolfo
  • Carracedo Añón, Julia María
  • Ramírez, Rafael
  • Aljama, Pedro
Hemodiafiltration with endogenous reinfusion (HFR) after ultrafiltrate passage through a resin cartridge combines adsorption, convection, and diffusion. Our prospective single-center crossover study compared HFR and online-hemodiafiltration (OLHDF) effects on two uremic toxins and 13 inflammatory, endothelial status, or oxidative stress markers. After an 8-week run-in period of high-flux hemodialysis, 17 eligible stable dialysis patients (median age 65 years, 10 male) without overt clinical inflammation were scheduled for four 8-week periods in the sequence: HFR/OLHDF/HFR/OLHDF. Relative to OLHDF, HFR was associated with greater indoxyl sulfate removal and lesser abnormalities in all other study variables, namely circulating interleukin-6, tumor necrosis factor-alpha, proportions of activated proinflammatory (CD14+CD16+, CD14++CD16+) monocytes, endothelial progenitor cells, apoptotic endothelial microparticles, vascular endothelial growth factor, vascular cellular adhesion molecule, angiopoietins 2 and 1, annexin V, and superoxide dismutase. Differences were significant (P < 0.05) in median values of 13/15 variables. Study period comparisons were generally consistent with dialysis technique comparisons, as were data from the subgroup completing all study periods (n = 9). Our investigation provides hypothesis-generating results suggesting that compared with OLHDF, HFR improves protein-bound toxin removal, inflammatory and endothelial status, and oxidative stress.
Docta Complutense
Publication Artículo científico (JournalArticle)

Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.

  • Rúa-Figueroa I
  • López Longo, Francisco Javier
  • Del Campo V
  • Galindo Izquierdo, María
  • Uriarte E
  • Torre-Cisneros J
  • Vela P
  • Tomero E
  • Narváez J
  • Olivé A
  • Freire M
  • Salgado E
  • Andreu JL
  • Martínez-Taboada V
  • Calvo-Alén J
  • Hernández-Cruz B
  • Raya E
  • Quevedo V
  • Expósito Pérez L
  • Fernández-Nebro A
  • Ibañez M
  • Pascual-Valls È
  • Rúa-Figueroa D
  • Naranjo A
  • Pego-Reigosa JM
Objective: To describe the incidence of bacteremia in a large multicentric cohort of patients with systemic lupus erythematosus (SLE) and their clinical characteristics and to identify risk factors. Methods: All bacteremic episodes from the Spanish RELESSER registry were included. Clinical and laboratory characteristics concerning bacteremia and SLE status, as well as comorbidities at the time of infection, were retrospectively collected. A comparison with sex- and age-matched SLE controls without bacteremia was made. A logistic regression was conducted. Results: The study included 114 episodes of bacteremia in 83 patients. The incidence rate was 2.7/1000 patient-years. At the time of bacteremia, the median age was 40.5 (range: 8-90) years, and 88.6% of patients were female. The Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index was 4 [interquartile range (IQR) 8]; 41% had an SLE flare (66% severe); Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index was 3 (IQR 4). A comorbidity was recorded in 64% of cases. At the time of bacteremia, 88.6% received corticosteroids (68.6% > 10 mg/day) and 57% immunosuppressors. Gram-negative bacilli, most frequently Escherichia coli (29.8%), caused 52.6% of the episodes. The bacteremia-related mortality was 14% and bacteremia was recurrent in 27.2% of cases. A dose-response relationship was found between corticosteroids and bacteremia risk. In the multivariate analysis, these factors were associated with bacteremia: elevated creatinine (OR 1.31, 95% CI 1.01-1.70; p = 0.045), diabetes (OR 6.01, 95% CI 2.26-15.95; p < 0.001), cancer (OR 5.32, 95% CI 2.23-12.70; p < 0.001), immunosuppressors (OR 6.35, 95% CI 3.42-11.77; p < 0.001), and damage (OR 1.65, 95% CI 1.31-2.09; p < 0.001). Conclusion: Bacteremia occurred mostly in patients with active SLE and was frequently associated with severe flares and corticosteroid use. Recurrence and mortality were high. Immunosuppressors, comorbidities, and disease-related damage were associated with bacteremia.
Docta Complutense
Publication Artículo científico (JournalArticle)

Microparticles released by vascular endothelial cells increase hypoxia inducible factor expression in human proximal tubular HK-2 cells

  • Fernández Martínez, Ana Belén
  • Valdehita Torija, Ana
  • Carracedo Añón, Julia María
  • Ramírez, Rafael
  • Lucio Cazaña, Francisco Javier de
Microparticles are produced by vesiculation of the cell plasma membrane and serve as vectors of cell-to-cell communication. Co-culture experiments have shown that hypoxia-inducible factor-α (HIF-α)-regulated-genes are up-regulated in human renal proximal tubular HK-2 cells by endothelial cell factors which might be transported inside endothelial microparticles (EMP). Here we aimed to study in HK-2 cells the effect of EMP, produced by activated endothelial cells, on HIF-α and HIF-α-regulated vascular endothelial growth factor-A (VEGF-A). EMP, at a concentration much lower than that found in plasma, increased the expression of HIF-α/VEGF-A in a COX-2/EP2 receptor dependent manner. Since the EMP/cells ratio was ∼1/1000, we hypothesized that paracrine mediators produced by HK-2 cells amplified the initial signal. This hypothesis was confirmed by two facts which also suggested that the mediators were conveyed by particles released by HK-2 cells: (i) HIF-α was up-regulated in HK-2 cells treated with the pellet obtained from the conditioned medium of the EMP-treated HK-2 cells. (ii) In transwell experiments, EMP-treated cells increased the expression of HIF-α in untreated HK-2 cells. Interestingly, we detected these cells, particles that were released by EMP-treated HK-2 cells. Depending on the pathological context, activation of HIF-α and VEGF-A signaling in renal tissue/cells may have either beneficial or harmful effects. Therefore, our results suggest that their presence in the urinary space of EMP produced by activated endothelial cells may influence the outcome of a number of renal diseases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genetic Variants at the 9p21.3 Locus Are Associated with Risk for Non-Compressible Artery Disease, Results from the ARTPER Study

  • Via, Marc|||0000-0002-9966-9921
  • Pera, Guillem|||0000-0003-3188-7268
  • Forés Raurell, Rosa|||0000-0001-7803-7442
  • Costa-Garrido, Anna|||0000-0001-5428-1408
  • Heras, Antonio|||0000-0001-8132-6712
  • Baena Díez, José Miguel
  • Pedrosa, Edurne
  • Clemente, Inmaculada C.
  • Lamonja-Vicente, Noemí|||0000-0003-1342-1130
  • Mataró, M.
  • Torán-Monserrat, Pere|||0000-0002-9865-7427
  • Alzamora, M. Teresa|||0000-0002-0094-6547
Peripheral artery disease (PAD) and non-compressible artery disease (NCAD) constitute predictors of subclinical atherosclerosis easily assessed through the ankle brachial index (ABI). Although both diseases show substantial genetic influences, few genetic association studies have focused on the ABI and PAD, and none have focused on NCAD. To overcome these limitations, we assessed the role of several candidate genes on the ABI, both in its continuous distribution and in the clinical manifestations associated to its extreme values: PAD and NCAD. We examined 13 candidate genomic regions in 1606 participants from the ARTPER study, a prospective population-based cohort, with the ABI assessed through ultrasonography. Association analyses were conducted independently for individuals with PAD (ABI < 0.9) or with NCAD (ABI.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma

  • Mariñas-Pardo, Luis
  • Mirones, Isabel
  • Amor-Carro, Oscar|||0009-0009-0696-5739
  • Fraga-Iriso, Rebeca
  • Lema-Costa, Beatriz
  • Cubillo, Isabel María
  • Rodríguez Milla, Miguel Ángel
  • García-Castro, Javier
  • Ramos-Barbón, David|||0000-0002-9615-6557
Background Mesenchymal stem cells may offer therapeutic potential for asthma due to their immunomodulatory properties and host tolerability, yet prior evidence suggests that bloodborne progenitor cells may participate in airway remodeling. Here, we tested whether mesenchymal stem cells administered as anti-inflammatory therapy may favor airway remodeling and therefore be detrimental. Methods Adipose tissue-derived mesenchymal stem cells were retrovirally transduced to express green fluorescent protein and intravenously injected into mice with established experimental asthma induced by repeat intranasal house dust mite extract. Controls were house dust mite-instilled animals receiving intravenous vehicle or phosphate-buffered saline-instilled animals receiving mesenchymal stem cells. Data on lung function, airway inflammation, and remodeling were collected at 72 h after injection or after 2 weeks of additional intranasal challenge. Results The mesenchymal stem cells homed to the lungs and rapidly downregulated airway inflammation in association with raised T-helper-1 lung cytokines, but such effect declined under sustained allergen challenge despite a persistent presence of mesenchymal stem cells. Conversely, airway hyperresponsiveness and contractile tissue underwent a late reduction regardless of continuous pathogenic stimuli and inflammatory rebound. Tracking of green fluorescent protein did not show mesenchymal stem cell integration or differentiation in airway wall tissues. Conclusions Therapeutic mesenchymal stem cell infusion in murine experimental asthma is free of unwanted pro-remodeling effects and ameliorates airway hyper-responsiveness and contractile tissue remodeling. These outcomes support furthering the development of mesenchymal stem cell-based asthma therapies, although caution and solid preclinical data building are warranted. © 2014 The Authors. Allergy published by John Wiley & Sons Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Coverage of overdose prevention programs for opiate users and injectors, A cross-sectional study

  • Arribas-Ibar, Elisabet
  • Sanchez-Niubo, Albert|||0000-0003-0309-181X
  • Majó, Xavier|||0000-0003-4338-6014
  • Domingo Salvany, Antònia|||0000-0003-3302-4538
  • Brugal, María Teresa|||0000-0003-0580-676X
Background: The use of opiates, particularly heroin, remains an important cause of morbidity and mortality. Half of the deaths among heroin consumers are attributed to overdose. In response to this problem, overdose prevention programs (OPPs) were designed. The objective of our study was to assess coverage of OPPs among the target population in a specific Spanish region (Catalonia) and to identify characteristics related to attendance. Methods: A cross-sectional survey recruited individuals from outpatient treatment centers (OTCs), therapeutic communities (ThCs), and harm reduction facilities (HRFs) in Catalonia. From 513 participants, 306 opiate users and/ or injectors were selected for this study. Coverage was calculated as the proportion of subjects who declared having participated in an OPP. A Poisson regression with robust variance was used to assess factors (socio-demographic aspects and psychoactive substance use patterns) associated to OPP participation, taking into account recruitment strategy. Results: Average age of the 306 subjects was 39.7 years (s.d.: 7.7); 79% were male; 79.2% lived in urban areas and 56.3% were unemployed or had never worked. Overall OPP coverage was 43.5% (95% CI: 37%-49%). Training was received mostly in HRF (60%), followed by OTC (24.4%), prison (19%), and ThC (16%). OPP sessions were attended by 41% of Spanish-born study participants and by 63.3% of foreigners; 92.2% of the participants lived in urban areas. The Poisson regression analysis adjusted by age, sex, and type of recruitment center showed that OPP participation rates were higher for individuals with foreign nationality (PR = 1.3; 95% CI: 1.04-1.72), for those living in municipalities with more than 100,000 inhabitants (PR = 2.0; 95% CI: 1.37-2.81) or the Barcelona conurbation (PR = 2.5; 95% CI: 1.68-3.77), and for those having ever been in prison (PR = 1.6; 95% CI: 1.41-1.81) and had first consumption when they were less than 12 years old (PR = 1.2; 95% CI: 1.06-1.45). Conclusion: Coverage as a whole can be considered high. However, in Catalonia, new strategies ought to be developed in order to attract opiate users and injectors not currently participating, by expanding OPP offer to services and regions where coverage is poor.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Oxidative stress and mitochondrial dysfunction in Kindler syndrome

  • Zapatero-Solana, Elisabeth
  • García-Giménez, José Luis|||0000-0001-7547-7872
  • Guerrero-Aspizua, Sara
  • García, Marta|||0000-0001-5155-4730
  • Toll Abelló, Agustí|||0000-0003-2656-0076
  • Baselga Torres, Eulàlia|||0000-0003-1086-8439
  • Durán-Moreno, Maria
  • Markovic, Jelena
  • García Verdugo, José Manuel|||0000-0001-9872-6499
  • Conti, Claudio J.
  • Has, Cristina
  • Larcher, Fernando
  • Pallardó, Federico V.|||0000-0003-3715-1980
  • Del Rio, Marcela
BACKGROUND: Kindler Syndrome (KS) is an autosomal recessive skin disorder characterized by skin blistering, photosensitivity, premature aging, and propensity to skin cancer. In spite of the knowledge underlying cause of this disease involving mutations of FERMT1 (fermitin family member 1), and efforts to characterize genotype-phenotype correlations, the clinical variability of this genodermatosis is still poorly understood. In addition, several pathognomonic features of KS, not related to skin fragility such as aging, inflammation and cancer predisposition have been strongly associated with oxidative stress. Alterations of the cellular redox status have not been previously studied in KS. Here we explored the role of oxidative stress in the pathogenesis of this rare cutaneous disease. METHODS: Patient-derived keratinocytes and their respective controls were cultured and classified according to their different mutations by PCR and western blot, the oxidative stress biomarkers were analyzed by spectrophotometry and qPCR and additionally redox biosensors experiments were also performed. The mitochondrial structure and functionality were analyzed by confocal microscopy and electron microscopy. RESULTS: Patient-derived keratinocytes showed altered levels of several oxidative stress biomarkers including MDA (malondialdehyde), GSSG/GSH ratio (oxidized and reduced glutathione) and GCL (gamma-glutamyl cysteine ligase) subunits. Electron microscopy analysis of both, KS skin biopsies and keratinocytes showed marked morphological mitochondrial abnormalities. Consistently, confocal microscopy studies of mitochondrial fluorescent probes confirmed the mitochondrial derangement. Imbalance of oxidative stress biomarkers together with abnormalities in the mitochondrial network and function are consistent with a pro-oxidant state. CONCLUSIONS: This is the first study to describe mitochondrial dysfunction and oxidative stress involvement in KS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Obstetric complications and clinical presentation in first episode of psychosis

  • Valli, Isabel|||0000-0003-3052-7383
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Cuesta, M.
  • Vieta, Eduard|||0000-0002-0548-0053
  • Bioque, Miquel|||0000-0001-6887-7149
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Garriga, Marina|||0000-0001-7312-4969
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Martínez Sadurní, Laura|||0000-0001-8693-8902
  • Bitanihirwe, B.
  • Cannon, M.
  • Bernardo, Miquel|||0000-0001-8748-6717
Psychotic disorders exhibit a complex aetiology that combines genetic and environmental factors. Among the latter, obstetric complications (OCs) have been widely studied as risk factors, but it is not yet well understood how OCs relate to the heterogeneous presentations of psychotic disorders. We assessed the clinical phenotypes of individuals with a first episode of psychosis (FEP) in relation to the presence of OCs. Two-hundred seventy-seven patients with an FEP were assessed for OCs using the Lewis-Murray scale, with data stratified into three subscales depending on the timing and the characteristics of the obstetric event, namely: complications of pregnancy, abnormal foetal growth and development and difficulties in delivery. We also considered other two groups: any complications during the pregnancy period and all OCs taken altogether. Patients were clinically evaluated with the Positive and Negative Syndrome Scale for schizophrenia. Total OCs and difficulties in delivery were related to more severe psychopathology, and this remained significant after co-varying for age, sex, traumatic experiences, antipsychotic dosage and cannabis use. Our results highlight the relevance of OCs for the clinical presentation of psychosis. Describing the timing of the OCs is essential in understanding the heterogeneity of the clinical presentation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma

  • Téllez-Gabriel, Marta
  • Arroyo Solera, Irene|||0000-0003-0425-1483
  • León i Vintró, Xavier|||0000-0001-6286-630X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • López, Montserrat
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Quer, Miquel|||0000-0003-2563-6729
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
  • Mangues, Ramon|||0000-0003-2661-9525
  • Pavón, Miguel A.
Currently there are no molecular markers able to predict clinical outcome in locally advanced head and neck squamous cell carcinoma (HNSCC). In a previous microarray study, RAB25 was identified as a potential prognostic marker. The aim of this study was to analyze the association between RAB25 expression and clinical outcome in patients with locally advanced HNSCC treated with standard therapy. In a retrospective immunohistochemical study (n = 97), we observed that RAB25-negative tumors had lower survival (log-rank, P = 0.01) than patients bearing positive tumors. In an independent prospective mRNA study (n = 117), low RAB25 mRNA expression was associated with poor prognosis. Using classification and regression tree analysis (CART) we established two groups of patients according to their RAB25 mRNA level and their risk of death. Low mRNA level was associated with poor local recurrence-free (log-rank, P = 0.005), progression-free (log-rank, P = 0.002) and cancer-specific (log-rank, P < 0.001) survival. Multivariate Cox model analysis showed that low expression of RAB25 was an independent poor prognostic factor for survival (hazard ratio: 3.84, 95% confidence interval: 1.93-7.62, P < 0.001). Patients whose tumors showed high RAB25 expression had a low probability of death after treatment. We also found lower RAB25 expression in tumors than in normal tissue (Mann-Whitney U, P < 0.001). Moreover, overexpression of RAB25 in the UM-SCC-74B HNSCC cell line increased cisplatin sensitivity, and reduced cell migration and invasion. Our findings support a tumor suppressor role for RAB25 in HNSCC and its potential use to identify locally advanced patients with a high probability of survival after genotoxic treatment. © 2013 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The polygenic basis of relapse after a first episode of schizophrenia

  • González-Segura, Àlex|||0000-0002-9398-2183
  • Prohens, Llucia|||0000-0003-1039-8027
  • Gassó, Patricia|||0000-0001-6930-3454
  • Rodríguez, Natalia|||0000-0002-9618-9383
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Moreno-Izco, Lucía
  • Andreu-Bernabeu, Álvaro
  • Zorrilla, Iñaki|||0000-0001-6444-8208
  • Mané, Anna|||0000-0003-2127-349X
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Sarró, Salvador|||0000-0003-1835-2189
  • Ibañez, Angela|||0000-0003-2751-0150
  • Usall, Judith|||0000-0002-1746-7737
  • Sáiz, Pilar A.|||0000-0002-5705-4523
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Parellada, Mara|||0000-0001-7977-3601
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Berrocoso, Ester
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Mas, Sergi|||0000-0003-3336-6298
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Arbelo, Néstor|||0000-0002-2630-3259
  • De Matteis, Mario
  • Galvañ, Joaquín
  • Duque Guerra, Alejandra
  • Arias i Queralt, Laia
  • Perez-Bacigalupe, Maria
  • González-Ortega, Itxaso|||0000-0001-7074-4353
  • Toll, Alba|||0000-0003-2399-5250
  • Casanovas, Francesc|||0000-0003-0557-8381
  • Sánchez Pastor, Luis|||0000-0002-5360-6351
  • Valtueña, Mercedes
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • García-León, Maria Ángeles|||0000-0002-9329-3732
  • Butjosa, Ana
  • Rubio-Abadal, Elena|||0000-0002-5845-5636
  • Ribeiro, María
  • López-Ilundain, Jose Manuel|||0000-0003-0361-0667
  • Saiz-Ruiz, Jeronimo
  • León-Quismondo, Luis
  • Rivero, Olga|||0000-0002-2664-4053
  • Ruiz, Pedro
  • Echevarría, Rafael Segarra
  • García-Portilla, María Paz|||0000-0003-3643-1622
Little is known about genetic predisposition to relapse. Previous studies have linked cognitive and psychopathological (mainly schizophrenia and bipolar disorder) polygenic risk scores (PRS) with clinical manifestations of the disease. This study aims to explore the potential role of PRS from major mental disorders and cognition on schizophrenia relapse. 114 patients recruited in the 2EPs Project were included (56 patients who had not experienced relapse after 3 years of enrollment and 58 patients who relapsed during the 3-year follow-up). PRS for schizophrenia (PRS-SZ), bipolar disorder (PRS-BD), education attainment (PRS-EA) and cognitive performance (PRS-CP) were used to assess the genetic risk of schizophrenia relapse.Patients with higher PRS-EA, showed both a lower risk (OR=0.29, 95% CI [0.11-0.73]) and a later onset of relapse (30.96± 1.74 vs. 23.12± 1.14 months, p=0.007. Our study provides evidence that the genetic burden of neurocognitive function is a potentially predictors of relapse that could be incorporated into future risk prediction models. Moreover, appropriate treatments for cognitive symptoms appear to be important for improving the long-term clinical outcome of relapse.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Low Density Lipoproteins Promote Unstable Calcium Handling Accompanied by Reduced SERCA2 and Connexin-40 Expression in Cardiomyocytes

  • Barriga, Montserrat
  • Cal, Roi
  • Cabello, Nuria
  • Llach, Anna|||0000-0002-7486-1079
  • Vallmitjana, Alexander
  • Benítez, Raúl|||0000-0002-8782-9406
  • Badimon, Lina|||0000-0002-9162-2459
  • Cinca, Juan|||0000-0003-4819-4265
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Madsen, Leif Hove|||0000-0001-5493-3998
The damaging effects of high plasma levels of cholesterol in the cardiovascular system are widely known, but little attention has been paid to direct effects on cardiomyocyte function. We therefore aimed at testing the hypothesis that Low Density Lipoprotein (LDL) cholesterol affects calcium dynamics and signal propagation in cultured atrial myocytes. For this purpose, mRNA and protein expression levels were determined by real time PCR and western blot analysis, respectively, and intracellular calcium was visualized in fluo-4 loaded atrial HL-1 myocyte cultures subjected to field stimulation. At low stimulation frequencies all cultures had uniform calcium transients at all tested LDL concentrations. However, 500 μg LDL/mL maximally reduced the calcium transient amplitude by 43% from 0.30±0.04 to 0.17±0.02 (p<0.05). Moreover, LDL-cholesterol dose-dependently increased the fraction of alternating and irregular beat-to-beat responses observed when the stimulation interval was shortened. This effect was linked to a concurrent reduction in SERCA2, RyR2, IP3RI and IP3RII mRNA levels. SERCA2 protein levels were also reduced by 43% at 200 μg LDL/mL (p<0.05) and SR calcium loading was reduced by 38±6% (p<0.001). By contrast, HDL-cholesterol had no significant effect on SERCA expression or SR calcium loading. LDL-cholesterol also slowed the conduction velocity of the calcium signal from 3.2+0.2 mm/s without LDL to 1.7±0.1 mm/s with 500 μg LDL/mL (p<0.05). This coincided with a reduction in Cx40 expression (by 44±3%; p<0.05 for mRNA and by 79±2%; p<0.05 for Cx40 protein at 200 μg/ml LDL) whereas the Cx-43 expression did not significantly change. In conclusion, LDL-cholesterol destabilizes calcium handling in cultured atrial myocytes subjected to rapid pacing by reducing SERCA2 and Cx40 expression and by slowing the conduction velocity of the calcium signal. © 2013 Barriga et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Low density lipoprotein receptor-related protein 1 expression correlates with cholesteryl ester accumulation in the myocardium of ischemic cardiomyopathy patients

  • Cal, Roi
  • Juan-Babot, Oriol|||0000-0002-4328-0335
  • Brossa, Vicenç
  • Roura, Santiago|||0000-0003-4063-9661
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Portoles, Manolo
  • Rivera, Miguel
  • Cinca, Juan|||0000-0003-4819-4265
  • Badimon, Lina|||0000-0002-9162-2459
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Our hypothesis was that overexpression of certain lipoprotein receptors might be related to lipid accumulation in the human ischemic myocardium. Intramyocardial lipid overload contributes to contractile dysfunction and arrhythmias in cardiomyopathy. Thus, the purpose of this study was to assess the effect of hypercholesterolemic LDL and hypertrigliceridemic VLDL dose on LRP1 expression in cardiomyocytes, as well as the potential correlation between LRP1 expression and neutral lipid accumulation in the left ventricle tissue from ischemic cardiomyopathy patients. Cell culture experiments include control and LRP1-deficient cardiomyocytes exposed to lipoproteins under normoxic and hypoxic conditions. Explanted hearts from 18 ICM patients and eight non-diseased hearts (CNT) were included. Low density lipoprotein receptor-related protein 1 (LRP1), very low density lipoprotein receptor (VLDLR) and low density lipoprotein receptor (LDLR) expression was analyzed by real time PCR and Western blotting. Cholesteryl ester (CE), triglyceride (TG) and free cholesterol (FC) content was assess by thin layer chromatography following lipid extraction. Western blotting experiments showed that protein levels of LRP1, VLDLR and HIF-1α were significantly upregulated in ischemic hearts. Immunohistochemistry and confocal microscopy analysis showed that LRP1 and HIF-1α were upregulated in cardiomyocytes of ICM patients. In vitro studies showed that VLDL, LDL and hypoxia exerted an upregulatory effect on LRP1 expression and that LRP1 played a major role in cholesteryl ester accumulation from lipoproteins in cardiomyocytes. Myocardial CE accumulation strongly correlated with LRP1 levels in ischemic hearts. Taken together, our results suggest that LRP1 upregulation is key for myocardial cholesterol ester accumulation in ischemic human hearts and that LRP1 may be a target to prevent the deleterious effects of myocardial cholesterol accumulation in ischemic cardiomyopathy. © 2012 Cal et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex-specific regulation of mitochondrial DNA levels, Genome-wide linkage analysis to identify quantitative trait loci

  • López, Sonia|||0000-0002-5023-5153
  • Buil, Alfonso|||0000-0002-3097-1014
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Casademont i Pou, Jordi|||0000-0002-8100-1827
  • Blangero, John
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Fontcuberta, Jordi
  • Lathrop, Mark
  • Almasy, Laura
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
Altered mitochondrial DNA (mtDNA) levels have been associated with common diseases in humans. We investigated the genetic mechanism that controls mtDNA levels using genome-wide linkage analyses in families from the Genetic Analysis of Idiopathic Thrombophilia Project (GAIT). We measure mtDNA levels by quantitative real-time PCR in 386 subjects from 21 extended Spanish families. A variance component linkage method using 485 microsatellites was conducted to evaluate linkage and to detect quantitative trait loci (QTLs) involved in the control of mtDNA levels. The heritalibility of mtDNA levels was 0.33 (p = 1.82e-05). We identified a QTL on Chromosome 2 (LOD = 2.21) using all of the subjects, independently on their sex. When females and males were analysed separately, three QTLs were identified. Females showed the same QTL on Chromosome 2 (LOD = 3.09), indicating that the QTL identified in the analysis using all of the subjects was a strong female QTL, and another one on Chromosome 3 (LOD = 2.67), whereas in males a QTL was identified on Chromosome 1 (LOD = 2.81). These QTLs were fine-mapped to find associations with mtDNA levels. The most significant SNP association was for the rs10888838 on Chromosome 1 in males. This SNP mapped to the gene MRPL37, involved in mitochondrial protein translation. The rs2140855 on Chromosome 2 showed association in the analysis using all of the subjects. It was near the gene CMPK2, which encodes a mitochondrial enzyme of the salvage pathway of deoxyribonucleotide synthesis. Our results provide evidence of a sex-specific genetic mechanism for the control of mtDNA levels and provide a framework to identify new genes that influence mtDNA levels. © 2012 López et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight, comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Davila-Batista, Veronica|||0000-0001-8888-395X
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier|||0000-0001-8569-861X
  • Tardón, Guillermo Fernández
  • Alguacil, Juan|||0000-0003-2703-9725
  • Vanaclocha Espí, Mercedes|||0000-0002-7202-2861
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Aragonés, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela|||0000-0001-9242-6364
  • Reguero Celada, Sofía
  • Pollán, Marina|||0000-0002-4328-1565
  • Martín, Vicente|||0000-0003-0552-2804
10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m 2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Double-stranded DNA breaks hidden in the neutralcometassay suggest a role of the sperm nuclearmatrix in DNA integrity maintenance

  • Ribas-Maynou, Jordi|||0000-0002-9101-2044
  • Gawecka, Joanna E.
  • Benet i Català, Jordi|||0000-0001-6185-2555
  • Ward, W. Steven
We used a mouse model in which sperm DNA damage was induced to understand the relationship of double-stranded DNA (dsDNA) breaks to sperm chromatin structure and to the Comet assay. Sperm chromatin fragmentation (SCF) produces dsDNA breaks located on the matrix attachment regions, between protamine toroids. In this model, epididymal sperm induced to undergo SCF can religate dsDNAbreaks while vas deferens sperm cannot. Here,wedemonstrated that the conventional neutral Comet assay underestimates the epididymal SCF breaks because the brokenDNAends remain attached to the nuclear matrix, causing theDNAto remain associated with the dispersion halo, and the Comet tails to be weak. Therefore, we term these hidden dsDNA breaks. When the Comet assay was modified to include an additional incubation with sodium dodecyl sulfate (SDS) and dithiothreitol (DTT) after the conventional lysis, thereby solubilizing the nuclear matrix, the broken DNA was released from the matrix, which resulted in a reduction of the sperm head halo and an increase in the Comet tail length, exposing the hidden dsDNA breaks. Conversely, SCF-induced vas deferens sperm had small halos and long tails with the conventional neutral Comet assay, suggesting that the broken DNA ends were not tethered to the nuclear matrix. These results suggest that the attachment to the nuclear matrix is crucial for the religation of SCF-induced DNA breaks in sperm. Our data suggest that the neutral Comet assay identifies only dsDNA breaks that are released from the nuclear matrix and that the addition of an SDS treatment can reveal these hidden dsDNA breaks. © The Author 2013. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis, A two-year follow-up study

  • Clougher, Derek|||0000-0001-7631-3845
  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Penadés, Rafael|||0000-0002-1564-3717
  • Lobo, Antonio|||0000-0002-9098-655X
  • Pinto, A.G.
  • Panadero, Rocío
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Vieta, Eduard|||0000-0002-0548-0053
  • de la Serna, Elena|||0000-0002-7869-9881
  • Trabsa, Amira|||0000-0002-8669-0676
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Torrent, Carla|||0000-0003-0335-582X
  • Tortorella, A.
  • Menculini, G.
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Cuesta, M.J.
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Salmerón, Sergi|||0000-0002-0212-4491
  • Arbelo, Néstor|||0000-0002-2630-3259
  • Ferrer-Quintero, Marta|||0000-0002-7935-9424
  • Echevarría, A.
  • Selma, Judit
  • Grasa, Eva|||0000-0003-1100-7489
  • Marin, Julen
  • Mar, Lorea
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Ruíz-Lázaro, P.M.
  • Nacher, Juan|||0000-0001-7599-3957
  • Cañete Nicolas, Carlos
  • Mané, Anna|||0000-0003-2127-349X
  • Toll, Alba|||0000-0003-2399-5250
  • Solé, Brisa|||0000-0003-1673-8248
  • Mallorquí, Aida|||0000-0003-4038-3045
  • Castro-Fornieles, Josefina|||0000-0003-0632-2687
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Contreras, Fernando|||0000-0003-2929-2804
  • Sáiz, Pilar A.|||0000-0002-5705-4523
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Segarra, R.
  • Zabala Torres, Alaitz|||0000-0002-3931-4221
  • Scala, Marcello|||0000-0003-2194-7239
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Usall, J.
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Pomarol-Clotet, E.
  • García-León, M.Á.
  • Ibañez, A.
  • Moreno-Izco, L.
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system, A longitudinal analysis

  • Altabás-González, Irene|||0000-0002-0797-5391
  • Rua Figueroa, Íñigo|||0000-0002-7894-1690
  • Mouriño, Coral
  • Roberts, Karen
  • Jimenez, Norman
  • Martínez Barrio, Julia
  • Galindo, María|||0000-0002-7264-2577
  • Calvo Alén, Jaime|||0000-0001-9378-8412
  • Campo Pérez, Víctor del|||0000-0002-9424-9653
  • Uriarte Itzazelaia, Esther
  • Tomero, Eva
  • Freire-González, Mercedes
  • Martínez Taboada, Víctor
  • Salgado, Eva
  • Vela, Paloma|||0000-0001-8566-5172
  • Fernández-Nebro, Antonio|||0000-0002-2962-9844
  • Olivé Marqués, Alejandro|||0000-0002-6707-8043
  • Narváez, Javier|||0000-0002-1614-8064
  • Menor-Almagro, Raúl
  • Santos Soler, Gregorio
  • Hernández-Beriain, Jose Ángel
  • Manero, Javier
  • Aurrecoechea, Elena|||0000-0001-6789-7236
  • Ibarguengoitia-Barrena, Oihane
  • Montilla, Carlos
  • Bonilla, Gema
  • Torrente-Segarra, Vicenç|||0000-0001-6597-3565
  • Cacheda, Ana Paula
  • García-Villanueva, María Jesús
  • Moriano-Morales, Claudia
  • Manteca, Concepción Fito
  • Lozano-Rivas, Nuria
  • Bohórquez, Cristina
  • Pego-Reigosa, José María|||0000-0003-3461-3537
Objective To assess organ damage, with emphasis on the cardiovascular system, over the different stages of the disease in a large SLE cohort. Methods Multicentre, longitudinal study of a cohort of 4219 patients with SLE enrolled in the Spanish Society of Rheumatology Lupus Registry. Organ damage was ascertained using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). We longitudinally analysed SDI (globally and for each domain) over time only in the 1274 patients whose dates of damage events had been recorded. Results During the first year after diagnosis of SLE, 20% of the 1274 patients presented with new damage manifestations. At years 2 and 3, new damage was recorded in 11% and 9% of patients. The annual percentage of patients with new damage after year 5 decreased to 5%. In the first year with the disease, most damage was accumulated in the musculoskeletal, neuropsychiatric and renal systems; in later stages, most damage was in the musculoskeletal, ocular and cardiovascular systems. Considering 'cerebrovascular accident' and claudication for 6 months' as cardiovascular items, the cardiovascular system was the second most affected system during the early stages of SLE, with 19% of the patients who presented with damage affected at first year after diagnosis. During the late stages, 20-25% of the patients presenting with new damage did so in this modified cardiovascular domain of the SDI. Conclusions New damage occurs mainly during the first year following diagnosis of SLE. Cardiovascular damage is relevant in both the early and the late stages of the disease. Strategies to prevent cardiovascular damage should be implemented early after diagnosis of SLE.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Weight decrease improves live birth rates in obese women undergoing IVF: a pilot study

  • Espinós, Juan José|||0000-0003-4838-8940
  • Polo, Ana|||0000-0001-6643-8871
  • Sánchez-Hernández, Juan
  • Bordas, Ramón
  • Pares, Pere
  • Martinez, Olga
  • Calaf Alsina, Joaquim|||0000-0002-2407-7884
Obese women have lower pregnancy rates than normal-weight women undergoing assisted reproductive treatment. We conducted a pilot study to evaluate whether a 12-week diet and exercise intervention before an IVF cycle would influence pregnancy rates in obese women. Forty-one patients were enrolled in this study. They were randomly allocated to two groups: an intervention group (n = 21), who underwent an individualized diet and physical exercise programme supervised by a dietician, and a control group (n = 20), who started IVF with no previous intervention. The primary outcome was clinical pregnancy rate after a single treatment cycle. Mean weight loss in the study group after the intervention was 5.4 kg (range 1.1-14.6 kg). The study and control groups had similar total FSH consumption, number of oocytes and embryos obtained, and number and quality of embryos transferred. There was a non-significant trend towards a higher clinical pregnancy rate after fresh embryo transfer (66.7% versus 41.2%). The intervention group had a significantly higher cumulative live birth rate (61.9% versus 30%, P = 0.045) (odds ratio for intervention group, 3.8; 95% confidence interval, 1.03 to 13.9) The data suggest that weight loss resulted in a significantly increased cumulative live birth rate.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Free-IgE as a Predictor of Responsiveness to Omalizumab in Oral Corticosteroid-Dependent Asthma Patients

  • Domingo, Christian|||0000-0001-8358-773X
  • Monserrate Mitchell, Daniel-Ross
  • Ollert, Marcus|||0000-0002-8055-0103
  • Pomares, Xavier|||0000-0002-2783-414X
  • Forne, Carles|||0000-0002-8133-3274
  • del Estal, Jorge|||0000-0001-7299-2211
  • Amengual Guedan, Maria Jose|||0000-0002-5385-3061
To date, no biomarkers have been found that are able to predict the clinical response to omalizumab. The aim of this study was to assess whether blood concentration of free Immunoglobulin E (IgE) can predict response to treatment with this monoclonal antibody. In a group of patients who were candidates for omalizumab treatment, forced spirometry and blood IgE were measured at entry and at each six-month visit, and free-IgE blood concentrations were measured at month 6. At month 18, the OMADORE protocol was applied. The complete follow-up lasted 30 months. Patients were considered responders if they met at least one of the following criteria: increase in forced expiratory volume in one second (FEV) at the follow-up visit compared to baseline; reduction in corticosteroid dose at the last visit compared to baseline; reduction in omalizumab dose at the follow-up visit; a positive score on the composite index combining all three criteria. The biomarker used to predict treatment response was the free IgE value and the percentage of free IgE to total IgE measured at visit 1, after six months of omalizumab treatment. The percentage of responders varied according to the parameter used (FEV, omalizumab, corticosteroid dose, and the composite index; 45.2%, 64.5%, 48.4%, and 77.4%, respectively). IgE blockade was around 97% both for the group as a whole and for the subgroups. There were no differences in free IgE values nor in the ratio of free IgE to total IgE between responders and non-responders. These results confirm that there is a group of patients who may benefit from the reduction/withdrawal of omalizumab. Determination of free IgE six months after initiation of omalizumab treatment does not discriminate between responders and non-responders.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments

  • Cendrós, Marc
  • Catalán, Rosa|||0000-0001-7003-2401
  • Torra, Mercè
  • Penadés, Rafael|||0000-0002-1564-3717
  • González-Rodríguez, Alexandre|||0000-0003-1855-8566
  • Brunet, Mercè|||0000-0002-7154-916X
  • Perez Blanco, Josefina|||0000-0002-6489-8871
  • Cullell, Natalia|||0000-0001-5118-1014
  • Serra-Llovich, Alexandre|||0000-0001-8318-851X
  • Hernandez, Marta H.
  • Arranz, María Jesús|||0000-0002-6757-9198
Traditionally, the aetiology of schizophrenia has been attributed to dopaminergic neurotransmission, but more recent information points to the role of glutamate pathways. Glutamatergic involvement in schizophrenia might be extensible to drug response. The aim of the study was to explore whether the variation in glutamate receptors, transporters and metabolism can influence the outcome of drug treatments. A total of 45 polymorphisms in the genes GRIN1, GRIN2A, GRIN2B, GRIN3A, GRIA1, GRIK2, GRM2, GRM3, GRM5, GRM8, SLC1A1, SLC1A3 and GAD1 were genotyped in 258 patients with schizophrenia. Efficacy and side effects were evaluated with the Positive and Negative Symptoms Scale and the UKU scale, respectively, at baseline and after 12 weeks. The analysis revealed associations between outcomes, including response and adverse effects and genetic variants in several genes (GAD1, GRIA1, GRIN2A, GRIN3A, GRIK2, GRM2, GRM5, GRM8 and SLC1A3). An association of rs1864205 in GRIA1 with autonomic side effects bordered statistical significance after correction for multiple comparisons. Our results suggest that genetic variation in glutamatergic pathways can influence the efficacy and safety of antipsychotic drugs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Psychological and personality predictors of weight loss and comorbid metabolic changes after bariatric surgery

  • Agüera, Zaida|||0000-0003-4453-4939
  • García Ruiz de Gordejuela, Amador|||0000-0002-0485-8536
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • Sánchez Díaz, Isabel María|||0000-0001-5874-8204
  • Baño, Marta|||0000-0002-9916-611X
  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Granero, Roser|||0000-0001-6308-3198
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Virgili, Nuria
  • López-Urdiales, Rafael|||0000-0002-2355-3041
  • Montserrat-Gil de Bernabé, Monica
  • Garrido, Pilar|||0000-0002-5899-6125
  • Monasterio, Carmen
  • Steward, Trevor|||0000-0003-3116-8175
  • Pujol-Gebelli, Jordi
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
Bariatric surgery (BS) has proven to be the most effective treatment for weight loss and for improving comorbidities in severe obesity. A comprehensive psychological assessment prior to surgery is proposed to prepare patients for a successful post-surgical outcome. There- fore, the main aim of the present study was to assess psychological and personality predictors of BS outcome. The sample comprised 139 severely obese patients who underwent BS. Assessment measures included the Eating Disorders Inventory-2, the Symptom Checklist- Revised and the Temperament and Character Inventory-Revised. Our results show that favourable BS outcome, after 2 years follow up, was associated with younger age, less depression, moderate anxiety symptoms and high cooperativeness levels. Likewise, metabolic improvements were found to be linked to younger age and certain psychopathological factors. In conclusion, our findings suggest that age, baseline body mass index, psychopathological indexes and personality traits predict successful BS outcome.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass

  • Hernández-Montoliu, Laura
  • Rodríguez-Peña, M.Mar
  • Puig, Rocío
  • Astiarraga, Brenno|||0000-0003-2216-8974
  • Guerrero-Pérez, Fernando
  • Virgili, Nuria
  • López-Urdiales, Rafael|||0000-0002-2355-3041
  • Osorio, Javier|||0000-0002-0889-4585
  • Monseny, Rosa
  • Lazzara, Claudia
  • Sobrino, Lucía
  • Pérez-Maraver, Manuel|||0000-0003-4427-7581
  • Pérez-Prieto, María
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
  • Vilarrasa, Nuria|||0000-0003-3188-1990
Objective: To determine changes in incretins, systemic inflammation, intestinal permeability and microbiome modifications 12 months after metabolic RYGB (mRYGB) in patients with type 2 diabetes (T2D) and their relationship with metabolic improvement. Materials and methods: Prospective single-center non-randomized controlled study, including patients with class II-III obesity and T2D undergoing mRYGB. At baseline and one year after surgery we performed body composition measurements, biochemical analysis, a meal tolerance test (MTT) and lipid test (LT) with determination of the area under the curve (AUC) for insulin, C-peptide, GLP-1, GLP-2, and fasting determinations of succinate, zonulin, IL-6 and study of gut microbiota. Results: Thirteen patients aged 52.6 ± 6.5 years, BMI 39.3 ± 1.4 kg/m, HbA 7.62 ± 1.5% were evaluated. After mRYGB, zonulin decreased and an increase in AUC after MTT was observed for GLP-1 (pre 9371 ± 5973 vs post 15788 ± 8021 pM, P<0.05), GLP-2 (pre 732 ± 182 vs post 1190 ± 447 ng/ml, P<0.001) and C- peptide, as well as after LT. Species belonging to Streptococaceae, Akkermansiacea, Rickenellaceae, Sutterellaceae, Enterobacteriaceae, Oscillospiraceae, Veillonellaceae, Enterobacterales_uc, and Fusobacteriaceae families increased after intervention and correlated positively with AUC of GLP-1 and GLP-2, and negatively with glucose, HbA, triglycerides and adiposity markers. Clostridium perfringens and Roseburia sp. 40_7 behaved similarly. In contrast, some species belonging to Lachnospiraceae, Erysipelotricaceae, and Rumnicocaceae families decreased and showed opposite correlations. Higher initial C-peptide was the only predictor for T2D remission, which was achieved in 69% of patients. Conclusions: Patients with obesity and T2D submitted to mRYGB show an enhanced incretin response, a reduced gut permeability and a metabolic improvement, associated with a specific microbiota signature.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex-based differences in jumping to conclusions, a multidimensional analysis of first-episode psychosis

  • Díaz-Cutraro, L.|||0000-0003-3985-2780
  • Verdaguer-Rodríguez, Marina|||0000-0001-9910-1220
  • García-Mieres, Helena|||0000-0002-2813-1737
  • Ferrer-Quintero, Marta|||0000-0002-7935-9424
  • López-Carrilero, Raquel|||0000-0003-4110-794X
  • Palma-Sevillano, Carolina|||0000-0001-5371-7417
  • Lamarca, Maria
  • Espinosa, Victoria
  • Barrigón, María Luisa|||0000-0002-2497-6353
  • González-Higueras, Fermín|||0000-0002-0826-5981
  • Pousa Tomàs, Esther|||0000-0003-4423-6739
  • Grasa, Eva|||0000-0003-1100-7489
  • Lorente Rovira, Esther
  • Gutiérrez-Zotes, Alfonso|||0000-0002-4858-1487
  • Barajas Vélez, Ana|||0000-0003-1103-9499
  • Ruiz Delgado, Isabel
  • Cid Colom, Jordi|||0000-0002-6406-0585
  • Moritz, Steffen|||0000-0001-8601-0143
  • Rico, Julia
  • Sevilla-Llewellyn-Jones, Julia|||0000-0002-9582-3389
  • Haro Abad, Josep Maria|||0000-0002-3984-277X
  • Ochoa, Susana|||0000-0001-6792-1080
Jumping to conclusions (JTC) bias is a hallmark cognitive bias in psychosis that involves hasty decision-making with limited evidence. Previous research has shown links between JTC and neurocognitive (NC), social cognitive (SC), metacognitive (MC), and clinical (CV) variables, but sex-based differences in these relationships remain understudied. This multicenter cross-sectional study included 121 first-episode psychosis (FEP) patients from nine Spanish mental health centers. Participants underwent comprehensive assessments of JTC, SC, NC, MC, and CV, and the interaction between JTC and sex was analysed. JTC-women attributed negative causes of events to themselves more often than non-JTC women and men, while JTC-men displayed more cognitive rigidity, slower processing speed, and better self-esteem compared to their non-JTC counterparts. Non-JTC-women showed better verbal memory recall. Logistic regression revealed distinct predictors for JTC by sex: women were influenced by negative internalization of events and visuospatial speed, while men's JTC was linked to errors in executive functions and memory. These results highlight the importance of sex-specific patterns in JTC and suggest that women might benefit from interventions targeting reflective thinking and social cognition, whereas men may need neurocognitive rehabilitation strategies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

From Genetics to Psychosocial Functioning, Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis

  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Clougher, Derek|||0000-0001-7631-3845
  • González-Segura, Àlex|||0000-0002-9398-2183
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Vieta, Eduard|||0000-0002-0548-0053
  • Garriga, Marina|||0000-0001-7312-4969
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Diaz-Caneja, C.M.
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • de la Serna, Elena|||0000-0002-7869-9881
  • Mané, Anna|||0000-0003-2127-349X
  • Mas, Sergi|||0000-0003-3336-6298
  • Torrent, Carla|||0000-0003-0335-582X
  • Allot, K.|||0000-0002-0640-4634
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Pérez, Antonio|||0000-0001-5528-1143
  • Meseguer, A.
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Ruiz-Lazaro, P.M.
  • Calvo, L.
  • Estébanez, M.J.
  • Ferrer, Marta
  • Echevarría, A.
  • Escarti, M.J.
  • Rivero, O.
  • Trabsa, Amira|||0000-0002-8669-0676
  • Legido, Teresa|||0000-0002-1175-2641
  • Serra, M.
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Castro Gutiérrez, Jorge
  • Parra, S.M.
  • Santo, F.D.
  • García-Portilla, María Paz
  • Echevarría, R.S.
  • Rabadán, A.Z.
  • Martínez-Gras, I.
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Usall, J.
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Clotet, E.P.
  • Salvador, R.
  • Ibañez, Angela|||0000-0003-2751-0150
  • Cuesta, M.J.
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
Background: Studies have shown associations between polygenic risk scores for educational attainment (PRS), cognitive reserve (CR), cognition, negative symptoms (NS), and psychosocial functioning in first-episode psychosis (FEP). However, their specific interactions remain unclear. This study aimed to investigate the mediating roles of CR, cognition, and NS in the relationship between PRS and psychosocial functioning one year after a FEP. Additionally, we sought to explore the impact of two NS subtypes on this relationship: diminished Expression (EXP-NS) and Motivation and Pleasure (MAP-NS). Methods: A total of 138 FEP participants, predominantly male (70%), with a mean age of 24.77 years (SD = 5.29), underwent genetic, clinical, and cognitive assessments two months after study enrollment. Functioning evaluation followed at one-year follow-up. To investigate the mediating role of CR, cognition, and NS in the relationship between PRS and functioning, a serial mediation model was employed. Two further mediation models were tested to explore the differential impact of EXP-NS and MAP-NS. Mediation analysis was performed using the PROCESS macro version 4.1 within SPSS version 26. Results: The serial mediation model revealed a causal chain for PRS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Negative symptoms and sex differences in first episode schizophrenia, What's their role in the functional outcome? A longitudinal study

  • Amoretti, Silvia|||0000-0001-6017-2734
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Verdolini, Norma|||0000-0001-9488-2881
  • Bioque, Miquel|||0000-0001-6887-7149
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Zorrilla, Iñaki|||0000-0001-6444-8208
  • Trabsa, Amira|||0000-0002-8669-0676
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Sarró, Salvador|||0000-0003-1835-2189
  • Ibañez, A.
  • Usall, J.
  • Segarra, R.
  • Vieta, Eduard|||0000-0002-0548-0053
  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Tortorella, Alfonso|||0000-0002-8095-2305
  • Menculini, G.
  • Parellada, Mara|||0000-0001-7977-3601
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Berrocoso, E.
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Alonso-Solís, Anna|||0000-0002-5393-9391
  • Grasa, Eva|||0000-0003-1100-7489
  • Corres, E.G.
  • Fernandez Sevillano, J.
  • Toll Abelló, Agustí|||0000-0003-2656-0076
  • Martínez Sadurní, Laura|||0000-0001-8693-8902
  • Nuñez-Doyle, A.
  • Sánchez Pastor, Luis|||0000-0002-5360-6351
  • Pomarol-Clotet, E.
  • Guerrero-Pedraza, Amalia|||0000-0001-7567-9407
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Pardo, M.
  • López-Ilundain, J.M.
  • Ribeiro, M.
  • Saiz-Ruiz, J.
  • Escarti, M.J.
  • Contreras, Fernando|||0000-0003-2929-2804
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Zabala Rabadán, Arantzazu
  • Portilla, M.P.
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • León-Quismondo, Leticia
Introduction: Negative symptoms (NS) include asociality, avolition, anhedonia, alogia, and blunted affect and are linked to poor prognosis. It has been suggested that they reflect two different factors: diminished expression (EXP) (blunted affect and alogia) and amotivation/pleasure (MAP) (anhedonia, avolition, asociality). The aim of this article was to examine potential sex differences among first-episode schizophrenia (FES) patients and analyze sex-related predictors of two NS symptoms factors (EXP and MAP) and functional outcome. Material and methods: Two hundred and twenty-three FES (71 females and 152 males) were included and evaluated at baseline, six-months and one-year. Repeated measures ANOVA was used to examine the effects of time and sex on NS and a multiple linear regression backward elimination was performed to predict NS factors (MAP-EXP) and functioning. Results: Females showed fewer NS (p = 0.031; Cohen's d = -0.312), especially those related to EXP (p = 0.024; Cohen's d = -0.326) rather than MAP (p = 0.086), than males. In both male and female group, worse premorbid adjustment and higher depressive symptoms made a significant contribution to the presence of higher deficits in EXP at one-year follow-up, while positive and depressive symptoms predicted alterations in MAP. Finally, in females, lower deficits in MAP and better premorbid adjustment predicted better functioning at one-year follow-up (R = 0.494; p < 0.001), while only higher deficits in MAP predicted worse functioning in males (R = 0.088; p = 0.012). Conclusions: Slightly sex differences have been found in this study. Our results lead us to consider that early interventions of NS, especially those focusing on motivation and pleasure symptoms, could improve functional outcomes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia

  • González-Segura, Àlex
  • Prohens, Llucia|||0000-0003-1039-8027
  • Julià, L.|||0000-0001-5161-2267
  • Amoretti, Silvia|||0000-0001-6017-2734
  • RIbero, M.
  • Pino-Camacho, L.
  • Cano-Escalera, G.
  • Mané, Anna|||0000-0003-2127-349X
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Sarró, Salvador|||0000-0003-1835-2189
  • Ibañez, Angela|||0000-0003-2751-0150
  • Usall, J.
  • Lobo, Antonio|||0000-0002-9098-655X
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Parellada, Mara|||0000-0001-7977-3601
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Berrocoso, E.
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Mas, Sergi|||0000-0003-3336-6298
  • Rodríguez, Natalia|||0000-0002-9618-9383
  • Perez-Ramos, A.
  • Salmerón, Sergi|||0000-0002-0212-4491
  • González-Peñas, Javier|||0000-0002-3850-3012
  • Gurriarán, Xaquin
  • Farre, Albert|||0000-0001-8970-6146
  • Pousa Tomàs, Esther|||0000-0003-4423-6739
  • Zorrilla, Iñaki|||0000-0001-6444-8208
  • Mar-Barrutia, L.
  • Trabsa, Amira|||0000-0002-8669-0676
  • Martínez Sadurní, Laura|||0000-0001-8693-8902
  • Sánchez Cabezudo, Ángeles
  • Jiménez-López, E.
  • Pomarol-Clotet, E.
  • Salvador, R.
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Elena, R.A.
  • Moreno-Izco, L.
  • Torres, A.M.S.
  • Saiz, J.
  • Rivero, O.
  • González-Blanco, L.
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Cuesta, M.J.
  • León-Quismondo, L.
Both genetic and environmental factors have been found to play a significant role in psychosis relapse, either independently or through their synergistic interaction. Recently, DNA methylation (DNAm) has been proposed through the calculation of methylation profile scores (MPS). The aim of the present study is to evaluate the association of MPS as a surrogate marker of the biological impact of early stressful life events (including stressful intrauterine conditions and obstetric complications, childhood adversity and toxic habits), with the risk of schizophrenia (SCZ) relapse. 91 participants from a cohort of first-episode schizophrenia (FES) patients with less than five years of evolution were classified as non-relapse (patients who had not experienced a relapse after 3 years of enrollment) or relapse (patients who relapsed during the 3-year follow-up). As inclusion criteria, patients fulfilled Andreasen's criteria of symptomatic remission. Genome-wide DNA methylation (DNAm) was profiled and fourteen MPS reflecting environmental exposure were constructed including both early stressful life events (including stressful intrauterine conditions and delivery issues, childhood adversity) and toxic habits. Increased levels of MPS reflecting gestational diabetes (p = 0.009), hypertensive disorders during pregnancy (p = 0.004), pre-eclampsia (p = 0.049), early preterm birth (p = 0.030), childhood adversity abuse (p = 0.021) and all childhood adversity (p = 0.030) were significantly associated with an increased risk of relapse. Our study suggests that changes in specific methylation patterns may represent one of the biological mechanisms linking early stressful life events to an increased risk of relapse.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis

  • Verdolini, Norma|||0000-0001-9488-2881
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Janssen, Joost|||0000-0001-7613-2067
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Bioque, Miquel|||0000-0001-6887-7149
  • Lobo, Antonio|||0000-0002-9098-655X
  • Vieta, Eduard|||0000-0002-0548-0053
  • Mané, Anna|||0000-0003-2127-349X
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Cuesta, M.J.
  • Parellada, Mara|||0000-0001-7977-3601
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Costas-Carrera, A.
  • Valli, Isabel|||0000-0003-3052-7383
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Rapado-Castro, M.
  • de la Serna, Elena|||0000-0002-7869-9881
  • Crossley, N.
  • Penadés, R.
Background Patients with a first episode of psychosis (FEP) display clinical, cognitive, and structural brain abnormalities at illness onset. Ventricular enlargement has been identified in schizophrenia since the initial development of neuroimaging techniques. Obstetric abnormalities have been associated with an increased risk of developing psychosis but also with cognitive impairment and brain structure abnormalities. Difficulties during delivery are associated with a higher risk of birth asphyxia leading to brain structural abnormalities, such as ventriculomegaly, which has been related to cognitive disturbances. Methods We examined differences in ventricular size between 142 FEP patients and 123 healthy control participants using magnetic resonance imaging. Obstetric complications were evaluated using the Lewis-Murray scale. We examined the impact of obstetric difficulties during delivery on ventricle size as well as the possible relationship between ventricle size and cognitive impairment in both groups. Results FEP patients displayed significantly larger third ventricle size compared with healthy controls. Third ventricle enlargement was associated with diagnosis (higher volume in patients), with difficulties during delivery (higher volume in subjects with difficulties), and was highest in patients with difficulties during delivery. Verbal memory was significantly associated with third ventricle to brain ratio. Conclusions Our results suggest that difficulties during delivery might be significant contributors to the ventricular enlargement historically described in schizophrenia. Thus, obstetric complications may contribute to the development of psychosis through changes in brain architecture.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

  • Enjuanes, Anna|||0000-0002-4679-6687
  • Albero Gallego, Robert|||0000-0001-5527-0997
  • Clot, Guillem|||0000-0003-2588-7413
  • Navarro, Alba|||0000-0002-4041-0974
  • Bea, Sílvia|||0000-0001-7192-2385
  • Pinyol, Magda
  • Martin-Subero, Jose Ignacio|||0000-0001-8809-5195
  • Klapper, Wolfram|||0000-0001-7208-4117
  • Staudt, L.M.
  • Jaffe, E.S.
  • Rimsza, L.M.
  • Braziel, Rita M
  • Delabie, Jan
  • Cook, James R.
  • Tubbs, R.S.
  • Gascoyne, Randy
  • Connors, Joseph M
  • Weisenburger, Dennis D
  • Greiner, Timothy C
  • Chan, Wing-Chung
  • López Guillermo, Armando|||0000-0002-8588-8381
  • Rosenwald, Andreas|||0000-0001-7282-8374
  • Ott, German|||0000-0001-7990-6793
  • Campo, Elias|||0000-0001-9850-9793
  • Jares, Pedro
Mantle cell lymphoma (MCL) is a B-cell neoplasm with an aggressive clinical behavior characterized by the t(11;14)(q13;q32) and cyclin D1 overexpression. To clarify the potential contribution of altered DNA methylation in the development and/or progression of MCL, we performed genome-wide methylation profiling of a large cohort of primary MCL tumors (n = 132), MCL cell lines (n = 6) and normal lymphoid tissue samples (n = 31), using the Infinium HumanMethylation27 BeadChip. DNA methylation was compared to gene expression, chromosomal alterations and clinicopathological parameters. Primary MCL displayed a heterogeneous methylation pattern dominated by DNA hypomethylation when compared to normal lymphoid samples. A total of 454 hypermethylated and 875 hypomethylated genes were identified as differentially methylated in at least 10% of primary MCL. Annotation analysis of hypermethylated genes recognized WNT pathway inhibitors and several tumor suppressor genes as frequently methylated, and a substantial fraction of these genes (22%) showed a significant downregulation of their transcriptional levels. Furthermore, we identified a subset of tumors with extensive CpG methylation that had an increased proliferation signature, higher number of chromosomal alterations and poor prognosis. Our results suggest that a subset of MCL displays a dysregulation of DNA methylation characterized by the accumulation of CpG hypermethylation highly associated with increased proliferation that may influence the clinical behavior of the tumors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib

  • Reig, María|||0000-0002-5711-9534
  • Torres, Ferran|||0000-0002-7355-7913
  • Rodríguez Lope, Carlos|||0000-0002-6713-8800
  • Forner, Alejandro|||0000-0002-9014-4950
  • Llarch, Neus|||0000-0003-3209-0453
  • Rimola, Jordi|||0000-0002-1814-4198
  • Darnell, Anna
  • Ríos, José|||0000-0002-0716-8784
  • Ayuso, Carmen|||0000-0002-9606-6957
  • Bruix, Jordi|||0000-0002-9826-0753
Background & Aims There are no clinical data/markers to predict improved survival in patients with hepatocellular carcinoma treated with sorafenib. Majority of sorafenib adverse events appear within the first 60 days of treatment and studies correlating them with outcome are needed. Methods We prospectively studied 147 hepatocellular carcinoma patients (97% cirrhotic, 82% Child-Pugh A, BCLC-B 77, BCLC-C 69) treated with sorafenib. Follow-up included monthly clinical and laboratory monitoring and tumor staging at week 4 and every 8 weeks. Results After a median follow up of 11.6 months (treatment duration 6.7 months), time to progression and overall survival were 5.1 and 12.7 months. All but one patient presented at least one adverse event (median time to appearance 56 days). Time dependent covariate analysis (HR [95% CI]) identified baseline performance status (2.86 [1.75 to 4.55], p <0.001), BCLC (1.69 [1.18 to 2.50], p = 0.005), and dermatologic adverse event requiring dose adjustment within the first 60 days (0.58 [0.36 to 0.92], p = 0.022) as independent predictors of better outcome. Other early adverse events did not have an impact in outcome. The predictive value of dermatologic adverse events for survival was confirmed by the landmark analysis (p = 0.0270). Conclusions Development of dermatologic adverse events within 60 days of sorafenib initiation is associated with better survival. Therefore, this should not to be taken as a negative event and discourage treatment maintenance. Likewise, second line clinical trials should be designed and/or evaluated considering this information to avoid significant bias.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Postprogression survival of patients with advanced hepatocellular carcinoma, Rationale for second-line trial design

  • Reig, María|||0000-0002-5711-9534
  • Rimola, Jordi|||0000-0002-1814-4198
  • Torres, Ferran|||0000-0002-7355-7913
  • Darnell, Anna
  • Forner, Alejandro|||0000-0002-9014-4950
  • Llarch, Neus|||0000-0003-3209-0453
  • Ríos, José|||0000-0002-0716-8784
  • Ayuso, Carmen|||0000-0002-9606-6957
  • Bruix, Jordi|||0000-0002-9826-0753
Sorafenib improves overall survival (OS) of patients with hepatocellular carcinoma (HCC) in the absence of objective response. Thus, time to tumor progression (TTP) is used to capture benefits of novel molecular agents, but proof of its surrogacy with survival is lacking. Furthermore, survival predictors upon progression are not established and there is a need to characterize postprogression survival (PPS) and assess with time-dependent covariates analysis if it is influenced by progression pattern, and not solely by simultaneous impairment of liver function and performance status. We prospectively followed HCC patients treated with sorafenib. Clinical and biochemical evaluation were done every 4 weeks. Radiologic assessment of progression was done at week 4 and then every 8 weeks using RECIST 1.1. The progression pattern was divided into: intrahepatic/extrahepatic increase in tumor size, new intrahepatic lesion, and new extrahepatic lesion (NEH). We included 147 patients (hepatitis C virus [HCV] 57.1%, performance status [PS] 0 83.6%, Child-Pugh A 82.3%, and BCLC-C 47.3%). The median OS was 12.7 months and its independent predictors (hazard ratio [HR], 95% confidence interval [CI]) were: baseline BCLC 2.49 [1.66-3.73], PS 1.86 [1.12-3.10], registration during follow-up of Child-Pugh B or Child-Pugh C scores (2.36 [1.51-3.69] and 2.89 [1.62-5.15], respectively), definitive sorafenib interruption 2.48 [1.54-4.01], and TTP 3.39 [1.89-6.1]. The presence of NEH 2.42 [1.32-4.44] is also an independent predictor of OS and PPS in patients with radiologic progression. Conclusion: Tumor progression is a surrogate of survival but its impact varies according to progression pattern. Thus, PPS is influenced by progression pattern and this is key in prognostic prediction and second-line trial design and analysis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure, A Propensity Score-Matching Analysis Based on the EAHFE Registry

  • Miró, Oscar|||0000-0002-7924-9751
  • Gil, Víctor
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Jacob, Javier|||0000-0003-1101-1066
  • Mebazaa, Alexandre|||0000-0001-8715-7753
  • Harjola, Veli-Pekka
  • Ríos, José|||0000-0002-0716-8784
  • Hollander, Judd E.
  • Peacock, W. Frank
  • Llorens Soriano, Pere|||0000-0002-9291-7179
Objective The objective was to determine the relationship between short-term mortality and intravenous morphine use in ED patients who received a diagnosis of acute heart failure (AHF). Methods Consecutive patients with AHF presenting to 34 Spanish EDs from 2011 to 2014 were eligible for inclusion. The subjects were divided into those with (M) or without IV morphine treatment (WOM) groups during ED stay. The primary outcome was 30-day all-cause mortality, and secondary outcomes were mortality at different intermediate time points, in-hospital mortality, and length of hospital stay. We generated a propensity score to match the M and WOM groups that were 1:1 according to 46 different epidemiological, baseline, clinical, and therapeutic factors. We investigated independent risk factors for 30-day mortality in patients receiving morphine. Results We included 6,516 patients (mean age, 81 [SD, 10] years; 56% women): 416 (6.4%) in the M and 6,100 (93.6%) in the WOM group. Overall, 635 (9.7%; M, 26.7%; WOM, 8.6%) died by day 30. After propensity score matching, 275 paired patients constituted each group. Patients receiving morphine had a higher 30-day mortality (55 [20.0%] vs 35 [12.7%] deaths; hazard ratio, 1.66; 95% CI, 1.09-2.54; P =.017). In patients receiving morphine, death was directly related to glycemia (P =.013) and inversely related to the baseline Barthel index and systolic BP (P =.021) at ED arrival (P =.021). Mortality was increased at every intermediate time point, although the greatest risk was at the shortest time (at 3 days: 22 [8.0%] vs 7 [2.5%] deaths; OR, 3.33; 95% CI, 1.40-7.93; P =.014). In-hospital mortality did not increase (39 [14.2%] vs 26 [9.1%] deaths; OR, 1.65; 95% CI, 0.97-2.82; P =.083) and LOS did not differ between groups (median [interquartile range] in M, 8 [7]; WOM, 8 [6]; P =.79). Conclusions This propensity score-matched analysis suggests that the use of IV morphine in AHF could be associated with increased 30-day mortality.
Repisalud
Publication Artículo científico (JournalArticle)

Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis

  • Garcia-Alvarez, Monica
  • Jimenez-Sousa, Maria Angeles
  • Fernandez-Rodriguez, Amanda
  • Guzman-Fulgencio, Maria
  • Resino, Salvador
There is growing evidence that vitamin D is related to chronic hepatitis C (CHC) pathogenicity. We analyzed the relationship of vitamin D status with advanced liver fibrosis (ALF) in CHC treatment-naïve patients and sustained virologic response (SVR) in CHC patients on pegylated interferon alpha plus ribavirin (pegIFNα/ribavirin) therapy. We performed a meta-analysis of all eligible studies published to date (April, 2014) in PubMed, SCOPUS, LILACS, and the Cochrane Library, assessing plasma/serum vitamin D levels related to ALF and/or SVR. Pooled odds ratios (ORs) were estimated by either fixed or random effects models. Fourteen studies were selected from the literature search, seven for ALF (1,083 patients) and 11 for SVR (2,672 patients). For liver fibrosis, low vitamin D status was related to a diagnosis of ALF, with the cutoffs of 10 ng/mL (OR=2.37, 95% confidence interval [CI]=1.20, 4.72) and 30 ng/mL (OR=2.22, 95% CI=1.24, 3.97) being significant, and a near-significance for 20 ng/mL (OR=1.44, 95% CI=0.99, 2.12). Regarding SVR, a significant heterogeneity among studies was found (P<0.001), and we only found a significant association with SVR for a vitamin D cutoff of 20 ng/mL (OR=0.53, 95% CI=0.31, 0.91). When meta-analysis was performed excluding the outliers, significant pooled ORs were found for all patients (10 ng/mL [OR=0.48, 95% CI=0.34, 0.67] and 20 ng/mL [OR=0.58, 95% CI=0.45, 0.76]) and GT1/4 patients (10 ng/mL [OR=0.53, 95% CI=0.34, 0.81] and 20 ng/mL [OR=0.54, 95% CI=0.39, 0.74]). Conclusion: Low vitamin D status in CHC patients is associated with a higher likelihood of having ALF and lower odds of achieving SVR following pegIFNα/ribavirin therapy.
Repisalud
Publication Artículo científico (JournalArticle)

Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.

  • Cascon Soriano, Alberto
  • Comino-Méndez, Iñaki
  • Currás-Freixes, María
  • de Cubas, Aguirre A
  • Contreras, Laura
  • Richter, Susan
  • Peitzsch, Mirko
  • Mancikova, Veronika
  • Inglada-Pérez, Lucía
  • Pérez-Barrios, Andrés
  • Calatayud, María
  • Azriel, Sharona
  • Villar-Vicente, Rosa
  • Aller, Javier
  • Setién, Fernando
  • Moran, Sebastian
  • Garcia, Juan F
  • Río-Machín, Ana
  • Letón, Rocío
  • Gómez-Graña, Álvaro
  • Apellániz-Ruiz, María
  • Roncador, Giovanna
  • Esteller, Manel
  • Rodríguez-Antona, Cristina
  • Satrústegui, Jorgina
  • Eisenhofer, Graeme
  • Urioste, Miguel
  • Robledo Batanero, Mercedes
Disruption of the Krebs cycle is a hallmark of cancer. IDH1 and IDH2 mutations are found in many neoplasms, and germline alterations in SDH genes and FH predispose to pheochromocytoma/paraganglioma and other cancers. We describe a paraganglioma family carrying a germline mutation in MDH2, which encodes a Krebs cycle enzyme. Whole-exome sequencing was applied to tumor DNA obtained from a man age 55 years diagnosed with multiple malignant paragangliomas. Data were analyzed with the two-sided Student's t and Mann-Whitney U tests with Bonferroni correction for multiple comparisons. Between six- and 14-fold lower levels of MDH2 expression were observed in MDH2-mutated tumors compared with control patients. Knockdown (KD) of MDH2 in HeLa cells by shRNA triggered the accumulation of both malate (mean ± SD: wild-type [WT] = 1±0.18; KD = 2.24±0.17, P = .043) and fumarate (WT = 1±0.06; KD = 2.6±0.25, P = .033), which was reversed by transient introduction of WT MDH2 cDNA. Segregation of the mutation with disease and absence of MDH2 in mutated tumors revealed MDH2 as a novel pheochromocytoma/paraganglioma susceptibility gene.
Repisalud
Publication Artículo científico (JournalArticle)

Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.

  • Comino-Méndez, Iñaki
  • de Cubas, Aguirre A
  • Bernal, Carmen
  • Álvarez-Escolá, Cristina
  • Sánchez-Malo, Carolina
  • Ramírez-Tortosa, César L
  • Pedrinaci, Susana
  • Rapizzi, Elena
  • Ercolino, Tonino
  • Bernini, Giampaolo
  • Bacca, Alessandra
  • Letón, Rocío
  • Pita, Guillermoó
  • Alonso, María R
  • Leandro-García, Luis J
  • Gómez-Graña, Alvaro
  • Inglada-Pérez, Lucía
  • Mancikova, Veronika
  • Rodríguez-Antona, Cristina
  • Mannelli, Massimo
  • Robledo Batanero, Mercedes
  • Cascon Soriano, Alberto
Pheochromocytomas (PCCs) and paragangliomas (PGLs) are chromaffin-cell tumors that arise from the adrenal medulla and extra-adrenal paraganglia, respectively. The dysfunction of genes involved in the cellular response to hypoxia, such as VHL, EGL nine homolog 1, and the succinate dehydrogenase (SDH) genes, leads to a direct abrogation of hypoxia inducible factor (HIF) degradation, resulting in a pseudo-hypoxic state implicated in PCC/PGL development. Recently, somatic post-zygotic mutations in EPAS1 (HIF2A) have been found in patients with multiple PGLs and congenital erythrocytosis. We assessed 41 PCCs/PGLs for mutations in EPAS1 and herein describe the clinical, molecular and genetic characteristics of the 7 patients found to carry somatic EPAS1 mutations; 4 presented with multiple PGLs (3 of them also had congenital erythrocytosis), whereas 3 were single sporadic PCC/PGL cases. Gene expression analysis of EPAS1-mutated tumors revealed similar mRNA EPAS1 levels to those found in SDH-gene- and VHL-mutated cases and a significant up-regulation of two hypoxia-induced genes (PCSK6 and GNA14). Interestingly, single nucleotide polymorphism array analysis revealed an exclusive gain of chromosome 2p in three EPAS1-mutated tumors. Furthermore, multiplex-PCR screening for small rearrangements detected a specific EPAS1 gain in another EPAS1-mutated tumor and in three non-EPAS1-mutated cases. The finding that EPAS1 is involved in the sporadic presentation of the disease not only increases the percentage of PCCs/PGLs with known driver mutations, but also highlights the relevance of studying other hypoxia-related genes in apparently sporadic tumors. Finally, the detection of a specific copy number alteration affecting chromosome 2p in EPAS1-mutated tumors may guide the genetic diagnosis of patients with this disease.
Repisalud
Publication Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Dávila-Batista, Verónica
  • Fernández-Villa, Tania
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier
  • Tardón, Guillermo Fernández
  • Alguacil, Juan
  • Vanaclocha-Espi, Mercedes
  • Marcos-Gragera, Rafael
  • Moreno, Victor
  • Aragones, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela
  • Reguero Celada, Sofía
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Background: 10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. Methods: This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Results: Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. Conclusion: These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Repisalud
Publication Artículo científico (JournalArticle)

Prevalence and factors linked to renal involvement in prediabetes patients across Europe in the ePREDICE trial

  • Más-Fontao, Sebastián
  • Civantos, Esther
  • Boukichou-Abdelkader, Nisa
  • Moreno, Juan A
  • Tuomilehto, Jaakko
  • Gabriel-Sanchez, Rafael
  • Egido, Jesús
This sub-analysis of the ePREDICE trial, investigated the prevalence and determinants of renal complications, specifically glomerular hyperfiltration, albuminuria, and reduced kidney function, in individuals with prediabetes (PD). The cohort consisted of 967 participants from diverse backgrounds across seven countries. The kidney function was evaluated using the MDRD-4 equation, and the influence of various clinical and demographic factors on renal involvement was assessed by multivariable regression models. Additionally, insulinogenic and disposition indices were examined. Overall, the prevalence of renal abnormalities in this PD cohort was 9.2% (n = 89). Key findings included the detection of hyperfiltration in 20 (2%) individuals, albuminuria in 45 (4.7%), and CKD stage G3a in 29 (3%). Hyperfiltration was inversely correlated with age and height, while albuminuria showed a significant direct association with the disposition index (DI). Age and waist circumference were significantly and directly associated with estimated glomerular filtration rate (eGFR). The ePREDICE study highlights critical factors that affect renal involvement in PD individuals, revealing complex interactions among various parameters. These findings further emphasize the necessity for the search of early kidney abnormalities in people with PD especially in those in older age groups and with a large waist circumference.
Repisalud
Publication Artículo científico (JournalArticle)

DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers.

  • de Cubas, Aguirre A
  • Korpershoek, Esther
  • Inglada-Pérez, Lucia
  • Letouzé, Eric
  • Currás-Freixes, Maria
  • Fernández, Agustin F
  • Comino-Méndez, Iñaki
  • Schiavi, Francesca
  • Mancikova, Veronika
  • Eisenhofer, Graeme
  • Mannelli, Massimo
  • Opocher, Guiseppe
  • Timmers, Henri
  • Beuschlein, Felix
  • de Krijger, Ronald
  • Cascon Soriano, Alberto
  • Rodríguez-Antona, Cristina
  • Fraga, Mario F
  • Favier, Judith
  • Gimenez-Roqueplo, Anne-Paule
  • Robledo Batanero, Mercedes
Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors, associated with highly variable postoperative evolution. The scarcity of reliable PPGL prognostic markers continues to complicate patient management. In this study, we explored genome-wide DNA methylation patterns in the context of PPGL malignancy to identify novel prognostic markers.
Repisalud
Publication Artículo científico (JournalArticle)

MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.

  • Burnichon, Nelly
  • Cascon Soriano, Alberto
  • Schiavi, Francesca
  • Morales, Nicole Paes
  • Comino-Méndez, Iñaki
  • Abermil, Nasséra
  • Inglada-Pérez, Lucía
  • de Cubas, Aguirre A
  • Amar, Laurence
  • Barontini, Marta
  • de Quirós, Sandra Bernaldo
  • Bertherat, Jérôme
  • Bignon, Yves-Jean
  • Blok, Marinus J
  • Bobisse, Sara
  • Borrego, Salud
  • Castellano, Maurizio
  • Chanson, Philippe
  • Chiara, María-Dolores
  • Corssmit, Eleonora P M
  • Giacchè, Mara
  • de Krijger, Ronald R
  • Ercolino, Tonino
  • Girerd, Xavier
  • Gómez-García, Encarna B
  • Gómez-Graña, Alvaro
  • Guilhem, Isabelle
  • Hes, Frederik J
  • Honrado, Emiliano
  • Korpershoek, Esther
  • Lenders, Jacques W M
  • Letón, Rocío
  • Mensenkamp, Arjen R
  • Merlo, Anna
  • Mori, Luigi
  • Murat, Arnaud
  • Pierre, Peggy
  • Plouin, Pierre-François
  • Prodanov, Tamara
  • Quesada-Charneco, Miguel
  • Qin, Nan
  • Rapizzi, Elena
  • Raymond, Victoria
  • Reisch, Nicole
  • Roncador, Giovanna
  • Ruiz-Ferrer, Macarena
  • Schillo, Frank
  • Stegmann, Alexander P A
  • Suarez, Carlos
  • Taschin, Elisa
  • Timmers, Henri J L M
  • Tops, Carli M J
  • Urioste, Miguel
  • Beuschlein, Felix
  • Pacak, Karel
  • Mannelli, Massimo
  • Dahia, Patricia L M
  • Opocher, Giuseppe
  • Eisenhofer, Graeme
  • Gimenez-Roqueplo, Anne-Paule
  • Robledo, Mercedes
Pheochromocytomas (PCC) and paragangliomas (PGL) are genetically heterogeneous neural crest-derived neoplasms. Recently we identified germline mutations in a new tumor suppressor susceptibility gene, MAX (MYC-associated factor X), which predisposes carriers to PCC. How MAX mutations contribute to PCC/PGL and associated phenotypes remain unclear. This study aimed to examine the prevalence and associated phenotypic features of germline and somatic MAX mutations in PCC/PGL.
Repisalud
Publication Artículo científico (JournalArticle)

Functional and in silico assessment of MAX variants of unknown significance.

  • Comino-Méndez, Iñaki
  • Leandro-García, Luis J
  • Montoya, Guillermo
  • Inglada-Pérez, Lucía
  • de Cubas, Aguirre A
  • Currás-Freixes, María
  • Tysoe, Carolyn
  • Izatt, Louise
  • Letón, Rocío
  • Gómez-Graña, Álvaro
  • Mancikova, Veronika
  • Apellániz-Ruiz, María
  • Mannelli, Massimo
  • Schiavi, Francesca
  • Favier, Judith
  • Gimenez-Roqueplo, Anne-Paule
  • Timmers, Henri J L M
  • Roncador, Giovanna
  • Garcia, Juan F
  • Rodríguez-Antona, Cristina
  • Robledo, Mercedes
  • Cascon Soriano, Alberto
The presence of germline mutations affecting the MYC-associated protein X (MAX) gene has recently been identified as one of the now 11 major genetic predisposition factors for the development of hereditary pheochromocytoma and/or paraganglioma. Little is known regarding how missense variants of unknown significance (VUS) in MAX affect its pivotal role in the regulation of the MYC/MAX/MXD axis. In the present study, we propose a consensus computational prediction based on five "state-of-the-art" algorithms. We also describe a PC12-based functional assay to assess the effects that 12 MAX VUS may have on MYC's E-box transcriptional activation. For all but two of these 12 VUS, the functional assay and the consensus computational prediction gave consistent results; we classified seven variants as pathogenic and three as nonpathogenic. The introduction of wild-type MAX cDNA into PC12 cells significantly decreased MYC's ability to bind to canonical E-boxes, while pathogenic MAX proteins were not able to fully repress MYC activity. Further clinical and molecular evaluation of variant carriers corroborated the results obtained with our functional assessment. In the absence of clear heritability, clinical information, and molecular data, consensus computational predictions and functional models are able to correctly classify VUS affecting MAX.
Repisalud
Publication Artículo científico (JournalArticle)

Risk of prostate cancer in the proximity of industrial installations: A multicase-control study in Spain (MCC-Spain).

  • García-Pérez, Javier
  • Fernandez de Larrea-Baz, Nerea
  • Lope Carvajal, Virginia
  • Domínguez-Castillo, Alejandro
  • Espinosa, Ana
  • Dierssen-Sotos, Trinidad
  • Contreras-Llanes, Manuel
  • Sierra, Maria Angeles
  • Castaño-Vinyals, Gemma
  • Tardón, Adonina
  • Jiménez-Moleón, José J
  • Molina-Barceló, Ana
  • Aragonés, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Perez-Gomez, Beatriz
Background: Prostate cancer (PC) is the second most frequent tumor in men worldwide; however, its etiology remains largely unknown, with the exception of age and family history. The wide variability in incidence/mortality across countries suggests a certain role for environmental exposures that has not yet been clarified. Objective: To evaluate the association between risk of PC (by clinical profile) and residential proximity to pollutant industrial installations (by industrial groups, groups of carcinogens, and specific pollutants released), within the context of a Spanish population-based multicase-control study of incident cancer (MCC-Spain). Methods: This study included 1186 controls and 234 PC cases, frequency matched by age and province of residence. Distances from participants' residences to the 58 industries located in the study area were calculated and categorized into "near" (considering different limits between ≤1 km and ≤ 3 km) or "far" (>3 km). Odds ratios (ORs) and 95 % confidence intervals (95%CIs) were estimated using mixed and multinomial logistic regression models, adjusted for potential confounders and matching variables. Results: No excess risk was detected near the overall industries, with ORs ranging from 0.66 (≤2 km) to 1.11 (≤1 km). However, positive associations (OR; 95%CI) were found, by industrial group, near (≤3 km) industries of ceramic (2.54; 1.28-5.07), food/beverage (2.18; 1.32-3.62), and disposal/recycling of animal waste (2.67; 1.12-6.37); and, by specific pollutant, near plants releasing fluorine (4.65; 1.45-14.91 at ≤1.5 km) and chlorine (5.21; 1.56-17.35 at ≤1 km). In contrast, inverse associations were detected near industries releasing ammonia, methane, dioxins+furans, polycyclic aromatic hydrocarbons, trichloroethylene, and vanadium to air. Conclusions: The results suggest no association between risk of PC and proximity to the overall industrial installations. However, some both positive and inverse associations were detected near certain industrial groups and industries emitting specific pollutants.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Targeted Cargo Delivery in Senescent Cells Using Capped Mesoporous Silica Nanoparticles

  • Agostini, Alessandro
  • Mondragón Martínez, Laura
  • Soto Camino, Juan
  • Costero, Ana
  • Manguan-García, Cristina
  • Perona, Rosario
  • Moreno Torres, Marta
  • Aparicio Sanchis, Rafael
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Murguía, Jose R.|||0000-0001-9364-4603
We thank the Spanish Government (projects MAT2009-14564-C04 and FIS PI11-0949) the Generalitat Valencia (project PROMETEO/2009/016), and the Universidad Politecnica de Valencia (UPV PAID-05-09) for support. We thank Fundacion Ramon Areces for support. C. M.-G. is supported by CIBERER. L. M. thanks the Generalitat Valenciana for her VALI + D postdoctoral contract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A score model for the continuous grading of early allograft dysfunction severity

  • Pareja, Eugenia
  • Cortes, Miriam
  • Mir, José
  • Valdivieso, Andrés
  • Castell, Jose Vicente
  • Lahoz Rodríguez, Agustín Gerardo
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] Early allograft dysfunction (EAD) dramatically influences graft and patient outcomes. A lack of consensus on an EAD definition hinders comparisons of liver transplant outcomes and management of recipients among and within centers. We sought to develop a model for the quantitative assessment of early allograft function [Model for Early Allograft Function Scoring (MEAF)] after transplantation. A retrospective study including 1026 consecutive liver transplants was performed for MEAF score development. Multivariate data analysis was used to select a small number of postoperative variables that adequately describe EAD. Then, the distribution of these variables was mathematically modeled to assign a score for each actual variable value. A model, based on easily obtainable clinical parameters (ie, alanine aminotransferase, international normalized ratio, and bilirubin) and scoring liver function from 0 to 10, was built. The MEAF score showed a significant association with patient and graft survival at 3-, 6- and 12-month follow-ups. Hepatic steatosis and age for donors; cold/warm ischemia times and postreperfusion syndrome for surgery; and intensive care unit and hospital stays, Model for End-Stage Liver Disease and Child-Pugh scores, body mass index, and fresh frozen plasma transfusions for recipients were factors associated significantly with EAD. The model was satisfactorily validated by its application to an independent set of 200 patients who underwent liver transplantation at a different center. In conclusion, a model for the quantitative assessment of EAD severity has been developed and validated for the first time. The MEAF provides a more accurate graft function assessment than current categorical classifications and may help clinicians to make early enough decisions on retransplantation benefits. Furthermore, the MEAF score is a predictor of recipient and graft survival., This work was supported by the Carlos III Institute of Health of the Spanish Ministry of Science and Innovation (PI11/02942). Agustin Lahoz is grateful for a Miguel Server contract (CP08/00125) from the Spanish Ministry of Science and Innovation/Carlos III Institute of Health
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Fluoroquinolone photodegradation influences specific basophil activation

  • Mayorga, Cristobalina
  • Aranda, Ana
  • Doña, Inmaculada
  • Montañez, M. Isabel
  • Blanca-López, Natalia
  • Ariza, Adriana
  • Nuin Plá, Neus Edurne
  • Blanca, Miguel
  • Miranda Alonso, Miguel Ángel
  • Torres, Mª José
  • Andreu, Inmaculada|||0000-0003-3409-9443
Fluoroquinolones (FQs) are photoreactive drugs, but it is not known whether laboratory light exposure can influence the induction of photoproducts and modify in vitro test results. The basophil activation test (BAT) has proven to be useful for evaluating immunoglobulin E (IgE)-mediated hypersensitivity to FQs, with a higher percentage of positive responders with ciprofloxacin (CIP) than with moxifloxacin (MOX). We studied the effect of laboratory light on CIP and MOX degradation, and drug-protein conjugate formation, and its influence on the BAT for evaluating IgE-mediated hypersensitivity to FQs. The results showed an important decrease in fluorescence emission intensity under light compared to dark conditions for MOX, and that BAT positivity was lower in light (17.9%) than in dark (35.7%) conditions. No changes were found for CIP in either fluorescence emission intensity or BAT results (46.4% in both conditions). We can conclude that light exposure is a critical factor in BAT results when photolabile drugs like MOX are used. Therefore, light is important when interpreting in vitro results. Copyright (C) 2012 S. Karger AG, Basel, We thank Ian Johnstone for his help with the English language version of the manuscript, and Jose Luis Rodriguez-Bada and Lidia Melendez for their technical support. This study was funded by the FIS-Thematic Networks and Co-operative Research Centres: RIRAAF (RD07/0064) and the Spanish Health Ministry (FIS PS09/01768, PI11/01416 and M Servet contract CP11/00154 for I.A.), the Andalusia Health Ministry (PI-0545-2010), and the Andalusia Economic Innovation and Science Ministry (CTS 06603).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Ozonation of hospital raw wastewaters for cytostatic compounds removal. Kinetic modelling and economic assessment of the process

  • Ferre Aracil, Jesús
  • Valcárcel, Yolanda
  • Negreira, N.
  • López de Alda, Miren
  • Barceló, D.
  • Cardona, S. C.
  • Navarro-Laboulais, J.|||0000-0001-6347-5407
[EN] The kinetics of the ozone consumption for the pretreatment of hospital wastewater has been analysed in order to determine the reaction rate coefficients between the ozone and the readily oxidisabled organic matter and cytostatic compounds. The wastewater from a medium size hospital was treated with ozone and peroxone methodologies, varying the ozone concentration, the reaction time and the hydrogen peroxide doses. The analysis shows that there are four cytostatic compounds, i.e. irinotecan, ifosfamide, cyclophosphamide and capecitabine, detected in the wastewaters and they are completely removed with reasonably short times after the ozone treatment. Considering the reactor geometry, the gas hydrodynamics, the mass transfer of ozone from gas to liquid and the reaction of all oxidisable compounds of the wastewater it is possible to determine the chemical ozone demand, COzD, of the sample as 256 mg O-3 L-1 and the kinetic rate coefficient with the dissolved organic matter as 8.4 M (1) s(-1). The kinetic rate coefficient between the ozone and the cyclophosphamide is in the order of 34.7M(-1) s(-1) and higher for the other cytostatics. The direct economic cost of the treatment was evaluated considering this reaction kinetics and it is below 0.3 (sic)/m(3) under given circumstances. (C) 2016 Elsevier B.V. All rights reserved., J. Ferre-Aracil acknowledges the support of the doctoral fellowship from the Universitat Politecnica de Valencia (UPV-PAID-FPI-2010-04). Y. Valcarcel acknowledges the financial support provided by the Spanish Ministry for Economy and Competitiveness, through the Carlos III Health Institute with the program "Projects on Health Research 2011-2012 FIS (PI11/00180)". N. Negreira, M. Lopez de Alda and D. Barcelo acknowledge the financial support by the EU through the EU FP7 projects CytoThreat (265264) and SOLUTIONS (603437), by the Spanish Ministry of Economy and Competitiveness through the project SCARCE (Consolider-Ingenio 2010 CSD2009-00065), and by the Generalitat de Catalunya (Consolidated Research Groups "2014 SGR 418 - Water and Soil Quality Unit" and 2014 SGR 291 - ICRA). Merck is acknowledged for the gift of LC columns.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer

  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] Background There is a medical need for diagnostic biomarkers in lung cancer. We evaluated the diagnostic performance of complement activation fragments. Methods We assessed complement activation in four bronchial epithelial and seven lung cancer cell lines. C4d, a degradation product of complement activation, was determined in 90 primary lung tumors; bronchoalveolar lavage supernatants from patients with lung cancer (n = 50) and nonmalignant respiratory diseases (n = 22); and plasma samples from advanced (n = 50) and early lung cancer patients (n = 84) subjects with inflammatory lung diseases (n = 133), and asymptomatic individuals enrolled in a lung cancer computed tomography screening program (n = 190). Two-sided P values were calculated by Mann-Whitney U test. Results Lung cancer cells activated the classical complement pathway mediated by C1q binding that was inhibited by phosphomonoesters. Survival was decreased in patients with high C4d deposition in tumors (hazard ratio [HR] = 3.06; 95% confidence interval [CI] = 1.18 to 7.91). C4d levels were increased in bronchoalveolar lavage fluid from lung cancer patients compared with patients with nonmalignant respiratory diseases (0.61 +/- 0.87 vs 0.16 +/- 0.11 mu g/mL; P < .001). C4d levels in plasma samples from lung cancer patients at both advanced and early stages were also increased compared with control subjects (4.13 +/- 2.02 vs 1.86 +/- 0.95 mu g/mL, P < 0.001; 3.18 +/- 3.20 vs 1.13 +/- 0.69 mu g/mL, P < .001, respectively). C4d plasma levels were associated with shorter survival in patients at advanced (HR = 1.59; 95% CI = 0.97 to 2.60) and early stages (HR = 5.57; 95% CI = 1.60 to 19.39). Plasma C4d levels were reduced after surgical removal of lung tumors (P < .001) and were associated with increased lung cancer risk in asymptomatic individuals with (n = 32) or without lung cancer (n = 158) (odds ratio = 4.38; 95% CI = 1.61 to 11.93). Conclusions Complement fragment C4d may serve as a biomarker for early diagnosis and prognosis of lung cancer., This work was supported by UTE project CIMA; the Spanish Government (grant numbers ISCIII-RTICC RD06/0020/0066, RD06/0020/1024, RD12/0036/0025, RD12/0036/0040, RD12/0036/0062, PI08/0923, PI10/01652, PI10/00166, and PI11/00618); the European Regional Development Fund; the European Community’s Seventh Framework Programme (HEALTH-F2-2010-258677- CURELUNG); and the Early Detection Research Network from the National Cancer Institute (grant number U01 CA152662). This work was supported (in part) by a grant (RD12/0036/XXXX) from Red Temática de Investigación Cooperativa en Cáncer, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness & European Regional Development Fund “Una manera de hacer Europa”.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Characterization of normal regional myocardial function by magnetic resonance imaging cardiac tagging

  • Del Canto Serrano, Irene
  • López Lereu, María Pilar
  • Monmeneu Menadas, José Vicente
  • Croisille, Pierre
  • Clarysse, Patrick
  • Chorro Gasco, Francisco Javier
  • Bodí, Vicente
  • Moratal, David|||0000-0002-2825-3646
PurposeThe aim of this study was to establish reference values for segmental myocardial strain measured by magnetic resonance (MR) cardiac tagging in order to characterize the regional function of the heart. Material and MethodsWe characterized the left ventricular (LV) systolic deformation in 39 subjects (26 women and 13 men, age 58.811.6 years) whose cardiological study had not revealed any significant abnormality. The deformation was measured from MR-tagged (Siemens 1.5T MR) images using an algorithm based on sine wave modeling. Circumferential and radial peak systolic strain values along with the torsion angle and circumferential-longitudinal (CL) shear were determined in 16 LV segments in order to settle the reference values for these parameters. ResultsCircumferential strain was highest at the anterior and lateral walls (-20.2 +/- 4.0% and -21.8 +/- 4.3%, respectively; P<0.05) and was lowest at the base level (-17.2 +/- 3.1% vs. -20.1 +/- 3.1% mid level, P<0.05; -17.2 +/- 3.1% vs. -20.3 +/- 3.0% apical level, P<0.05). Radial strain highest values were from inferior and lateral walls (13.7 +/- 7.4% and 12.8 +/- 7.8%, respectively; P<0.05) and it was lowest medially (9.4 +/- 4.1% vs. 13.1 +/- 4.1% base level, P<0.05; 9.4 +/- 4.1% vs. 12.1 +/- 4.4% apical level, P<0.05). Torsion angle (counterclockwise when viewed from the apex) increased with the distance from the base (7.9 +/- 2.4 degrees vs. 16.8 +/- 4.4 degrees, P<0.05), and the highest and lowest values were found at lateral (medial lateral: 12.0 +/- 4.4 degrees, apical lateral: 25.1 +/- 6.4 degrees, P<0.05) and septal wall (medial septal: 3.6 +/- 2.1 degrees, apical septal: 8.3 +/- 5.3 degrees, P<0.05), respectively. These differences were found again in CL shear values, around the LV circumference. However, CL shear remained constant with increasing distance from the base (9.1 +/- 2.6 degrees, medium and 9.8 +/- 2.4 degrees, apex). ConclusionIn summary, this study provides reference values for the assessment of regional myocardial function by MR cardiac tagging. Comparison of patient deformation parameters with normal deformation patterns may permit early detection of regional systolic dysfunction. J. Magn. Reson. Imaging 2015;41:83-92. (c) 2013 Wiley Periodicals, Inc., Contract grant sponsor: "Instituto de Salud Carlos III"; Contract grant number: FIS PI12/00407, FIS PI11/02323, and RETICS RIC RD12/0042/0048; Contract grant sponsor: "Generalitat Valenciana"; Contract grant number: PROMETEO 2010/093 and 2013/007.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Genetic polymorphisms located in genes related to immune and inflammatory processes are associated with end-stage renal disease: a preliminary study

  • Jimenez-Sousa, Mª Angeles
  • López, Elisabeth
  • Fernandez-Rodriguez, Amanda
  • Tamayo, Eduardo
  • Fernández-Navarro, Pablo
  • Segura Roda, Laura
  • Heredia, Maria
  • Gómez-Herreras, José I.
  • Bustamante, Jesus
  • Bermejo-Martin, Jesus F.
  • Garcia-Gomez, Juan M
  • Resino, Salvador
Background Chronic kidney disease progression has been linked to pro-inflammatory cytokines and markers of inflammation. These markers are also elevated in end-stage renal disease (ESRD), which constitutes a serious public health problem. Objective To investigate whether single nucleotide polymorphisms (SNPs) located in genes related to immune and inflammatory processes, could be associated with ESRD development. Design and methods A retrospective case-control study was carried out on 276 patients with ESRD and 288 control subjects. Forty-eight SNPs were genotyped via SNPlex platform. Logistic regression was used to assess the relationship between each sigle polymorphism and the development of ESRD. Results Four polymorphisms showed association with ESRD: rs1801275 in the interleukin 4 receptor (IL4R) gene (OR: 0.66 (95%CI=0.46-0.95); p=0.025; overdominant model), rs4586 in chemokine (C-C motif) ligand 2 (CCL2) gene (OR: 0.70 (95%CI=0.54-0.90); p=0.005; additive model), rs301640 located in an intergenic binding site for signal transducer and activator of transcription 4 (STAT4) (OR: 1.82 (95%CI=1.17-2.83); p=0.006; additive model) and rs7830 in the nitric oxide synthase 3 (NOS3) gene (OR: 1.31 (95%CI=1.01-1.71); p=0.043; additive model). After adjusting for multiple testing, results lost significance. Conclusion Our preliminary data suggest that four genetic polymorphisms located in genes related to inflammation and immune processes could help to predict the risk of developing ESRD., This work was supported by grants from Instituto de Salud Carlos III (Ref: PI08/0738 and PI11/00245) to SR and Junta de Castilla y Leon (Ref: GRS 234/A/08) to ET. MAJS is supported by a grant from Instituto de Salud Carlos III (CM10/00105).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Head-to-head comparison of 1 week versus 6 months CMR-derived infarct size for prediction of late events after STEMI

  • Husser, Oliver
  • Monmeneu Menadas, José Vicente
  • Bonanad, Clara
  • Gomez, Cristina
  • Chaustre, Fabian
  • Nuñez, Julio
  • López Lereu, María Pilar
  • Minana, Gema
  • Sanchis, Juan
  • Mainar, Luis
  • Ruiz, Vicente
  • Forteza, Maria J.
  • Trapero, Isabel
  • Chorro, Francisco J.
  • Bodi, Vicente
  • Moratal, David|||0000-0002-2825-3646
Infarct size (IS) at 1 week after ST-elevation myocardial infarction (MI) diminishes during the first months. The incremental prognostic value of IS regression and of scar size (SS) at 6 months is unknown. We compared cardiovascular magnetic resonance (CMR)-derived IS at 1 week and SS at 6 months after MI for predicting late major adverse cardiac events (MACE). 250 patients underwent CMR at 1 week and 6 months after MI. IS and SS were determined as the extent of transmural late enhancement (in > 50 % of wall thickness, ETLE). During 163 weeks, 23 late MACE (cardiac death, MI or readmission for heart failure after the 6 months CMR) occurred. Patients with MACE had a larger IS at 1 week (6 [4-9] vs. 3 [1-5], p < .0001) and a larger SS at 6 months (5 [2-6] vs. 3 [1-5], p = .005) than those without MACE. Late MACE rates in IS > median were higher at 1 week (14 vs. 4 %, p = .007) and in SS > median at 6 months (12 vs. 5 %, p = .053). The C-statistic for predicting late MACE of CMR at 1 week and 6 months was comparable (.720 vs. .746, p = .1). Only ETLE at 1 week (HR 1.31 95 % CI [1.14-1.52], p < .0001, per segment) independently predicted late MACE. CMR-derived SS at 6 months does not offer prognostic value beyond IS at 1 week after MI. The strongest predictor of late MACE is ETLE at 1 week., y This work was supported by the "Instituto de Salud Carlos III" (PI1102323 grant). O. Husser was supported by the "Regensburger Forschungsforderung in der Medizin (ReForM)".
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Effect of ischemic postconditioning on microvascular obstruction in reperfused myocardial infarction. Results of a randomized study in patients and of an experimental model in swine

  • Bodí, Vicente
  • Ruiz Nodar, Juan M.
  • Feliu, Eloisa
  • Minana, Gema
  • Nuñez, Julio
  • Husser, Oliver
  • Martinez Elvira, Javier
  • Ruiz, Amparo
  • Bonanad, Clara
  • Monmeneu, Jose V.
  • López Lereu, María Pilar
  • Forteza, Maria J.
  • De Dios, Elena
  • Hervas, Arantxa
  • Gomez, Cristina
  • Mainar, Luis
  • Sanchis, Juan
  • Mainar, Vicente
  • Valencia, Jose
  • Diaz, Ana
  • Noguera, Inmaculada
  • Chaustre Mendoza, Luis Fabián
  • Chorro, Francisco J.
  • Moratal, David|||0000-0002-2825-3646
Background: Ischemic postconditioning (PCON) appears as a potentially beneficial tool in ST-segment elevation myocardial infarction (STEMI). We evaluated the effect of PCON on microvascular obstruction (MVO) in STEMI patients and in an experimental swine model. Methods: A prospective randomized study in patients and an experimental study in swine were carried out in two university hospitals in Spain. 101 consecutive STEMI patients were randomized to undergo primary angio-plasty followed by PCON or primary angioplasty alone (non-PCON). Using late gadolinium enhancement cardiovascular magnetic resonance, infarct size and MVO were quantified (% of left ventricular mass). In swine, using an angioplasty balloon-induced anterior STEMI model, MVO was defined as the % of area at risk without thioflavin-S staining. Results: In patients, PCON (n = 49) in comparison with non-PCON (n = 52) did not significantly reduce MVO (0 [0-1.02]% vs. 0 [0-2.1]% p = 0.2) or IS (18 +/- 13% vs. 21 +/- 14%, p = 0.2). MVO (>1 segment in the 17-segment model) occurred in 12/49 (25%) PCON and in 18/52 (35%) non-PCON patients, p = 0.3. No significant differences were observed between PCON and non-PCON patients in left ventricular volumes, ejection fraction or the extent of hemorrhage. In the swine model, MVO occurred in 4/6 (67%) PCON and in 4/6 (67%) non-PCON pigs, p = 0.9. The extent of MVO (10 +/- 7% vs. 10 +/- 8%, p = 0.9) and infarct size (23 +/- 14% vs. 24 +/- 10%, p = 0.8) was not reduced in PCON compared with non-PCON pigs. Conclusions: Ischemic postconditioning does not significantly reduce microvascular obstruction in ST-segment elevation myocardial infarction., The present study was supported by the "Instituto de Salud Carlos III" (PI1102323 grant), FEDER, the "Conselleria de Educacio, Cultura i Esport de la Generalitat Valenciana" (PROMETEO/2013/007 grant) and by the Regensburger Forschungsforderung in der Medizin (ReForM).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles

  • Agostini, Alessandro
  • Mondragón Martínez, Laura
  • Soto Camino, Juan
  • Costero, Ana
  • Manguan-García, Cristina
  • Perona, Rosario
  • Moreno-Torres, Marta
  • APARICIO-SANCHIS, RAFAEL
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Murguía, Jose R.|||0000-0001-9364-4603
[EN] Learning to let go with age: Intracellular controlled release of molecules within senescent cells was achieved using mesoporous silica nanoparticles (MSNs) capped with a galacto-oligosaccharide (GOS) to contain the cargo molecules (magenta spheres; see scheme). The GOS is a substrate of the senescent biomarker, senescence-associated ß-galactosidase (SA-ß-gal), and releases the cargo upon entry into SA-ß-gal expressing cells., We thank the Spanish Government (projects MAT2009-14564-C04 and FIS PI11-0949) the Generalitat Valencia (project PROMETEO/2009/016), and the Universidad Politecnica de Valencia (UPV PAID-05-09) for support. We thank Fundacion Ramon Areces for support. C. M.-G. is supported by CIBERER. L. M. thanks the Generalitat Valenciana for her VALI + D postdoctoral contract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Determination of Oxygen Permeability in Acrylic-Based Hydrogels by Proton NMR Spectroscopy and Imaging

  • Compañ Moreno, Vicente|||0000-0001-8233-7472
  • Mollá Romano, Sergio
  • Vallejos, Saul
  • Garcia, Felix
  • Miguel Garcia, Jose
  • Guzman, Julio
  • Garrido, Leoncio
Polymer network membranes with a high capacity for water absorption are obtained by radical polymerization of N-[2-(2-hydroxyethoxy)ethyl]methacrylamide (HEEMAM). The permeability, solubility, and diffusion coefficients of oxygen in hydrogels are determined using nuclear magnetic resonance (NMR) methods based on the paramagnetic effect of dissolved oxygen gas on the proton spin-lattice relaxation times of water, and the results are compared with those obtained with electrochemical procedures. The results of NMR measurements of oxygen transport coefficients in distilled water show excellent agreement with corresponding literature values. The results of the potentiostatic and NMR oxygen transport measurements in hydrogels are in reasonable agreement and support the viability of the NMR method, The authors gratefully acknowledge financial support provided by the Spanish Ministerio de Economia y Competitividad, projects MAT2011-29174-C02-02, FEDER MAT2011-22544, and FIS PI11/01436, and the Consejeria de Educacion-Junta de Castilla y Leon, project BU232U13.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Multi-omics factor analysis v2 (MOFA+) reveals specific co-variation patterns in women with PMOS that are strongly influenced by obesity

  • Géraud-Aguilar, Edmond
  • Martinez-Garcia, M. Angeles
  • Insenser, Maria
  • Luque-Ramirez, Manuel
  • Garcia-Garcia, Francisco
  • Escobar-Morreale, Hector F.
  • Barceló-Cerdá, Susana|||0000-0001-5110-6698
[EN] STUDY QUESTION What are the mechanisms underlying the complex interactions between polyendocrine metabolic ovarian syndrome (PMOS) and obesity as studied by a multi-omics integration approach? SUMMARY ANSWER Multi-Omics Factor Analysis v2 (MOFA+) suggested that PMOS was characterized by an androgen-driven metabolic reprogramming in which sexual dimorphism was reshaped in an obesity-and omics-specific manner, consisting of strong associations of proinflammatory proteins and adipokines with gut microbiota genera and metabolomics variables that were amplified by obesity. WHAT IS KNOWN ALREADY PMOS is a common metabolic-endocrine disorder in which androgen excess, weight excess, and obesity complex interactions define a particularly unfavorable cardiometabolic phenotype. STUDY DESIGN, SIZE, DURATION Cross-sectional study with 2 control groups involving 46 Caucasian young adults, conducted at an academic hospital in Madrid, Spain. PARTICIPANTS/MATERIALS, SETTING, METHODS We recruited 15 women with PMOS, 16 healthy control women, and 15 control men of similar mean age and BMI. Participants were further grouped into non-obese (BMI < 30 kg/m & sup2;) or obese (BMI >= 30 kg/m & sup2;) subjects. We integrated serum metabolomics and circulating proteins with gut microbiota composition, using MOFA+. MAIN RESULTS AND THE ROLE OF CHANCE MOFA+ identified five latent factors explaining the main sources of variation across omics layers. Results showed sexual dimorphism in an omics-and obesity-specific manner: the metabolomics profile presented sexual dimorphism in non-obese individuals, whereas circulating proteins and gut microbiota differed between women with or without PMOS and men only in obese subjects. Correlation analyses revealed a global weakening of associations in men, particularly among metabolites, a reinforcement of protein-related associations with obesity, and a distinct PMOS-specific pattern characterized by strengthened correlations within and between gut microbiota and proteomic features. Women with PMOS exhibited the strongest metabolomics-proteomics correlations, further exacerbated by obesity. LIMITATIONS, REASONS FOR CAUTION The relatively small sample size of our study might have missed relevant associations that could have reached statistical significance in larger samples. Also, we only included women with hyperandrogenic phenotypes of PMOS. Hence, our results may not apply to non-hyperandrogenic phenotypes of the syndrome. WIDER IMPLICATIONS OF THE FINDINGS PMOS showed a metabolic profile similar to that of obesity even in the absence of excess weight, supporting the concept that adipose tissue dysfunction, proinflammatory proteins, and adipokines, rather than fat mass excess per se, were a central driver of the metabolic disturbances of the syndrome. Altogether, these findings highlight the complex interplay between androgen excess, adiposity, and host-microbiota interactions and provide a systems-level framework that may facilitate the identification of novel biomarkers and targeted therapeutic strategies in PMOS. Also, these findings highlight the importance of considering sex, sex hormones, and obesity-specific contexts in biomarker discovery and mechanistic studies., This research was funded by Instituto de Salud Carlos III grants PI11/0357, PI18/01122, PI21/00116 and PI25/00434 and co-funded by the European Union. F.G.-G. was supported by CIAICO/2023/149 and funded by the Conselleria de Educacion, Cultura y Universidades de la Generalitat Valenciana, and PID2021-124430OA-I00 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU. CIBERDEM and IRYCIS are also an initiative of Instituto de Salud Carlos III. The funding organizations played no role in the study design; collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the report for publication.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study

  • Galvez-Fernandez, Marta
  • Rodríguez-Hernández, Zulema
  • Grau-Perez, Maria
  • Chaves, F. Javier
  • García-García, Ana Bárbara
  • Amigo, Nuria
  • Monleón, Daniel
  • Garcia-Barrera, Tamara
  • Gomez-Ariza, Jose L.
  • Briongos-Figuero, Laisa S.
  • Perez-Castrillon, Jose L.
  • Redón, Josep
  • Tellez-Plaza, Maria
  • Martin-Escudero, Juan C.
[EN] Background: The potential joint influence of metabolites on bone fragility has been rarely evaluated. We assessed the association of plasma metabolic patterns with bone fragility endpoints (primarily, incident osteoporosisrelated bone fractures, and, secondarily, bone mineral density BMD) in the Hortega Study participants. Redox balance plays a key role in bone metabolism. We also assessed differential associations in participant subgroups by redox-related metal exposure levels and candidate genetic variants. Material and methods: In 467 participants older than 50 years from the Hortega Study, a representative sample from a region in Spain, we estimated metabolic principal components (mPC) for 54 plasma metabolites from NMR-spectrometry. Metals biomarkers were measured in plasma by AAS and in urine by HPLC-ICPMS. Redoxrelated SNPs (N = 341) were measured by oligo-ligation assay. Results: The prospective association with incident bone fractures was inverse for mPC1 (non-essential and essential amino acids, including branched-chain, and bacterial co-metabolites, including isobutyrate, trimethylamines and phenylpropionate, versus fatty acids and VLDL) and mPC4 (HDL), but positive for mPC2 (essential amino acids, including aromatic, and bacterial co-metabolites, including isopropanol and methanol). Findings from BMD models were consistent. Participants with decreased selenium and increased antimony, arsenic and, suggestively, cadmium exposures showed higher mPC2-associated bone fractures risk. Genetic variants annotated to 19 genes, with the strongest evidence for NCF4, NOX4 and XDH, showed differential metabolic-related bone fractures risk. Conclusions: Metabolic patterns reflecting amino acids, microbiota co-metabolism and lipid metabolism were associated with bone fragility endpoints. Carriers of redox-related variants may benefit from metabolic interventions to prevent the consequences of bone fragility depending on their antimony, arsenic, selenium, and, possibly, cadmium, exposure levels., Funding statement The work was funded by theo State Research Agency at the Ministerio de Ciencia Innovacion y Universidades of Spain (PID2019-108973RB-C21, PID2019-108973RB-C22 and PCIN-2017-117) ; the Generalitat Valenciana of Spain (IDIFEDER/2021/072, GRUPOS 03/101, PROMETEO/2009/029, ACOMP/2013/039, IDIFEDER/2021/072 and GRISOLIAP/2021/119) ; the EU Joint Programming Initiative Healthy Diet Healthy Life (HDHL) GUTMOM (INTIMIC-085) ; the Strategic Action for Research in Health sciences [CP12/03080, PI15/00071, PI10/0082, PI13/01848, PI14/00874, PI16/01402, PI17/00544 and PI11/00726] ; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN) (CIBER-02-08-2009, CB06/03 and CB12/03/30016) ; the Castilla-Leon Government (GRS/279/A/08) and European Network of Excellence Ingenious Hypercare (EPSS-037093) from the European Commission. The Strategic Action for Research in Health sciences and CIBEROBN are initiatives from Carlos III Health Institute Madrid and co-funded with European Funds for Regional Development (FEDER) . M.G-P received the support of a fellowship from "la Caixa" Foundation (ID 100010434, fellowship code LCF/BQ/IN18/11660001) . The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Metabolomic Profile of Human Myocardial Ischemia by Nuclear Magnetic Resonance Spectroscopy of Peripheral Blood Serum A Translational Study Based on Transient Coronary Occlusion Models

  • Bodi, Vicente
  • Sanchis, Juan
  • Morales, Jose M.
  • Marrachelli, Vannina G.
  • Nunez, Julio
  • Forteza, Maria J.
  • Chaustre Mendoza, Luis Fabián
  • Gomez, Cristina
  • Mainar, Luis
  • Minana, Gema
  • Rumiz, Eva
  • Husser, Oliver
  • Noguera, Inmaculada
  • Diaz, Ana
  • Carratala, Arturo
  • Bosch, Xavier
  • Llacer, Angel
  • Chorro, Francisco J.
  • Viña, Juan R.
  • Monleon, Daniel
  • Moratal, David|||0000-0002-2825-3646
Objectives The aim of this study was to investigate the metabolomic profile of acute myocardial ischemia (MIS) using nuclear magnetic resonance spectroscopy of peripheral blood serum of swine and patients undergoing angioplasty balloon-induced transient coronary occlusion. Background Biochemical detection of MIS is a major challenge. The validation of novel biosignatures is of utmost importance. Methods High-resolution nuclear magnetic resonance spectroscopy was used to profile 32 blood serum metabolites obtained (before and after controlled ischemia) from swine (n = 9) and patients (n = 20) undergoing transitory MIS in the setting of planned coronary angioplasty. Additionally, blood serum of control patients (n = 10) was sequentially profiled. Preliminary clinical validation of the developed metabolomic biosignature was undertaken in patients with spontaneous acute chest pain (n = 30). Results Striking differences were detected in the blood profiles of swine and patients immediately after MIS. MIS induced early increases (10 min) of circulating glucose, lactate, glutamine, glycine, glycerol, phenylalanine, tyrosine, and phosphoethanolamine; decreases in choline-containing compounds and triacylglycerols; and a change in the pattern of total, esterified, and nonesterified fatty acids. Creatine increased 2 h after ischemia. Using multivariate analyses, a biosignature was developed that accurately detected patients with MIS both in the setting of angioplasty-related MIS (area under the curve 0.94) and in patients with acute chest pain (negative predictive value 95%). Conclusions This study reports, to the authors' knowledge, the first metabolic biosignature of acute MIS developed under highly controlled coronary flow restriction. Metabolic profiling of blood plasma appears to be a promising approach for the early detection of MIS in patients. (J Am Coll Cardiol 2012;59:1629-41) (c) 2012 by the American College of Cardiology Foundation, From the *Cardiology Department, Hospital Clinico Universitario-INCLIVA, Universidad de Valencia, Valencia, Spain; dagger Unidad Central de Investigacion en Medicina, Universidad de Valencia, Valencia, Spain; double dagger Centro de Biomateriales e Ingenier a Tisular, Universidad Politecnica de Valencia, Valencia, Spain; Department of Clinical Analyses, Hospital Clinico Universitario-INCLIVA, Valencia, Spain; parallel to Cardiology Department, Hospital Clinic, IDIBAPS, Universidad de Barcelona, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Facultad de Medicina, Universidad de Valencia, Valencia, Spain; and the #Fundacion Investigacion, Hospital Clinico Universitario-INCLIVA, Valencia, Spain. The present study was supported by Instituto de Salud Carlos III (PI 11/02323 and Heracles grants to Dr. Bodi), Fundacion Gent per Gent (to Drs. Bodi and Monleon), the Ministry of Science and Innovation of Spain (grant SAF2008- 00270 to Dr. Monleon), and Generalitat Valenciana (grant GVASAN AP014/2009 to Dr. Monleon and grant PROMETEO2010-075 to Dr. Vina). Dr. Monleon gratefully acknowledges a 2006 Ramon y Cajal contract from the Ministry of Education of Spain. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Gene-environment interaction analysis of redox-related metals and genetic variants with plasma metabolic patterns in a general population from Spain: The Hortega Study

  • Galvez-Fernandez, Marta
  • Domingo-Relloso, Arce
  • Rodríguez-Hernández, Zulema
  • Gonzalez-Marrachelli, Vannina
  • Grau-Perez, Maria
  • Morales-Tatay, José M.
  • Amigo, Nuria
  • Garcia-Barrera, Tamara
  • Gomez-Ariza, Jose L.
  • Chaves, F. Javier
  • Garcia-Garcia, Ana Barbara
  • Melero, Rebeca
  • Tellez-Plaza, Maria
  • Sanchez Saez, Francisco|||0000-0002-3011-9884
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] Background: Limited studies have evaluated the joint influence of redox-related metals and genetic variation on metabolic pathways. We analyzed the association of 11 metals with metabolic patterns, and the interacting role of candidate genetic variants, in 1145 participants from the Hortega Study, a population-based sample from Spain. Methods: Urine antimony (Sb), arsenic, barium (Ba), cadmium (Cd), chromium (Cr), cobalt (Co), molybdenum (Mo) and vanadium (V), and plasma copper (Cu), selenium (Se) and zinc (Zn) were measured by ICP-MS and AAS, respectively. We summarized 54 plasma metabolites, measured with targeted NMR, by estimating metabolic principal components (mPC). Redox-related SNPs (N = 291) were measured by oligo-ligation assay. Results: In our study, the association with metabolic principal component (mPC) 1 (reflecting non-essential and essential amino acids, including branched chain, and bacterial co-metabolism versus fatty acids and VLDL subclasses) was positive for Se , Zn, but inverse for Cu, arsenobetaine-corrected arsenic (As) and Sb. The association with mPC2 (reflecting essential amino acids, including aromatic , bacterial co-metabolism) was inverse for Se, Zn and Cd. The association with mPC3 (reflecting LDL subclasses) was positive for Cu, Se and Zn, but inverse for Co. The association for mPC4 (reflecting HDL subclasses) was positive for Sb, but inverse for plasma Zn. These associations were mainly driven by Cu and Sb for mPC1; Se, Zn and Cd for mPC2; Co, Se and Zn for mPC3; and Zn for mPC4. The most SNP-metal interacting genes were NOX1, GSR, GCLC, AGT and REN. Co and Zn showed the highest number of interactions with genetic variants associated to enriched endocrine, car-diovascular and neurological pathways. Conclusions: Exposures to Co, Cu, Se, Zn, As, Cd and Sb were associated with several metabolic patterns involved in chronic disease. Carriers of redox-related variants may have differential susceptibility to metabolic alterations associated to excessive exposure to metals., This work was supported by the Strategic Action for Research in Health sciences [CP12/03080, PI15/00071, PI10/0082, PI13/01848, PI14/00874, PI16/01402, PI21/00506 and PI11/00726] , CIBER Fisio-patologia Obesidad y Nutricion (CIBEROBN) (CIBER-02-08-2009, CB06/03 and CB12/03/30,016) , the State Agency for Research (PID2019-108973RB-C21 and C22) , the Valencia Government (GRU-POS 03/101; PROMETEO/2009/029 and ACOMP/2013/039, IDI-FEDER/2021/072 and GRISOLIAP/2021/119) , the Castilla-Leon Government (GRS/279/A/08) and European Network of Excellence Ingenious Hypercare (EPSS-037093) from the European Commission. The Strategic Action for Research in Health sciences, CIBERDEM and CIBEROBN are initiatives from Carlos III Health Institute Madrid and co-funded with European Funds for Regional Development (FEDER) . The State Agency for Research and Carlos III Health Institute belong to the Spanish Ministry of Science and Innovation. ADR received the support of a fellowship from "la Caixa"Foundation (ID 100010434) (fellowship code "LCF/BQ/DR19/11740016") . MGP received the support of a fellowship from "la Caixa" Foundation (ID 100010434, fellowship code LCFLCF/BQ/DI18/11660001) . The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Reversible Axonal Dystrophy by Calcium Modulation in Frataxin-Deficient Sensory Neurons of YG8R Mice

  • Mollá, Belén
  • Muñoz-Lasso, Diana C.
  • Riveiro, Fátima
  • Bolinches-Amorós, Arantxa
  • Pallardó, Federico V.
  • Fernandez-Vilata, Angel
  • Palau, Francesc
  • Gonzalez-Cabo, Pilar
  • DE LA IGLESIA VAYÁ, MARIA DE LOS DESAMPARADOS
[EN] Friedreich's ataxia (FRDA) is a peripheral neuropathy involving a loss of proprioceptive sensory neurons. Studies of biopsies from patients suggest that axonal dysfunction precedes the death of proprioceptive neurons in a dying-back process. We observed that the deficiency of frataxin in sensory neurons of dorsal root ganglia (DRG) of the YG8R mouse model causes the formation of axonal spheroids which retain dysfunctional mitochondria, shows alterations in the cytoskeleton and it produces impairment of axonal transport and autophagic flux. The homogenous distribution of axonal spheroids along the neurites supports the existence of continues focal damages. This lead us to propose for FRDA a model of distal axonopathy based on axonal focal damages. In addition, we observed the involvement of oxidative stress and dyshomeostasis of calcium in axonal spheroid formation generating axonal injury as a primary cause of pathophysiology. Axonal spheroids may be a consequence of calcium imbalance, thus we propose the quenching or removal extracellular Ca2+ to prevent spheroids formation. In our neuronal model, treatments with BAPTA and o-phenanthroline reverted the axonal dystrophy and the mitochondrial dysmorphic parameters. These results support the hypothesis that axonal pathology is reversible in FRDA by pharmacological manipulation of intracellular Ca2+ with Ca2+ chelators or metalloprotease inhibitors, preventing Ca2+-mediated axonal injury. Thus, the modulation of Ca2+ levels may be a relevant therapeutic target to develop early axonal protection and prevent dying-back neurodegeneration., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía y Competitividad; Grant no. PI11/00678; SAF2015-66625-R) within the framework of the National R+D+I Plan and co-funded by the Instituto de Salud Carlos III (ISCIII)-Subdirección General de Evaluación y Fomento de la Investigación and FEDER funds; the European Community s Seventh Framework Program FP7/2007-2013 (grant agreement no. 242193 EFACTS); the Generalitat Valenciana (Prometeo programme). CIBERER is an initiative developed by the Instituto de Salud Carlos III in cooperative and translational research on rare diseases.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Evaluation of the effect of chance correlations on variable selection using Partial Least Squares -Discriminant Analysis

  • Kuligowski, Julia
  • Pérez Guaita, David
  • Escobar, Javier
  • Guardia, Miguel de la
  • Vento, Máximo
  • Quintás, Guillermo
  • Ferrer, Alberto|||0000-0001-7244-5947
Variable subset selection is often mandatory in high throughput metabolomics and proteomics. However, depending on the variable to sample ratio there is a significant susceptibility of variable selection towards chance correlations. The evaluation of the predictive capabilities of PLSDA models estimated by cross-validation after feature selection provides overly optimistic results if the selection is performed on the entire set and no external validation set is available. In this work, a simulation of the statistical null hypothesis is proposed to test whether the discrimination capability of a PLSDA model after variable selection estimated by cross-validation is statistically higher than that attributed to the presence of chance correlations in the original data set. Statistical significance of PLSDA CV-figures of merit obtained after variable selection is expressed by means of p-values calculated by using a permutation test that included the variable selection step. The reliability of the approach is evaluated using two variable selection methods on experimental and simulated data sets with and without induced class differences. The proposed approach can be considered as a useful tool when no external validation set is available and provides a straightforward way to evaluate differences between variable selection methods., JE and JK acknowledge the "Sara Borrell" Grants (CD11/00154 and CD12/00667) from the Instituto Carlos III (Ministry of Economy and Competitiveness). DPG acknowledge the "V Segles" Grant provided by the University of Valencia to carry out this study. MV acknowledges the FISPI11/0313 Grant from the Instituto Carlos III (Ministry of Economy and Competitiveness). AF acknowledges the DPI2011-28112-C04-02 Grant from Spanish Ministry of Science and Innovation (MICINN). GQ acknowledges the financial support from the Spanish Ministry of Economy and Competitivity (SAF2012-39948).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas

  • Bernaldo de Quirós, Sandra
  • Merlo, Anna
  • Secades, Pablo
  • Zambrano, Iriana
  • Saenz de Santa María, Inés
  • Ugidos, Nerea
  • Suarez, Carlos
  • Chiara, Maria Dolores
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
Abstract: Background: Cytogenetic and gene expression analyses in head and neck squamous cell carcinomas (HNSCC) have allowed identification of genomic aberrations that may contribute to cancer pathophysiology. Nevertheless, the molecular consequences of numerous genetic alterations still remain unclear. Methods: To identify novel genes implicated in HNSCC pathogenesis, we analyzed the genomic alterations present in five HNSCC-derived cell lines by array CGH, and compared high level focal gene amplifications with gene expression levels to identify genes whose expression is directly impacted by these genetic events. Next, we knocked down TRPC6, one of the most highly amplified and over-expressed genes, to characterize the biological roles of TRPC6 in carcinogenesis. Finally, real time PCR was performed to determine TRPC6 gene dosage and mRNA levels in normal mucosa and human HNSCC tissues. Results: The data showed that the HNSCC-derived cell lines carry most of the recurrent genomic abnormalities previously described in primary tumors. High-level genomic amplifications were found at four chromosomal sites (11q21-q22.2, 18p11.31-p11.21, 19p13.2-p13.13, and 21q11) with associated gene expression changes in selective candidate genes suggesting that they may play an important role in the malignant behavior of HNSCC. One of the most dramatic alterations of gene transcription involved the TRPC6 gene (located at 11q21-q22.2) which has been recently implicated in tumour invasiveness. siRNA-induced knockdown of TRPC6 expression in HNSCC-derived cells dramatically inhibited HNSCC-cell invasion but did not significantly alter cell proliferation. Importantly, amplification and concomitant overexpression of TRPC6 was also found in HNSCC tumour samples. Conclusions: Altogether, these data show that TRPC6 is likely to be a target for 11q21-22.2 amplification that confers enhanced invasive behavior to HNSCC cells. Therefore, TRPC6 may be a promising therapeutic target in the treatment of HNSCC., This work was supported by Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria [FIS PI11/929 to M.-D.C and C. S.]; Red Tematica de Investigacion Cooperativa en Cancer [RD12/0036/0015] Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF); and Obra Social CajAstur-Instituto Universitario de Oncologia del Principado de Asturias.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

  • Ajona, D.
  • Pajares, M. J.
  • Chiara, M. D.
  • Rodrigo, J. P.
  • Camps, C.
  • Suarez, C.
  • Bagan, J. V.
  • Montuenga, L. M.
  • Pio, R.
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
OBJECTIVE: Complement C4d-containing fragments have been proposed as diagnostic markers for lung cancer. The purpose of this study was to evaluate the presence of C4d in oropharyngeal (OPSCC) and oral (OSCC) squamous cell carcinomas. SUBJECTS AND METHODS: C4d staining was analyzed by immunohistochemistry in 244 OPSCC surgical specimens. C4d levels were quantified by ELISA in resting saliva samples from 48 patients with oral leukoplakia and 62 with OSCC. Plasma samples from 21 patients with leukoplakia and 30 with oral carcinoma were also studied. RESULTS: C4d staining in OPSCC specimens was associated with nodal invasion (P = 0.001), histopathologic grade (P = 0.014), disease stage (P = 0.040), and focal-adhesion kinase expression (P < 0.001). No association was found between C4d and prognosis. Saliva C4d levels were higher in patients with oral cancer than in subjects with leukoplakia (0.07 +/- 0.07 vs 0.04 +/- 0.03 mu g ml(-1), P = 0.003). The area under the ROC curve was 0.63 (95%CI: 0.55-0.71). Salivary C4d levels in stage IV patients were higher than in patients with earlier stages (P = 0.028) and correlated with tumor size (P = 0.045). Plasma C4d levels also correlated with salivary C4d levels (P = 0.041), but differences between patients with oral cancer and subjects with leukoplakia were not significant (1.26 +/- 0.59 vs 1.09 +/- 0.39 mu g ml(-1), P = 0.232). CONCLUSION: C4d-containing fragments are detected in oral primary tumors and are increased in saliva from patients with OSCC., We thank Amaya Lavin for technical assistance. This work was supported by Foundation for Applied Medical Research (FIMA), Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0015, RD12/0036/0025, and RD12/0036/0040), and Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER, PI11/00618, PI13/00806, PI11/00929, and PI14/01686).
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Progression of metabolic syndrome and associated cardiometabolic risk factors from prepuberty to puberty in children: The PUBMEP study

  • Lamas, Carmela de
  • Kalén, Anton
  • Ruiz Anguita, Augusto
  • Pérez Ferreirós, Alexandra
  • Picáns Leis, Rosaura
  • Flores, Katherine
  • Moreno, Luis A.
  • Bueno, Gloria
  • Gil, Ángel
  • Gil Campos, Mercedes
  • Aguilera, Concepción M.
  • Leis Trabazo, María Rosaura
Introduction: Metabolic syndrome (MetS) is a cluster of clinical and metabolic alterations related to the risk of cardiovascular diseases (CVD). Metabolic changes occurring during puberty, especially in children with overweight and obesity, can influence the risk of developing chronic diseases, especially CVD. Methods: Longitudinal study based on the follow-up until puberty of a cohort of 191 prepubertal Spanish boys and girls without congenital, chronic, or inflammatory diseases: undernutrition: or intake of any drug that could alter blood glucose, blood pressure, or lipid metabolism. The following parameters were used to determine the presence of MetS: obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low HDL-c. Results: A total of 75·5% of participants stayed in the same BMI category from prepuberty to puberty, whereas 6·3% increased by at least one category. The prevalence of MetS was 9·1% (prepubertal stage) and 11·9% (pubertal stage). The risk of presenting alterations in puberty for systolic blood pressure (SBP), plasma triacylglycerols, HDL cholesterol (HDL-c), and HOMA-IR was significantly higher in those participants who had the same alterations in prepuberty. MetS prevalence in puberty was predicted by sex and levels of HOMA-IR, BMI-z, and waist circumference in the prepubertal stage, in the whole sample: in puberty, the predictors were levels of HOMA-IR, BMI-z, and diastolic blood pressure in participants with obesity. Two fast-and-frugal decision trees were built to predict the risk of MetS in puberty based on prepuberty HOMA-IR (cutoff 2·5), SBP (cutoff 106 mm of Hg), and TAG (cutoff 53 mg/dl). Discussion: Controlling obesity and cardiometabolic risk factors, especially HOMA-IR and blood pressure, in children during the prepubertal stage appears critical to preventing pubertal MetS effectively.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Prepubertal Children With Metabolically Healthy Obesity or Overweight Are More Active Than Their Metabolically Unhealthy Peers Irrespective of Weight Status: GENOBOX Study

  • Llorente Cantarero, Francisco Jesús
  • Leis Trabazo, María Rosaura
  • Rupérez, Azahara I.
  • Anguita Ruiz, Augusto
  • Vázquez Cobela, Rocío
  • Flores Rojas, Katherine
  • González Gil, Esther M.
  • Aguilera, Concepción M.
  • Moreno, Luis A.
  • Gil Campos, Mercedes
  • Bueno, Gloria
Background and aim: The association of a metabolically healthy status with the practice of physical activity (PA) remains unclear. Sedentarism and low PA have been linked to increased cardiometabolic risk. The aim of this study was to evaluate the PA levels in metabolically healthy (MH) or unhealthy (MU) prepubertal children with or without overweight/obesity. Methods: A total 275 children (144 boys) with 9 ± 2 years old were selected for the GENOBOX study. PA times and intensities were evaluated by accelerometry, and anthropometry, blood pressure, and blood biochemical markers were analyzed. Children were considered to have normal weight or obesity, and further classified as MH or MU upon fulfillment of the considered metabolic criteria. Results: Classification resulted in 119 MH children (21% with overweight/obesity, referred to as MHO) and 156 MU children (47% with overweight/obesity, referred to as MUO). Regarding metabolic profile, MHO showed lower blood pressure levels, both systolic and diastolic and biochemical markers levels, such as glucose, Homeostatic Model Assessment of Insulin Resistance, triglycerides and higher HDL-c levels than MUO (P < 0.001). In addition, MHO children spent more time in PA of moderate intensity compared with MUO children. In relation to vigorous PA, MH normal weight (MHN) children showed higher levels than MUO children. Considering sex, boys spent more time engaged in moderate, vigorous, and moderate-vigorous (MV) PA than girls, and the number of boys in the MH group was also higher. Conclusion: Prepubertal MHO children are less sedentary, more active, and have better metabolic profiles than their MUO peers. However, all children, especially girls, should increase their PA engagement, both in terms of time and intensity because PA appears to be beneficial for metabolic health status itself.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Remodeling dental anatomy vs sham therapy for chronic temporomandibular disorders. A placebo-controlled randomized clinical trial

  • Collier, Timothy
  • Pocock, Stuart J.
  • Lorenzo-Franco, Fernanda
  • Varela Centelles, Pablo
  • López-Cedrún, José
  • Santana Penín, Urbano
  • Santana Mora, Urbano
  • López Solache, Alicia
  • Mora Bermúdez, María Jesús
Background: Evidence regarding the etiology or effective treatments for chronic orofacial pain, the majority diagnosed as temporomandibular disorder (TMD), is limited. Purpose: To investigate whether occlusal equilibration therapy (ET) and decreasing the (higher) angle of the lateral guidance on the nonworking-side leads to a reduction in chronic TMDs intensity. Methods: It was conducted a randomized, explanatory, single blind with blinded assessment, placebo-controlled trial with strong protection against bias involving patients with chronic TMDs. Participants were randomly assigned to receive equilibration therapy or sham therapy. ET in this study consisted of minimal invasive occlusal remodeling to obtain balanced occlusion with reduction of the steeper angle of lateral mandibular movement with respect to the Frankfort plane. The primary outcome was a change in the pain intensity score (on a 0–10 point scale, with 0 indicating no pain and 10 the worst possible pain) at month 6. Secondary outcomes include maximum unassisted mouth opening and psychological distress. Results: A total of 77 participants underwent randomization, 39 of whom received ET and 38 sham therapy. The trial was stopped early for efficacy, according to preestablished rules when 67 participants (n = 34, n = 33, respectively) had completed the analysis. At month 6, the mean unadjusted pain intensity score was 2.1 in the ET and 3.6 in the sham therapy group (adjusted mean difference, −1.54; 95% confidence interval [CI] −0.5 to −2.6; P = 0.004; ANCOVA model). The mean increase in maximum unassisted mouth opening (main secondary outcome) was significantly higher in the real therapy group (adjusted mean difference 3.1 mm, 95% CI 0.5–5.7, p = 0.02). Conclusion: ET significantly reduced the intensity of facial pain associated with chronic TMDs and increased maximum unassisted mouth opening, as compared with sham therapy, over the course of 6 months. There were no serious adverse events.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Longitudinal associations between cardiovascular biomarkers and metabolic syndrome during puberty: the PUBMEP study

  • González Gil, Esther M.
  • Anguita Ruiz, Augusto
  • Kalén, Anton
  • Lamas Pérez, Carmela de
  • Rupérez, Azahara I.
  • Vázquez Cobela, Rocío
  • Flores Rojas, Katherine
  • Gil Hernández, Ángel
  • Gil Campos, Mercedes
  • Bueno Lozano, Gloria
  • Leis Trabazo, María Rosaura
  • Aguilera, Concepción M.
Puberty has been described as a life stage of considerable metabolic risk specially for those with obesity. The low-grade systemic inflammatory status associated with obesity could be one of the connections with metabolic syndrome (MetS). Thus, we aimed to assess the relationship between inflammatory and cardiovascular biomarkers and the development of MetS during puberty. Seventy-five children from the PUBMEP study (33 females), aged 4–18 years, were included. Cardiovascular and inflammatory biomarkers were measured in the prepubertal and pubertal stage, including high-sensitivity C-reactive protein (CRP), leptin, tumor necrosis factor-alpha (TNFα), interleukin 8 (IL8), monocyte chemoattractant protein 1 (MCP-1), total plasminogen activator inhibitor-1 (tPAI), resistin, adiponectin, myeloperoxidase (MPO), and soluble intercellular adhesion molecule-1 (sICAM-1). MetS was diagnosed at each measurement point. Mixed-effects and logistic regressions were performed. Those children with MetS in puberty presented higher prepubertal values of several cardiometabolic biomarkers in comparison to those without MetS (z-score body mass index (zBMI), waist circumference, insulin, HOMA-IR, leptin, and tPAI (p < 0.05)). For prepubertal children with obesity, the odds of developing MetS in puberty were significantly higher in those having high zBMI (OR = 4.27; CI: 1.39–22.59) or high concentrations of tPAI (OR = 1.19; CI: 1.06–1.43)
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Adherence to the Mediterranean diet and changes in body mass index

  • Homs, Clara
  • Berruezo Torres Gómez de Cádiz, Paula
  • Según Mercader, Genís
  • Torres, Silvia
  • Ribera Sanuy, Mar
  • Sauri, Albert
  • Tejada, Julen
  • Ródenas Gálvez, Jan
  • Juton, Charlotte
  • Mila, Raimon
  • Fitó Colomer, Montserrat
  • Gómez, Santiago Felipe
  • Schroder, Helmut
Background Diet is considered a determinant of weight status, however, more evidence is needed for children. The Mediterranean diet (MedDiet) is one of the healthiest worldwide. This study analyzes the prospective association between adherence to the MedDiet at baseline and changes in standardized body mass index (zBMI) and the incidence of excessive weight. Methods 1389 children participated with a follow-up of 15 months. Weight, height, and adherence to the MedDiet were measured (baseline and follow-up). Results Multiple logistic regression analysis revealed that a high increase in zBMI was associated with lower odds of eating vegetables once [OR 0.74 (95% CI 0.57–0.98)] or more a day [OR 0.68 (95% CI 0.49—0.95)], nuts 2–3 times/week [OR 0.74 (95% CI 0.56–0.97)] or 2 cups of yogurt or/and cheese daily [OR 0.74 (95% CI 0.55–0.99)]. Not consuming each food item was used as reference. Multiple linear regression analysis showed a negative (β = −0.010, p = 0.040) association between the MedDiet at baseline and changes in zBMI at follow-up, significance disappeared (p = 0.082) after final adjustment for baseline zBMI. Conclusion: Baseline MedDiet was not significantly associated with the incidence of excessive weight at follow-up. The MedDiet was positively associated with changes in zBMI, however the effect size was small. Impact The present longitudinal study contributes knowledge regarding the adherence to Mediterranean diet as a predictive variable of weight status evolution in children. Higher adherence to the Mediterranean diet at baseline was prospectively and inversely associated with changes in zBMI after 15 months of follow-up. Consuming vegetables, nuts, and yoghurt/cheese according to the recommendations reduces the likelihood of having a high increase in zBMI after 15 months of follow-up., info:eu-repo/semantics/acceptedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Deficient Emotional Self-Regulation and Sleep Problems in ADHD with and without Pharmacological Treatment

  • Sanabra, Miriam
  • Gómez Hinojosa, Antonia Maria
  • Grau, Núria
  • Alda-Díez, José A.
Objective: The purpose of this study is to analyse DESR and its influence on sleep parameters in three different groups of children and adolescents: a group newly diagnosed with ADHD naïve, a group with ADHD under pharmacological treatment and a control group. Method: Subjects were a total of 327 children and adolescents. Two groups diagnosed with ADHD: 108 medication-naïve and 80 under pharmacological treatment; and one group with 136 healthy subjects. DESR was defined using anxious/depressed, attention problems and aggressive behaviors (AAA) scales from the Child Behavior Checklist (CBCL), and sleep through the Sleep Disturbance Scale for Children. Results: Significant differences were found comparing the three groups (p=.001), with a significantly higher profile on DESR in ADHD subjects, especially those who did not undergo treatment, and a positive correlation between DESR and sleep. Conclusion: Children and adolescents with ADHD without treatment present higher DESR than healthy controls and consequently higher sleep problems., info:eu-repo/semantics/updatedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Yearly attained adherence to Mediterranean diet and incidence of diabetes in a large randomized trial

  • Martínez-González, Miguel Ángel, 1957-
  • Montero, Pedro
  • Ruiz-Canela, Miguel
  • Toledo, Estefanía
  • Estruch Riba, Ramon
  • Gómez-Gracia, Enrique
  • Li, Jun
  • Ros Rahola, Emilio
  • Arós, Fernando
  • Hernáez, Álvaro
  • Corella Piquer, Dolores
  • Fiol, Miquel
  • Lapetra, José
  • Serra Majem, Lluís
  • Pintó Sala, Xavier
  • Cofán Pujol, Montserrat
  • Sorlí, José V.
  • Babio, Nancy
  • Márquez-Sandoval, Yolanda F.
  • Castañer, Olga
  • Salas Salvadó, Jordi
Background Several large observational prospective studies have reported a protection by the traditional Mediterranean diet against type 2 diabetes, but none of them used yearly repeated measures of dietary intake. Repeated measurements of dietary intake are able to improve subject classification and to increase the quality of the assessed relationships in nutritional epidemiology. Beyond observational studies, randomized trials provide stronger causal evidence. In the context of a randomized trial of primary cardiovascular prevention, we assessed type 2 diabetes incidence according to yearly repeated measures of compliance with a nutritional intervention based on the traditional Mediterranean diet. Methods PREDIMED (‘‘PREvención con DIeta MEDiterránea’’) was a Spanish trial including 7447 men and women at high cardiovascular risk. We assessed 3541 participants initially free of diabetes and originally randomized to 1 of 3 diets: low-fat diet (n = 1147, control group), Mediterranean diet supplemented with extra virgin olive (n = 1154) or Mediterranean diet supplemented with mixed nuts (n = 1240). As exposure we used actual adherence to Mediterranean diet (cumulative average), yearly assessed with the Mediterranean Diet Adherence Screener (scoring 0 to 14 points), and repeated up to 8 times (baseline and 7 consecutive follow-up years). This score was categorized into four groups: < 8, 8–< 10, 10– < 12, and 12–14 points. The outcome was new-onset type 2 diabetes. Results Multivariable-adjusted hazard ratios from time-varying Cox models were 0.80 (95% confidence interval, 0.70–0.92) per + 2 points in Mediterranean Diet Adherence Screener (linear trend p = .001), and 0.46 (0.25–0.83) for the highest (12–14 points) versus the lowest (< 8) adherence. This inverse association was maintained after additionally adjusting for the randomized arm. Age- and sex-adjusted analysis of a validated plasma metabolomic signature of the Mediterranean Diet Adherence Screener (constituted of 67 metabolites) in a subset of 889 participants also supported these results. Conclusions Dietary intervention trials should quantify actual dietary adherence throughout the trial period to enhance the benefits and to assist results interpretation. A rapid dietary assessment tool, yearly repeated as a screener, was able to capture a strong inverse linear relationship between Mediterranean diet and type 2 diabetes., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Cohort profile: The Girona heart registry

  • Degano, Irene R.
  • Herrera-Marín, Nuria
  • Subirana, Isaac
  • Camps-Vilaró, Anna
  • Hernáez, Álvaro
  • Sala, Joan
  • Masià, Rafael
  • Ramos, Rafel
  • Elosua, Roberto
  • Marrugat, Jaume
The Girona Heart Registry (REGICOR) is a population-based study designed to analyse the magnitude of and factors related to cardiovascular (CV) diseases in Southern Europe. The REGICOR cohort integrates the participants of four population-based surveys conducted in 1995, 2000, 2005, and 2018 in the Girona province (North-Eastern Spain), with a current reference population of approximately 790 000 inhabitants. The REGICOR cohort includes 11 631 individuals (1748 in 1995, 3030 in 2000, 6308 in 2005, and 545 in 2018). At inclusion, 52% of the study population were females; their mean ages were 51, 50, 57, and 45, respectively. Two re-examinations were conducted for the participants recruited in 1995, 2000, and 2005. Follow-up data on CV events and cause-specific mortality are available for 11 518 participants since baseline, with a median follow-up time of 18.6 years. Follow-up data on non-CV events have been available since 2008. During inclusion and re-examinations, we obtained blood samples and information on CV and other risk factors using validated questionnaires, standardized tests, and imaging assessments. Genotyping was performed on the whole cohort. Circulating biomarkers, DNA methylation, microRNAs, and proteomics have been measured in a cohort subset., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Efectos del tratamiento farmacológico estimulante sobre los patrones de actividad circadiana en niños con trastorno por déficit de atención/hiperactividad

  • Sanabra, Miriam
  • Gómez Hinojosa, Antonia Maria
  • Alda-Díez, José A.
Introducción. El trastorno por déficit de atención/hiperactividad (TDAH) es uno de los trastornos mentales más comunes en la infancia. Los síntomas nucleares del TDAH se tratan con estimulantes como el metilfenidato; aun así, existe mucha controversia respecto a sus efectos secundarios. Objetivos. Analizar los patrones de actividad en niños con TDAH durante un período de 24 horas durante siete días, antes y después de tomar tratamiento farmacológico estimulante (metilfenidato), y observar si existen diferencias entre las diferentes presentaciones del trastorno (subtipo inatento y combinado). Pacientes y métodos. Un total de 30 niños y adolescentes (recién diagnosticados de TDAH según los criterios diagnósticos del DSM-IV) fueron evaluados a través de un actígrafo, un instrumento que permite monitorizar los movimientos corporales analizando los patrones de movimiento y las diferencias entre sueño y vigilia. Resultados. Existen diferencias significativas antes y después de realizar el tratamiento, con niveles de actividad más altos en los pacientes con TDAH antes de empezar el tratamiento y un decrecimiento de esta actividad tras el tratamiento farmacológico. También existen diferencias entre los subtipos inatento y combinado, y el último grupo muestra un nivel de actividad mayor. Conclusiones. El nivel de activación que presentan los sujetos con TDAH es mayor antes de tomar tratamiento, e influye en los patrones circadianos, el sueño y la calidad de vida. El tratamiento farmacológico ayuda a disminuir el nivel de activación, Introduction. Attention deficit hyperactivity disorder (ADHD) is one of the most common mental disorders in childhood. The nuclear symptoms of ADHD are treated with stimulant medication such as methylphenidate; however, there’s a lot of controversy regarding its side effects. Aims. To analyse the activity patterns in children with ADHD during a period of 24 hours for seven days, before and after taking pharmacological treatment with stimulants (methylphenidate) and observe the differences between the different presentations of ADHD (inattentive and combined subtype). Patients and methods. A total of 30 children and adolescents (newly diagnosed with ADHD according to DSM-IV). Analyses were carried out through actigraphy, an instrument that allows us to monitor body movements by analysing movement patterns and differences between sleep and wakefulness. Results. There were significant differences before and after treatment showing higher activity levels in patients with ADHD before treatment, and a decrease in this situation after taking pharmacological treatment. There are also differences between inattentive and combined subtype, showing the last group, higher activity levels. Conclusions. The level of activation presented by ADHD subjects is higher before taking stimulant treatment, influencing circadian patterns, sleep and quality of life. Pharmacological treatments help to decrease the level of activation., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Factors associated with serum ferritin levels and iron excess: results from the EPIC‑EurGast study

  • Iglesias Vázquez, Lucía
  • Arija, Victoria
  • Aranda, Núria
  • Aglago, Elom K
  • Cross, Amanda J.
  • Schulze, Matthias B.
  • Quintana Pacheco, Daniel
  • Kühn, Tilman
  • Weiderpass, Elisabete
  • Tumino, Rosario
  • Redondo‑Sánchez, Daniel
  • Santucci de Magistris, Maria
  • Palli, Domenico
  • Ardanaz, Eva
  • Laouali, Nasser
  • Sonestedt, Emily
  • Drake, Isabel
  • Rizzolo-Brime, Lucía
  • Santiuste, Carmen
  • Sacerdote, Carlotta
  • Quirós, José Ramón
  • Amiano, Pilar
  • Agudo, Antonio
  • Jakszyn, Paula
Purpose Excess iron is involved in the development of non-communicable diseases such as cancer, type 2 diabetes and cardiovascular conditions. We aimed to describe the prevalence of excess iron and its determinants in healthy European adults. Methods Sociodemographic, lifestyle, iron status, dietary information, and HFE genotyping were obtained from controls from the nested case–control study EPIC-EurGast study. High sensitivity C-reactive protein (hsCRP) was measured to address possible systemic infammation. Descriptive and multivariate analyses were used to assess iron status and its determinants. Results Out of the 828 participants (median age: 58.7 years), 43% were females. Median serum ferritin and prevalence of excess iron were 143.7 µg/L and 35.2% in males, respectively, and 77 µg/L and 20% in females, both increasing with latitude across Europe. Prevalence of HFE C282Y mutation was signifcantly higher in Northern and Central Europe (~ 11%) than in the South (5%). Overweight/obesity, age, and daily alcohol and heme iron intake were independent determinants for iron status, with sex diferences even after excluding participants with hsCRP>5 mg/L. Obese males showed a greater consumption of alcohol, total and red meat, and heme iron, compared with those normal weight. Conclusion Obesity, higher alcohol and heme iron consumption were the main risk factors for excess iron in males while only age was associated with iron overload in females. Weight control and promoting healthy lifestyle may help prevent iron overload, especially in obese people. Further research is needed to clarify determinants of excess iron in the healthy adult population, helping to reduce the associated comorbidities., info:eu-repo/semantics/acceptedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Increased consumption of virgin olive oil, nuts, legumes, whole grains, and fish promotes HDL functions in humans

  • Hernáez, Álvaro
  • Sanllorente Melenchon, Albert
  • Castañer, Olga
  • Martínez-González, Miguel Ángel, 1957-
  • Ros Rahola, Emilio
  • Pintó Sala, Xavier
  • Estruch Riba, Ramon
  • Salas Salvadó, Jordi
  • Corella Piquer, Dolores
  • Alonso Gómez, Ángel M.
  • Serra Majem, Lluís
  • Fiol, Miquel
  • Lapetra, José
  • Gómez-Gracia, Enrique
  • de la Torre, Rafael
  • Lamuela Raventós, Rosa Ma.
  • Fitó Colomer, Montserrat
Scope To evaluate whether increases in the consumption of cardioprotective food groups (virgin olive oil, nuts, fruits/vegetables, legumes, whole grains, fish, and wine) are associated with improvements in high-density lipoprotein (HDL) functions in high cardiovascular risk subjects. Methods and Results The association between 1-year changes in food group consumption and HDL functionality traits in 296 high cardiovascular risk subjects is assessed. Increases in virgin olive oil (10 g d–1) and whole grain consumption (25 g d–1) are associated with increments in cholesterol efflux capacity (+0.7%, P = 0.026, and +0.6%, P = 0.017, respectively). Increases in nut (30 g d–1) and legume intake (25 g d–1) are linked to increments in paraoxonase-1 activity (+12.2%, P = 0.049, and +11.7%, P = 0.043, respectively). Legume intake increases are also related to decreases in cholesteryl ester transfer protein activity (–4.8%, P = 0.028). Fish consumption increments (25 g d–1) are associated with increases in paraoxonase-1 activity (+3.9%, P = 0.030) and declines in cholesteryl ester transfer protein activity (–1.6%, P = 0.021), HDL cholesterol concentrations (–1.1%, P = 0.039), and functions related to HDL levels (cholesterol efflux capacity, –1.1%, P = 0.010). Conclusion Increases in the consumption of virgin olive oil, nuts, legumes, whole grains, and fish (achievable through a regular diet) were associated with improvements in HDL functions in high cardiovascular risk subjects., info:eu-repo/semantics/acceptedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Validation of walking trails for the urban training of chronic obstructive pulmonary disease patients

  • Arbillaga-Etxarri, Ane
  • Torrent-Pallicer, Jaume
  • Gimeno-Santos, Elena
  • Barberan-Garcia, Anael
  • Delgado, Anna
  • Balcells Vilarnau, Eva
  • Rodríguez, Diego A.
  • Vilaro, Jordi
  • Vall-Casas, Pere
  • Irurtia, Alfredo
  • Rodríguez-Roisin, Robert
  • Garcia Aymerich, Judith
Purpose Accessible interventions to train patients with chronic obstructive pulmonary disease (COPD) are needed. We designed urban trails of different intensities (low, moderate and high) in different types of public spaces (boulevard, beach and park). We aimed to validate the trails’ design by assessing the physiological response to unsupervised walking trails of: (1) different intensities in COPD patients, and (2) same intensity from different public spaces in healthy adults. Methods On different days and under standardized conditions, 10 COPD patients walked the three intensity trails designed in a boulevard space, and 10 healthy subjects walked the three intensity trails in three different spaces. We measured physiological response and energy expenditure using a gas analyzer. We compared outcomes across trails intensity and/or spaces using mixed-effects linear regression. Results In COPD patients, physiological response and energy expenditure increased significantly according to the trails intensity: mean (SD) peak O2 15.9 (3.5), 17.4 (4.7), and 17.7 (4.4) mL/min/kg (p-trend = 0.02), and MET-min 60 (23), 64 (26), 72 (31) (p-trend<0.01) in low, moderate and high intensity trails, respectively. In healthy subjects there were no differences in physiological response to walking trails of the same intensity across different spaces. Conclusions We validated the trails design for the training of COPD patients by showing that the physiological response to and energy expenditure on unsupervised walking these trails increased according to the predefined trails’ intensity and did not change across trails of the same intensity in different public space. Walkable public spaces allow the design of trails that could be used for the training of COPD patients in the community., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD), Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD)

  • Arbillaga-Etxarri, Ane
  • Gimeno-Santos, Elena
  • Barberan-Garcia, Anael
  • Benet Mora, Marta
  • Borrell, Eulàlia
  • Dadvand, Payam
  • Foraster, Maria
  • Marin, Alicia
  • Monteagudo, Mònica
  • Rodríguez-Roisin, Robert
  • Vall-Casas, Pere
  • Vilaro, Jordi
  • Garcia Aymerich, Judith
Background: Study of the causes of the reduced levels of physical activity in patients with COPD has been scarce and limited to biological factors. Aim: To assess the relationship between novel socio-environmental factors, namely dog walking, grandparenting, neighbourhood deprivation, residential surrounding greenness and residential proximity to green or blue spaces, and amount and intensity of physical activity in COPD patients. Methods: This cross-sectional study recruited 410 COPD patients from five Catalan municipalities. Dog walking and grandparenting were assessed by questionnaire. Neighbourhood deprivation was assessed using the census Urban Vulnerability Index, residential surrounding greenness by the satellite-derived Normalized Difference Vegetation Index, and residential proximity to green or blue spaces as living within 300 m of such a space. Physical activity was measured during 1 week by accelerometer to assess time spent on moderate-to-vigorous physical activity (MVPA) and vector magnitude units (VMU) per minute. Findings: Patients were 85% male, had a mean (SD) age of 69 (9) years, and post-bronchodilator FEV1 of 56 (17) %pred. After adjusting for age, sex, socio-economic status, dyspnoea, exercise capacity and anxiety in a linear regression model, both dog walking and grandparenting were significantly associated with an increase both in time in MVPA (18 min/day (p<0.01) and 9 min/day (p<0.05), respectively) and in physical activity intensity (76 VMU/min (p=0.05) and 59 VMUs/min (p<0.05), respectively). Neighbourhood deprivation, surrounding greenness and proximity to green or blue spaces were not associated with physical activity. Conclusions: Dog walking and grandparenting are associated with a higher amount and intensity of physical activity in COPD patients., info:eu-repo/semantics/publishedVersion
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Plasma long-chain free fatty acids predict mammalian longevity

  • Naudí i Farré, Alba
  • Jové Font, Mariona
  • Aledo, Juan Carlos
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Cabré Cucó, Rosanna
  • Portero Otín, Manuel
  • Barja, Gustavo
  • Pamplona Gras, Reinald
determination of their longevity. In the present work, the use of high-throughput technologies allowed us to determine the plasma lipidomic profile of 11 mammalian species ranging in maximum longevity from 3.5 to 120 years. The non-targeted approach revealed a specie-specific lipidomic profile that accurately predicts the animal longevity. The regression analysis between lipid species and longevity demonstrated that the longer the longevity of a species, the lower is its plasma long-chain free fatty acid (LC-FFA) concentrations, peroxidizability index, and lipid peroxidation-derived products content. The inverse association between longevity and LC-FFA persisted after correction for body mass and phylogenetic interdependence. These results indicate that the lipidomic signature is an optimized feature associated with animal longevity, emerging LC-FFA as a potential biomarker of longevity, We acknowledge funding from the Spanish Ministry of Science and Innovation (CGL2010-18124) to J.C.A.; from the Spanish Ministry of Health (PI11-01532) to M.P.O.; and from the Spanish Ministry of Science and Innovation (BFU2009-11879/BFI), the Generalitat of Catalonia (2009SGR735), and the La MaratoTV3 Foundation to R.P. R.C. was supported by a Generalitat of Catalonia Predoctoral Fellowship. We thank David Argiles for excellent technical assistance. We thank Dr. Montserrat Rué for her support in statistical analyses.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

  • Alonso-Alconada, Lorena
  • Muinelo-Romay, Laura
  • Madissoo, Kadri
  • Díaz-López, Antonio
  • Krakstad, Camilla
  • Trovik, Jone
  • Wik, Elisabeth
  • Hapangama, Dharani
  • Coenegrachts, Lieve
  • Cano, Amparo
  • Gil-Moreno, Antonio
  • Chiva, Luís
  • Cueva, Juan
  • Vieito, María
  • Ortega Izquierdo, Maria Eugenia
  • Mariscal, Javier
  • Colás, Eva
  • Castellví, Josep
  • Cusido, Maite
  • Dolcet Roca, Xavier
  • Nijman, Hans W.
  • Bosse, Tjalling
  • Green, John A.
  • Romano, Andrea
  • Reventós, Jaume
  • López-López, Rafael
  • Salvesen, Helga B.
  • Amant, Frederic
  • Matias-Guiu, Xavier
  • Moreno Bueno, Gema
  • Abal, Miguel
Background: About 20% of patients diagnosed with endometrial cancer (EC) are considered high-risk with unfavorable prognosis. In the framework of the European Network for Individualized Treatment in EC (ENITEC), we investigated the presence and phenotypic features of Circulating Tumor Cells (CTC) in high-risk EC patients. Methods: CTC isolation was carried out in peripheral blood samples from 34 patients, ranging from Grade 3 Stage IB to Stage IV carcinomas and recurrences, and 27 healthy controls using two methodologies. Samples were subjected to EpCAM-based immunoisolation using the CELLection™ Epithelial Enrich kit (Invitrogen, Dynal) followed by RTqPCR analysis. The phenotypic determinants of endometrial CTC in terms of pathogenesis, hormone receptor pathways, stem cell markers and epithelial to mesenchymal transition (EMT) drivers were asked. Kruskal-Wallis analysis followed by Dunn’s post-test was used for comparisons between groups. Statistical significance was set at p < 0.05. Results: EpCAM-based immunoisolation positively detected CTC in high-risk endometrial cancer patients. CTC characterization indicated a remarkable plasticity phenotype defined by the expression of the EMT markers ETV5, NOTCH1, SNAI1, TGFB1, ZEB1 and ZEB2. In addition, the expression of ALDH and CD44 pointed to an association with stemness, while the expression of CTNNB1, STS, GDF15, RELA, RUNX1, BRAF and PIK3CA suggested potential therapeutic targets. We further recapitulated the EMT phenotype found in endometrial CTC through the up-regulation of ETV5 in an EC cell line, and validated in an animal model of systemic dissemination the propensity of these CTC in the accomplishment of metastasis. Conclusions: Our results associate the presence of CTC with high-risk EC. Gene-expression profiling characterized a CTC-plasticity phenotype with stemness and EMT features. We finally recapitulated this CTC-phenotype by over-expressing ETV5 in the EC cell line Hec1A and demonstrated an advantage in the promotion of metastasis in an in vivo mouse model of CTC dissemination and homing., ISCIII PI11/00873; Fundación Asociación Española Contra el Cancer (AECC), Grupos Estables 2011; InveNNta (Innovation in Nanomedicine), co-financed by the European Union (EU) through the Operational Programme for Cross-border Cooperation, Spain-Portugal (POCTEP 2007-2013), European Regional Development Fund (ERDF); Helse Vest, Research Council of Norway, Norwegian Cancer Society and Harald Andersens legat (H.B.S.); L. Alonso-Alconada is recipient of fellowship from the Basque Government (Spain).
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Lifelong treatment with atenolol decreases membrane fatty acid unsaturation and oxidative stress in heart and skeletal muscle mitochondria and improves immunity and behaviour, without changing mice longevity.

  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Naudí i Farré, Alba
  • Fuente, Monica de la
  • Barja, Gustavo
  • López Torres, Mónica
  • Mate, Ianire
  • Cruces, Julia
  • Gómez, José
  • Sánchez-Roman, Ines
  • Gómez Rodríguez, Alexia
The membrane fatty acid unsaturation hypothesis of aging and longevity is experimentally tested for the first time in mammals. Lifelong treatment of mice with the b1-blocker atenolol increased the amount of the extracellular-signal-regulated kinase signaling protein and successfully decreased one of the two traits appropriately correlating with animal longevity, the membrane fatty acid unsaturation degree of cardiac and skeletal muscle mitochondria, changing their lipid profile toward that present in much more longer-lived mammals. This was mainly due to decreases in 22:6n-3 and increases in 18:1n-9 fatty acids. The atenolol treatment also lowered visceral adiposity (by 24%), decreased mitochondrial protein oxidative, glycoxidative, and lipoxidative damage in both organs, and lowered oxidative damage in heart mitochondrial DNA. Atenolol also improved various immune (chemotaxis and natural killer activities) and behavioral functions (equilibrium, motor coordination, and muscular vigor). It also totally or partially prevented the aging-related detrimental changes observed in mitochondrial membrane unsaturation, protein oxidative modifications, and immune and behavioral functions, without changing longevity. The controls reached 3.93 years of age, a substantially higher maximum longevity than the best previously described for this strain (3.0 years). Side effects of the drug could have masked a likely lowering of the endogenous aging rate induced by the decrease in membrane fatty acid unsaturation. Weconclude that it is atenolol that failed to increase longevity, and likely not the decrease in membrane unsaturation induced by the drug., This investigation was supported by I + D grants from the Spanish Ministry of Science and Innovation (BFU2011-23888 to G.Barja); UCMGroups of Research (910379ENEROINN), BFU2011-30336, and RETICEF (RD 12/0043/0018) from ISCIII-FEDER of the European Union to M. De la Fuente; Spanish Ministry of Health (PI11/01532) to M.Portero Otin; and Spanish Ministry of Science and Innovation (BFU2009-11879) and the Generalitat of Catalonia (2009SGR735) to R. Pamplona.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Survival motor neuron protein reduction deregulates autophagy in spinal cord motoneurons in vitro

  • Garcera, Ana
  • Bahi i Pla, Núria
  • Periyakaruppiah, Ambika
  • Arumugam, Saravanan
  • Soler i Tatché, Rosa Ma.
Spinal muscular atrophy (SMA) is a genetic disorder characterized by degeneration of spinal cord motoneurons (MNs), resulting in muscular atrophy and weakness. SMA is caused by mutations in the Survival Motor Neuron 1 (SMN1) gene and decreased SMN protein. SMN is ubiquitously expressed and has a general role in the assembly of small nuclear ribonucleoproteins and pre-mRNA splicing requirements. SMN reduction causes neurite degeneration and cell death without classical apoptotic features, but the direct events leading to SMN degeneration in SMA are still unknown. Autophagy is a conserved lysosomal protein degradation pathway whose precise roles in neurodegenerative diseases remain largely unknown. In particular, it is unclear whether autophagosome accumulation is protective or destructive, but the accumulation of autophagosomes in the neuritic beadings observed in several neurite degeneration models suggests a close relationship between the autophagic process and neurite collapse. In the present work, we describe an increase in the levels of the autophagy markers including autophagosomes, Beclin1 and light chain (LC)3-II proteins in cultured mouse spinal cord MNs from two SMA cellular models, suggesting an upregulation of the autophagy process in Smn (murine survival motor neuron protein)-reduced MNs. Overexpression of Bcl-xL counteracts LC3-II increase, contributing to the hypothesis that the protective role of Bcl-xL observed in some SMA models may be mediated by its role in autophagy inhibition. Our in vitro experimental data indicate an upregulation in the autophagy process and autophagosome accumulation in the pathogenesis of SMA, thus providing a valuable clue in understanding the mechanisms of axonal degeneration and a possible therapeutic target in the treatment of SMA., This work was supported by grants from GENAME (Defining targets for Therapeutics in SMA) to RMS; from Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias (PI11-01047), Generalitat de Catalunya (SGR740) and Consolider-Ingenio 2010 (CSD2007-00020) to RMS. AG holds a post-doctoral contract from Genoma Espan˜a; SA holds a fellowship from Universitat de Lleida and AP holds a fellowship from Comissionat de Universitats i Recerca, Departament d’Innovacio´, Universitats i Empresa de la Generalitat de Catalunya and Fons Social Europeu.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Metabolomics predicts stroke recurrence after transient ischemic attack

  • Jové Font, Mariona
  • Mauri-Capdevila, Gerard
  • Suárez-Luis, Idalmis
  • Cambray Carner, Serafí
  • Sanahuja Montesinos, Jordi
  • Quilez Martínez, Alejandro
  • Farré, Joan
  • Benabdelhak Abbou, Ikram
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Purroy Garcia, Francisco
Objective: To discover, by using metabolomics, novel candidate biomarkers for stroke recurrence (SR) with a higher prediction power than present ones. Methods: Metabolomic analysis was performed by liquid chromatography coupled to mass spectrometry in plasma samples from an initial cohort of 131 TIA patients recruited ,24 hours after the onset of symptoms. Pattern analysis and metabolomic profiling, performed by multivariate statistics, disclosed specific SR and large-artery atherosclerosis (LAA) biomarkers. The use of these methods in an independent cohort (162 subjects) confirmed the results obtained in the first cohort. Results: Metabolomics analyses could predict SR using pattern recognition methods. Low concentrations of a specific lysophosphatidylcholine (LysoPC[16:0]) were significantly associated with SR. Moreover, LysoPC(20:4) also arose as a potential SR biomarker, increasing the prediction power of age, blood pressure, clinical features, duration of symptoms, and diabetes scale (ABCD2) and LAA. Individuals who present early (,3 months) recurrence have a specific metabolomic pattern, differing from non-SR and late SR subjects. Finally, a potential LAA biomarker, LysoPC(22:6), was also described. Conclusions: The use of metabolomics in SR biomarker research improves the predictive power of conventional predictors such as ABCD2 and LAA. Moreover, pattern recognition methods allow us to discriminate not only SR patients but also early and late SR cases., Supported by the Autonomous Government of Catalunya (2009SGR- 735), the Spanish Ministry of Health (FIS 11-02033), and the Marató of TV3 Foundation (95/C/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Samples were obtained with the support of IRBLleida biobank and RETICS BIOBANCOS (RD09/0076/00059)
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Notch signaling pathway is activated in motoneurons of spinal muscular atrophy

  • Cardona-Rossinyol, Andrea
  • Garcera, Ana
  • Torres-Benito, Laura
  • Soler i Tatché, Rosa Ma.
  • Tabares, Lucía
  • Lladó, Jerònia
  • Olmos, Gabriel
  • Caraballo-Miralles, Víctor
Spinal muscular atrophy (SMA) is a neurodegenerative disease produced by low levels of Survival Motor Neuron (SMN) protein that affects alpha motoneurons in the spinal cord. Notch signaling is a cell-cell communication system well known as a master regulator of neural development, but also with important roles in the adult central nervous system. Aberrant Notch function is associated with several developmental neurological disorders; however, the potential implication of the Notch pathway in SMA pathogenesis has not been studied yet. We report here that SMN deficiency, induced in the astroglioma cell line U87MG after lentiviral transduction with a shSMN construct, was associated with an increase in the expression of the main components of Notch signaling pathway, namely its ligands, Jagged1 and Delta1, the Notch receptor and its active intracellular form (NICD). In the SMNΔ7 mouse model of SMA we also found increased astrocyte processes positive for Jagged1 and Delta1 in intimate contact with lumbar spinal cord motoneurons. In these motoneurons an increased Notch signaling was found, as denoted by increased NICD levels and reduced expression of the proneural gene neurogenin 3, whose transcription is negatively regulated by Notch. Together, these findings may be relevant to understand some pathologic attributes of SMA motoneurons., This work was supported by grants from Fundación Genoma España, GENAME to JL, LT and RMS, and from Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (PI11/01047) to RMS. AG holds a postdoctoral contract from Genoma España. VC-M and AC-R have been supported by a predoctoral fellowship from “Govern de les Illes Balears, Conselleria d’Educació, Cultura i Universitats” under a program of joint financing with the European Social Fund.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Biochemical profiling of rat embryonic stem cells grown on electrospun polyester fibers using synchrotron infrared microspectroscopy

  • Doncel-Pérez, Ernesto
  • Ellis, Gary James
  • Sandt, Christophe
  • Shuttleworth, Peter S.
  • Bastida, Agatha
  • Revuelta, Julia
  • García-Junceda, Eduardo
  • Fernández-Mayoralas, Alfonso
  • Garrido, Leoncio
Therapeutic options for spinal cord injuries are severely limited; current treatments only offer symptomatic relief and rehabilitation focused on educating the individual on how to adapt to their new situation to make best possible use of their remaining function. Thus, new approaches are needed, and interest in the development of effective strategies to promote the repair of neural tracts in the central nervous system inspired us to prepare functional and highly anisotropic polymer scaffolds. In this work, an initial assessment of the behavior of rat neural progenitor cells (NPCs) seeded on poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) fiber scaffolds using synchrotron-based infrared microspectroscopy (SIRMS) is described. Combined with a modified touch imprint cytology sample preparation method, this application of SIRMS enabled the biochemical profiles of NPCs on the coated polymer fibers to be determined. The results showed that changes in the lipid and amide I–II spectral regions are modulated by the type and coating of the substrate used and the culture time. SIRMS studies can provide valuable insight into the early-stage response of NPCs to the morphology and surface chemistry of a biomaterial, and could therefore be a useful tool in the preparation and optimization of cellular scaffolds., Financial support was provided by theMinisterio de Economía y Competitividad (MINECO), projects FIS/ISCIII PI11/01436 and PI11/00592, MAT2015-65184-C2-2-R, and the CSIC. The research leading to these results was funded by the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 312284 (CALIPSO). Synchrotron measurements were performed at the SMIS beamline of Synchrotron SOLEIL. PS is grateful to MINECO for Ramón y Cajal postdoctoral fellowships (RYC-2014-16759). We would like to thank all the beamline staff for their helpful support and advice., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Transcriptional profiling of immune-related genes in Leishmania infantum-infected mice: Identification of potential biomarkers of infection and progression of disease

  • Ontoria, E
  • Hernández-Santana, Y.E.
  • González-García, Ana C.
  • López López, Manuel Carlos
  • Valladares, Basilio
  • Carmelo, Emma
Leishmania spp. is a protozoan parasite that affects millions of people around the world. At present, there is no effective vaccine to prevent leishmaniases in humans. A major limitation in vaccine development is the lack of precise understanding of the particular immunological mechanisms that allow parasite survival in the host. The parasite-host cell interaction induces dramatic changes in transcriptome patterns in both organisms, therefore, a detailed analysis of gene expression in infected tissues will contribute to the evaluation of drug and vaccine candidates, the identification of potential biomarkers, and the understanding of the immunological pathways that lead to protection or progression of disease. In this large-scale analysis, differential expression of 112 immune-related genes has been analyzed using high-throughput qPCR in spleens of infected and naïve Balb/c mice at four different time points. This analysis revealed that early response against Leishmania infection is characterized by the upregulation of Th1 markers and M1-macrophage activation molecules such as Ifng, Stat1, Cxcl9, Cxcl10, Ccr5, Cxcr3, Xcl1, and Ccl3. This activation doesn't protect spleen from infection, since parasitic burden rises along time. This marked difference in gene expression between infected and control mice disappears during intermediate stages of infection, probably related to the strong anti-inflammatory and immunosuppresory signals that are activated early upon infection (Ctla4) or remain activated throughout the experiment (Il18bp). The overexpression of these Th1/M1 markers is restored later in the chronic phase (8 wpi), suggesting the generation of a classical "protective response" against leishmaniasis. Nonetheless, the parasitic burden rockets at this timepoint. This apparent contradiction can be explained by the generation of a regulatory immune response characterized by overexpression of Ifng, Tnfa, Il10, and downregulation Il4 that counteracts the Th1/M1 response. This large pool of data was also used to identify potential biomarkers of infection and parasitic burden in spleen, on the bases of two different regression models. Given the results, gene expression signature analysis appears as a useful tool to identify mechanisms involved in disease outcome and to establish a rational approach for the identification of potential biomarkers useful for monitoring disease progression, new therapies or vaccine development., This study was funded by Fundación CajaCanarias (EC) (Ref. 2015 BIO14); Fondo de Investigaciones Sanitarias (FIS)- Instituto de Salud Carlos III, Ministerio de Economía y Competitividad (BV) (N° PI11/02172); Red de Investigación de Centros de Enfermedades Tropicales (RICET)-Ministerio de Economía y Competitividad- Instituto de Salud Carlos III (RD16/0027/0005 (ML) and RD16/0027/0001 (EC, BV); Plan Nacional de I+D+I, Ministerio de Economía y Competitividad (ML) SAF2016-81003-R. YH-S was supported by Beca de Investigación Obra Social La Caixa- Fundación CajaCanarias para postgraduados de la Universidad de La Laguna
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia

  • Brea, David
  • Agulla, Jesús
  • Rodríguez-Yáñez, Manuel
  • Barral, David
  • Ramos-Cabrer, Pedro
  • Campos, Francisco
  • Almeida, Ángeles
  • Dávalos, Antoni
  • Castillo, José
Brain ischaemia (stroke) triggers an intense inflammatory response predominately mediated by the accumulation of inflammatory cells and mediators in the ischaemic brain. In this context, regulatory T (Treg) cells, a subpopulation of CD4+ T cells with immunosuppressive and anti-inflammatory properties, are activated in the late stages of the disease. To date, the potential therapeutic usefulness of Treg cells has not been tested. In this study, we aimed to investigate whether Treg cells exert protection/repair following stroke. Both the adoptive transfer of Treg cells into ischaemic rats and the stimulation of endogenous T-cell proliferation using a CD28 superagonist reduced the infarct size at 3–28 days following the ischaemic insult. Moreover, T cell-treated animals had higher levels of FoxP3 and lower levels of IL-1β, CD11b+ and CD68+ cells in the infarcted hemisphere when compared with control animals. However, T-cell treatment did not alter the rate of proliferation of NeuN-, NCAM- or CD31-positive cells, thereby ruling out neurogenesis and angiogenesis in protection. These results suggest that adoptive transfer of T cells is a promising therapeutic strategy against the neurological consequences of stroke., Financial support from the Instituto de Salud Carlos III (projects PI11/02636 and RETICS-INVICTUS R012/0014) of the Spanish Ministry of Economy and Competitiveness and the European Union (FEDER programme) is gratefully acknowledged. Research contracts from the Miguel Servet programme (PRC) and the Sara Borrell programme (JA and D Brea) of the Instituto de Salud Carlos III are also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In Vivo Theranostics at the Peri-Infarct Region in Cerebral Ischemia

  • Agulla, Jesús
  • Brea, David
  • Campos, Francisco
  • Sobrino, Tomás
  • Argibay, Bárbara
  • Al-Soufi, Wajih
  • Blanco, Miguel
  • Castillo, José
  • Ramos-Cabrer, Pedro
The use of theranostics in neurosciences has been rare to date because of the limitations imposed on the free delivery of substances to the brain by the blood-brain barrier. Here we report the development of a theranostic system for the treatment of stroke, a leading cause of death and disability in developed countries. We first performed a series of proteomic, immunoblotting and immunohistological studies to characterize the expression of molecular biomarkers for the so-called peri-infarct tissue, a key region of the brain for stroke treatment. We confirmed that the HSP72 protein is a suitable biomarker for the peri-infarct region, as it is selectively expressed by at-risk tissue for up to 7 days following cerebral ischemia. We also describe the development of anti-HSP72 vectorized stealth immunoliposomes containing imaging probes to make them traceable by conventional imaging techniques (fluorescence and MRI) that were used to encapsulate a therapeutic agent (citicoline) for the treatment of cerebral ischemia. We tested the molecular recognition capabilities of these nano-platforms in vitro together with their diagnostic and therapeutic properties in vivo, in an animal model of cerebral ischemia. Using MRI, we found that 80% of vectorized liposomes were located on the periphery of the ischemic lesion, and animals treated with citicoline encapsulated on these liposomes presented lesion volumes up to 30% smaller than animals treated with free (non-encapsulated) drugs. Our results show the potential of nanotechnology for the development of effective tools for the treatment of neurological diseases., Financial support from the Instituto de Salud Carlos III of the Spanish Ministry of Health (projects PI11/02161 and CP09/00074), the Spanish Ministry of Economy and Competence (projects SAF2008-02190, SAF2011-30517 and RETICS-INVICTUS R012/0014), and the European Union (FEDER program) is gratefully acknowledged. Research contracts from the Miguel Servet program (PRC and TS) and the Sara Borrell program (JA and DB) of the Instituto de Salud Carlos III are acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Microvesicles and inflammatory markers in an animal model of chronic postcapillary pulmonary hypertension

  • Mendoza-Zambrano, Elva María
  • Gómez-Rodríguez, Belén
  • García-Lunar, Inés
  • Pereda-Arnau, Daniel
  • Sánchez-López, Verónica
  • García-Álvarez, Ana
  • Otero Candelera, Remedios
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions., This work was supported by Carlos III Health Institute [PI11/02308]; Spanish Society of Pulmonology and Thoracic Surgery, SEPAR [124/2011]; Ministry of Economy, Innovation, Science and Employment of the Junta de Andalucía [CVI-6654/2010]; Ministry for Science and Innovation (MCIN) and Pro CNIC Foundation. The CNIC is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Anthropometry in antipsychotic-naïve first-episode psychosis patients: An exploratory approach to the role of environmental early life events in two independent samples

  • García-Rizo, Clemente
  • Crespo-Facorro, Benedicto
  • Oliveira, Cristina
  • Gómez Revuelta, Marcos
  • Kirkpatrick, Brian
  • Son, Jacqueline Mayoral-van
  • Cayón de la Hoz, Laura
  • Garriga, Marina
  • Garrido-Torres, Nathalia
  • Bernardo, Miguel
  • Fernández-Egea, Emilio
  • Vázquez-Bourgon, Javier
[Background] Patients with schizophrenia exhibit a reduced life expectancy mainly due to medical-related pathologies which might have been initiated due to stressful events during fetal development. Indeed, intra-uterus growth patterns predict anthropometric measures in adulthood, describing risk factors for schizophrenia and metabolic disorders. We aim to evaluate anthropometric values in two cohorts of antipsychotic-naïve first-episode episode psychosis (FEP) and correlated them with surrogate markers of the fetal environment such as birth weight (BW) and season of birth., [Methods] BW, season of birth, and anthropometric values from 2 cohorts of FEP patients (Barcelona and Santander) were evaluated. In cohort B, 91 patients, and 110 controls while in cohort S, 644 and 235 were included respectively., [Results] Patients were shorter, slimmer, and with lower BMI compared with controls. In both cohorts, patients, and female patients born in winter displayed the shortest height. Regarding BW, height was significantly associated with the interaction of diagnosis and BW in the whole sample and the male subsample., [Conclusions] Our results confirm reduced anthropometric features in FEP at onset while suggesting the influence of winter birth and BW, highlighting the role of early life events in the later outcome of FEP with sex differences., Funding for this study was provided by grant RO1 DK069265 - National Institute of Diabetes and Digestive and Kidney Diseases (Dr. Kirkpatrick), PI14/00753 and PI20/00661 (Dr. Garcia-Rizo) PI08/0208; PI11/00325 and PI14/00612 (Dr.Bernardo), funded by the Carlos III Health Institute (ISCIII) and co-financed by the European Union, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, ERCA Program / Generalitat de Catalunya And Secretaria d’Universitats i Recerca del Departament d’Economia I Coneixement (2017SGR1355). Departament de Salut de la Generalitat de Catalunya, en la convocatoria corresponent a l’any 2017 de concessió de subvencions del Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020, SLT006/17/00345. This work and the research tasks carried out in the Santander cohort (PAFIP) were supported by the Instituto de Salud Carlos III and co-financed by the European Union (PI020499, PI050427 and PI060507; Prof. Crespo-Facorro) and the Valdecilla Institute of Biomedical Research (grant no. INT/A20/04 and INT/A21/10; Dr. Vázquez-Bourgon). Dr. Fernandez-Egea is supported by the 2022 MRC/NIHR CARP award (MR/W029987/1) and this research was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study

  • Rodríguez, Victoria
  • Alameda, Luis
  • Quattrone, Diego
  • Tripoli, Giada
  • Gayer-Anderson, Charlotte
  • Spinazzola, Edoardo
  • Trotta, Giulia
  • Jongsma, Hannah E
  • Stilo, Simona
  • La Cascia, Caterina
  • Ferraro, Laura
  • La Barbera, Daniele
  • Lasalvia, Antonio
  • Tosato, Sarah
  • Tarricone, Ilaria
  • Bonora, Elena
  • Jamain, Stéphane
  • Selten, Jean-Paul
  • Velthorst, Eva
  • de Haan, Lieuwe
  • Llorca, Pierre-Michel
  • Arrojo, Manuel
  • Bobes, Julio
  • Bernardo, Miguel
  • Arango, Celso
  • Kirkbride, James
  • Jones, Peter B
  • Rutten, Bart P
  • Richards, Alexander
  • Sham, Pak C
  • O'Donovan, Michael
  • Van Os, Jim
  • Morgan, Craig
  • Di Forti, Marta
  • Murray, Robin M
  • Vassos, Evangelos
Schizophrenia (SZ), bipolar disorder (BD) and depression (D) run in families. This susceptibility is partly due to hundreds or thousands of common genetic variants, each conferring a fractional risk. The cumulative effects of the associated variants can be summarised as a polygenic risk score (PRS). Using data from the EUropean Network of national schizophrenia networks studying Gene-Environment Interactions (EU-GEI) first episode case-control study, we aimed to test whether PRSs for three major psychiatric disorders (SZ, BD, D) and for intelligent quotient (IQ) as a neurodevelopmental proxy, can discriminate affective psychosis (AP) from schizophrenia-spectrum disorder (SSD)., This work was supported by funding from the European Community's Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI). VR was funded by a PhD scholarship supported by Lord Leverhulme's Charitable Trust and the Velvet Foundation. EV is funded by the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. CA was supported by the Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024), co-financed by ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM. Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), Fundación Familia Alonso and Fundación Alicia Koplowitz. MB was supported by the Ministry od Economy and Competitivity (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III – ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM, by the CERCA Programme/Generalitat de Catalunya and Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2017SGR1355). Departament de Salut de la Generalitat de Catalunya, en la convocatoria corresponent a l'any 2017 de concessió de subvencions del PERIS 2016-2020, modalitat Projectes de recerca orientats a l'atenció primària, amb el codi d'expedient SLT006/17/00345; and grateful for the support of the Institut de Neurociències, Universitat de Barcelona., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours

  • Tanic, M.
  • Andrés-León, Eduardo
  • Rodríguez-Pinilla, S. M.
  • Márquez-Rodas, I.
  • Cebollero-Presmanes, M.
  • Fernández, V.
  • Osorio, A.
  • Benítez, Javier
  • Martínez-Delgado, B.
[Background] Hereditary breast cancer comprises 5–10% of all breast cancers. Mutations in two high-risk susceptibility genes, BRCA1 and BRCA2, along with rare intermediate-risk genes and common low-penetrance alleles identified, altogether explain no more than 45% of the high-risk breast cancer families, although the majority of cases are unaccounted for and are designated as BRCAX tumours. Micro RNAs have called great attention for classification of different cancer types and have been implicated in a range of important biological processes and are deregulated in cancer pathogenesis., [Methods] Here we have performed an exploratory hypothesis-generating study of miRNA expression profiles in a large series of 66 primary hereditary breast tumours by microarray analysis., [Results] Unsupervised clustering analysis of miRNA molecular profiles revealed distinct subgroups of BRCAX tumours, ‘normal-like’ BRCAX-A, ‘proliferative’ BRCAX-B, ‘BRCA1/2-like’ BRCAX-C and ‘undefined’ BRCAX-D subgroup. These findings introduce a new insight in the biology of hereditary breast cancer, defining specific BRCAX subgroups, which could help in the search for novel susceptibility pathways in hereditary breast cancer., [Conclusion] Our data demonstrate that BRCAX hereditary breast tumours can be sub-classified into four previously unknown homogenous groups characterised by specific miRNA expression signatures and histopathological features., We thank all members of the Human Genetics Group and the Immunohistochemistry Unit of the Spanish National Cancer Research Centre for all their support. This work was funded by grants from Spanish Ministry of Health PI11/01059, PI08/1120 and PI12/00070, from the Fundación Mutua Madrileña 2011 and from Fundación Sandra Ibarra 2011., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

miRNA expression profiling of formalin-fixed paraffin-embedded (FFPE) hereditary breast tumors

  • Tanic, M.
  • Yanowski, Kira
  • Andrés-León, Eduardo
  • Gómez-López, Gonzalo
  • Rodríguez-Pinilla, S. M.
  • Pisano, David G.
  • Martínez-Delgado, B.
  • Benítez, Javier
Hereditary breast cancer constitutes only 5-10% of all breast cancer cases and is characterized by strong family history of breast and/or other associated cancer types. Only ~ 25% of hereditary breast cancer cases carry a mutation in BRCA1 or BRCA2 gene, while mutations in other rare high and moderate-risk genes and common low penetrance variants may account for additional 20% of the cases. Thus the majority of cases are still unaccounted for and designated as BRCAX tumors. MicroRNAs are small non-coding RNAs that play important roles as regulators of gene expression and are deregulated in cancer. To characterize hereditary breast tumors based on their miRNA expression profiles we performed global microarray miRNA expression profiling on a retrospective cohort of 80 FFPE breast tissues, including 66 hereditary breast tumors (13 BRCA1, 10 BRCA2 and 43 BRCAX), 10 sporadic breast carcinomas and 4 normal breast tissues, using Exiqon miRCURY LNA™ microRNA Array v.11.0. Here we describe in detail the miRNA microarray expression data and tumor samples used for the study of BRCAX tumor heterogeneity (Tanic et al., 2013) and biomarkers associated with positive BRCA1/2 mutation status (Tanic et al., 2014). Additionally, we provide the R code for data preprocessing and quality control., This work was supported by the Asociación Española Contra el Cancer (AECC) and the Spanish Fondo de Investigaciones Sanitarias (grant numbers FIS-PI081298 and FIS-PI081120), by grants from INNPRONTA from the Ministry of Science and Innovation PI11/01059, from the Fundación Mutua Madrileña 2011 (PI BMD), and from the Fundación Sandra Ibarra 2011 (PI BMD). The CIBER de Enfermedades Raras is an initiative of the Instituto de Salud Carlos III (ISCIII). MT had financial support from the Fundación La Caixa call 2008., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression

  • Matamala, Nerea
  • Vargas, Maria Teresa
  • González-Cámpora, Ricardo
  • Arias, José Ignacio
  • Menéndez, Primitiva
  • Andrés-León, Eduardo
  • Yanowsky, Kira
  • Llaneza-Folgueras, Ana
  • Miñambres, Rebeca
  • Martínez-Delgado, B.
  • Benítez, Javier
Emerging evidence suggests that BRCA1 pathway contributes to the behavior of sporadic triple negative breast cancer (TNBC), but little is known about the mechanisms underlying this association. Considering the central role that microRNAs (miRNAs) play in gene expression regulation, the aim of this study was to identify miRNAs specifically deregulated in TNBC and investigate their involvement in BRCA1 regulation. Using locked nucleic acid (LNA)-based microarrays, expression levels of 1919 miRNAs were measured in paraffin-embedded tissues from 122 breast tumors and 11 healthy breast tissue samples. Differential miRNA expression was explored among the main subtypes of breast cancer, and 105 miRNAs were identified as specific for triple negative tumors. In silico prediction revealed that miR-498 and miR-187-5p target BRCA1, and these results were confirmed by luciferase reporter assay. While miR-187-5p was found overexpressed in a luminal B cell line, miR-498 was highly expressed in a triple negative cell line, Hs578T, and its expression was negatively correlated with the levels of BRCA1. We functionally demonstrated that miR-498 inhibits BRCA1 in breast cancer cell lines, and showed that inhibition of miR-498 led to reduced proliferation in the triple negative cell line Hs578T. Our results indicate that miR-498 regulates BRCA1 expression in breast cancer and its overexpression could contribute to the pathogenesis of sporadic TNBC via BRCA1 downregulation., We thank all members of the Human Cancer Genetics Programme of the Spanish National Cancer Research Centre for all their support. We want to particularly acknowledge the patients, the INCLIVA BioBank (PT13/0010/0004) integrated in the Spanish National Biobanks Network, and Pablo Isidro Marrón, coordinator of Biobanco del Principado de Asturias, for their collaboration. This work has been funded by grants from the Spanish Ministry of Economy and Competitiveness (INNPRONTA LIFE project) and FIS PI11/01059 (BM-D)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Bone microenvironment signals in osteosarcoma development

  • Alfranca, Arantzazu
  • Martínez-Cruzado, Lucía
  • Tornin, Juan
  • Abarrategi, Ander
  • Amaral, Ana Teresa
  • Álava, Enrique de
  • Menéndez, Pablo
  • García-Castro, Javier
  • Rodríguez, René
The bone is a complex connective tissue composed of many different cell types such as osteoblasts, osteoclasts, chondrocytes, mesenchymal stem/progenitor cells, hematopoietic cells and endothelial cells, among others. The interaction between them is finely balanced through the processes of bone formation and bone remodeling, which regulates the production and biological activity of many soluble factors and extracellular matrix components needed to maintain the bone homeostasis in terms of cell proliferation, differentiation and apoptosis. Osteosarcoma (OS) emerges in this complex environment as a result of poorly defined oncogenic events arising in osteogenic lineage precursors. Increasing evidence supports that similar to normal development, the bone microenvironment (BME) underlies OS initiation and progression. Here, we recapitulate the physiological processes that regulate bone homeostasis and review the current knowledge about how OS cells and BME communicate and interact, describing how these interactions affect OS cell growth, metastasis, cancer stem cell fate and therapy outcome., This work was supported by the Plan Nacional de I+D+i 2008–2011 [ISCIII/FEDER (PI11/00377, Miguel Servet Program CP11/00024 & CP11/00206) and RTICC (RD12/0036/0015, RD12/0036/0027 & RD12/0036/0017)], the Plan Nacional de I+D+i 2013–2016 [MINECO/FEDER (SAF-2013-42946-R & SAF2013-43065)], Grupo Español de Investigación en Sarcomas (GEIS), Generalitat de Catalunya (Grupo SGR330), Health Canada and Obra Social La Caixa/Fundaciò Josep Carreras., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre study

  • Rodríguez-Martínez, José-Manuel
  • Machuca, Jesús
  • Calvo, Jorge
  • Díaz-de-Alba, Paula
  • Rodríguez-Mirones, Cristina
  • Gimeno, Concha
  • Martínez-Martínez, Luis
  • Pascual, Álvaro
[Objectives] The objective of this study was to evaluate the proficiency of Spanish laboratories with respect to accurate susceptibility testing and the detection and interpretation of quinolone resistance phenotypes in Enterobacteriaceae., [Methods] Thirteen strains of Enterobacteriaceae were sent to 62 participating centres throughout Spain; strains harboured GyrA/ParC modifications, reduced permeability and/or plasmid-mediated quinolone resistance genes. The centres were requested to evaluate nalidixic acid and five quinolones, provide raw/interpreted clinical categories and to detect/infer resistance mechanisms. Consensus results from reference centres were used to assign minor, major and very major errors (mEs, MEs and VMEs, respectively)., [Results] Susceptibility testing in the participating centres was frequently performed using the MicroScan WalkAway, Vitek 2 and Wider systems (48%, 30% and 8%, respectively). CLSI/EUCAST breakpoints were used in 71%/29% of the determinations. The percentage of VMEs for all quinolones was well below 2%. Only ofloxacin and moxifloxacin showed higher values for raw VMEs (6.6%), which decreased to 0% and 2.9%, respectively, in the interpreted VMEs. These errors were particularly associated with the CC-03 strain [qnrS2 + aac(6′)-Ib-cr]. For MEs, percentages were always <10%, except in the case of ofloxacin and nalidixic acid. There was a significantly higher percentage of all types of errors for strains whose MICs were at the border of clinical breakpoints., [Conclusion] The use of different breakpoints and methods, the complexity of mutation-driven and transferable resistance mechanisms and the absence of specific tests for detecting low-level resistance lead to high variability and represent a challenge to accuracy in susceptibility testing, particularly in strains with MICs on the border of clinical breakpoints., This work was supported by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (projects PI11-00934 and PI11/01117) and the Consejería de Innovación Ciencia y Empresa, Junta de Andalucía (P11-CTS-7730), Spain, by the Plan Nacional de I+D+i 2008-2011 and the Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)—co-financed by European Development Regional Fund ‘A way to achieve Europe’ ERDF., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Rescuing compound bioactivity in a secondary cell-based screening by using gamma-cyclodextrin as a molecular carrier

  • Claveria-Gimeno, R.
  • Vega, S.
  • Grazu, V.
  • de la Fuente, J.M.
  • Lanas, A.
  • Velazquez-Campoy, A.
  • Abian, O.
In vitro primary screening for identifying bioactive compounds (inhibitors, activators or pharmacological chaperones) against a protein target results in the discovery of lead com- pounds that must be tested in cell-based efficacy secondary screenings. Very often lead com- pounds do not succeed because of an apparent low potency in cell assays, despite an excellent performance in primary screening. Primary and secondary screenings differ significantly accord- ing to the conditions and challenges the compounds must overcome in order to interact with their intended target. Cellular internalization and intracellular metabolism are some of the difficulties the compounds must confront and different strategies can be envisaged for minimizing that prob- lem. Using a novel screening procedure we have identified 15 compounds inhibiting the hepatitis C NS3 protease in an allosteric fashion. After characterizing biophysically the interaction with the target, some of the compounds were not able to inhibit viral replication in cell assays. In order to overcome this obstacle and potentially improve cellular internalization three of these compounds were complexed with gamma-cyclodextrin. Two of them showed a five- and 16-fold activity increase, compared to their activity when delivered as free compounds in solution (while gamma-cyclodextrin did not show antiviral activity by itself ). The most remarkable result came from a third compound that showed no antiviral activity in cell assays when delivered free in solu- tion, but its gamma-cyclodextrin complex exhibited a 50% effective concentration of 5 micromoles. Thus, the antiviral activity of these compounds can be significantly improved, even completely rescued, using gamma-cyclodextrin as carrier molecule.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families

  • Calvete, O.
  • Martinez, P.
  • Garcia-Pavia, P.
  • Benitez-Buelga, C.
  • Paumard-Hernández, B.
  • Fernandez, V.
  • Dominguez, F.
  • Salas, C.
  • Romero-Laorden, N.
  • Garcia-Donas, J.
  • Carrillo, J.
  • Perona, R.
  • Trivinõ, J.C.
  • Andrés, R.
  • Cano, J.M.
  • Rivera, B.
  • Alonso-Pulpon, L.
  • Setien, F.
  • Esteller, M.
  • Rodriguez-Perales, S.
  • Bougeard, G.
  • Frebourg, T.
  • Urioste, M.
  • Blasco, M.A.
  • Benítez, J.
Cardiac angiosarcoma (CAS) is a rare malignant tumour whose genetic basis is unknown. Here we show, by whole-exome sequencing of a TP53-negative Li-Fraumeni-like (LFL) family including CAS cases, that a missense variant (p.R117C) in POT1 (protection of telomeres 1) gene is responsible for CAS. The same gene alteration is found in two other LFL families with CAS, supporting the causal effect of the identified mutation. We extend the analysis to TP53-negative LFL families with no CAS and find the same mutation in a breast AS family. The mutation is recently found once in 121, 324 studied alleles in ExAC server but it is not described in any other database or found in 1, 520 Spanish controls. In silico structural analysis suggests how the mutation disrupts POT1 structure. Functional and in vitro studies demonstrate that carriers of the mutation show reduced telomere-bound POT1 levels, abnormally long telomeres and increased telomere fragility.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Tiempo de estancia prolongado en los pacientes ingresados por insuficiencia cardiaca aguda

  • Martín-Sánchez, F.J.
  • Carbajosa, V.
  • Llorens, P.
  • Herrero, P.
  • Jacob, J.
  • Miró, Ò.
  • Fernández, C.
  • Bueno, H.
  • Calvo, E.
  • Ribera Casado, J.M.
  • Adrada, E.R.
  • Lage, M.C.
  • Muñoz, M.
  • Coloma, E.
  • Gil, V.
  • Escoda, R.
  • Pérez-Durá, M.J.
  • Salvo, E.
  • Pavón, J.
  • álvarez, A.B.
  • Noval, A.
  • Torres, J.M.
  • López-Grima, M.L.
  • Valero, A.
  • Juan-Gómez, M.A.
  • Aguirre, A.
  • Pedragosa, M.A.
  • Alonso, M.I.
  • Sancho, H.
  • Ruiz, F.
  • Giménez, A.
  • Franco, J.M.
  • Pardo, S.
  • Mecina, A.B.
  • Rocío, Merino Genicio
  • Tost, J.
  • Penco, B.F.
  • Sánchez, A.L.
  • Fabregat, J.
  • Epelde, F.
  • Sánchez, S.
  • Piñera, P.
  • Garate, R.T.
  • Alquezar, A.
  • Rizzi, M.A.
  • Cabello, I.
  • Richard, F.
  • Lucas, J.
  • álvarez, J.V.
  • Morilla, A.A.
  • Irimia, A.
  • e, Isis Ba
  • Fuentes, M.
  • Gil, C.
Objetivo: Identificar los factores asociados al tiempo de estancia hospitalaria prolongado en pacientes ingresados/as por insuficiencia cardiaca aguda. Método: Estudio observacional de cohorte multipropósito que incluyó pacientes del registro EAHFE (Epidemiology Acute Heart Failure in Emergency) ingresados/as por insuficiencia cardiaca aguda en 25 hospitales españoles. Se recogieron variables demográficas y clínicas, el día y el lugar del ingreso. La variable resultado principal fue el tiempo de estancia hospitalaria mayor que la mediana. Resultados: Se incluyeron 2400 pacientes con una edad media de 79, 5 (±9, 9) años, de los cuales 1334 (55, 6%) eran mujeres. Quinientos noventa (24, 6%) ingresaron en la unidad de corta estancia (UCE), 606 (25, 2%) en cardiología y 1204 (50, 2%) en medicina interna o geriatría. La mediana del tiempo de estancia hospitalaria fue de 7, 0 (intervalo intercuartílico: 4-11 días). Cincuenta y ocho (2, 4%) pacientes fallecieron y 562 (23, 9%) sufrieron un reingreso a los 30 días tras el alta. Los factores independientes asociados a un tiempo de estancia hospitalaria prolongado fueron la enfermedad pulmonar obstructiva crónica, ser portador de un dispositivo, tener un factor precipitante desconocido o no común, la presencia en urgencias de insuficiencia renal, hiponatremia y anemia, no ingresar en una UCE o no disponer de dicha unidad e ingresar un lunes, martes o miércoles; y los asociados a un tiempo de estancia hospitalaria =7 días fueron la hipertensión arterial y tener como factor precipitante una crisis hipertensiva o la falta de adherencia al tratamiento. El área bajo la curva del modelo mixto ajustado al centro fue de 0, 78 (intervalo de confianza del 95%: 0, 76-0, 80; p <0, 001).Conclusiones: Hay una serie de factores asociados con un tiempo de estancia hospitalaria prolongado que deben ser considerados para la gestión del proceso de la insuficiencia cardiaca aguda. Objective: To identify the factors associated with prolonged length of hospital stay in patients admitted for acute heart failure. Methods: Multipurpose observational cohort study including patients from the EAHFE registry admitted for acute heart failure in 25 Spanish hospitals. Data were collected on demographic and clinical variables and on the day and place of admission. The primary outcome was length of hospital stay longer than the median. Results: We included 2, 400 patients with a mean age of 79.5 (9.9) years; of these, 1, 334 (55.6%) were women. Five hundred and ninety (24.6%) were admitted to the short stay unit (SSU), 606 (25.2%) to cardiology, and 1, 204 (50.2%) to internal medicine or gerontology. The mean length of hospital stay was 7.0 (RIC 4-11) days. Fifty-eight (2.4%) patients died and 562 (23.9%) were readmitted within 30 days after discharge. The factors associated with prolonged length of hospital stay were chronic pulmonary disease; being a device carrier; having an unknown or uncommon triggering factor; the presence of renal insufficiency, hyponatremia and anaemia in the emergency department; not being admitted to an SSU or the lack of this facility in the hospital; and being admitted on Monday, Tuesday or Wednesday. The factors associated with length of hospital stay=7days were hypertension, having a hypertensive episode, or a lack of treatment adherence. The area under the curve of the mixed model adjusted to the center was 0.78 (95% CI: 0.76-0.80; p < 0.001). Conclusions: A series of factors is associated with prolonged length of hospital stay and should be taken into account in the management of acute heart failure.